Last update : June 2022

Note 1 : Lines appearing in pink colour indicate that the name or CAS number of the product has been modified by the WHO after the decision taken by the Committee.
Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
abacavir abacavir 2933.59 42.100 Ann. O (V) HSC/21 1998 76 136470-78-5
abafungin abafungine 2941.90 42.100 Ann. O (III) HSC/21 1998 74 129639-79-8
abagovomab abagovomab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 95 792921-10-9 HSC/39 (3002.10)
abaloparatide abaloparatide 2937.19 NC2004B1b Ann. O/5 HSC/53 2014 109 247062-33-5
abametapir abamétapir 2933.39 NC2116B1b Ann. R/4 HSC/55 2015 110 1762-34-1
abaperidone abapéridone 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 80 183849-43-6 HSC/23 (2934.90)
abarelix abarélix 2937.19 NC2116B1b Ann. R/7 HSC/55 2015 78 183552-38-7 HSC/22 (2933.39)
abatacept abatacept 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 91 332348-12-6 HSC/37 (3002.10)
abciximab abciximab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 70 143653-53-6 HSC/18 (3002.10)
abdavomeran abdavoméran 3002.41 NC2803Bc Ann. T/11 HSC/67 2021
124 COVID-192417899-75-1
abecomotide abécomotide 3002.41 NC2803Bc Ann. T/4 HSC/67 2021 109 907596-50-3 HSC/53 (3002.20)
abediterol abéditérol 2933.79 NC1760B1b Ann. N/7 HSC/49 2012 104 915133-65-2
abelacimab abélacimab 3002.13 NC2626B1b Ann. O/6 HSC/63 2019 119 2098724-83-3
abemaciclib abémaciclib 2933.59 NC2237B1b Ann. S/8 HSC/57 2016 112 1231929-97-7
abequolixron abéquolixron 2922.19 NC2930Bc Ann. P/25 HSC/69 2022 124 610318-54-2
abetimus abétimus 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 81 167362-48-3 HSC/25 (2934.90)
abexinostat abexinostat 2932.99 NC1760B1b Ann. N/8 HSC/49 2012 105 783355-60-2
abicipar pegol abicipar pégol 3907.29 NC2803Bc Ann. T/4 HSC/67 2021 108 1327278-94-3 HSC/53 (3907.20)
abiraterone abiratérone 2937.29 NC2116B1b Ann. R/7 HSC/55 2015 74 154229-19-3 HSC/21 (2933.39)
abitesartan abitésartan 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 73 137882-98-5 HSC/18 (2933.90)
abituzumab abituzumab 3002.13 NC2237B1b Ann. T/13 HSC/57 2016 109 1105038-73-0 HSC/53 (3002.10)
abivertinib abivertinib 2933.59 NC2626B1b Ann. O/6 HSC/63 2019 119 1557267-42-1
abrezekimab abrézékimab 3002.13 NC2626B1b Ann. O/5 HSC/63 2019 118 2043952-59-4
abrilumab abrilumab 3002.13 NC2237B1b Ann. T/13 HSC/57 2016 111 1342290-43-0 HSC/55 (3002.10)
abrineurin abrineurine 2937.19 NC0730B2 Ann. M/4 HSC/31 2003 84 178535-93-8
abrocitinib abrocitinib 2935.90 NC2803Bc Ann. T/2 HSC/67 2021 120 1622902-68-4
abrucomstat abrucomstat 2920.90 NC2930Bc Ann. P/25 HSC/69 2022 124 100502-66-7
acalabrutinib acalabrutinib 2933.39 NC2237B1b Ann. S/9 HSC/57 2016 113 1420477-60-6
acalisib acalisib 2933.59 NC2004B1b Ann. O/5 HSC/53 2014 109 870281-34-8

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
acapatamab acapatamab 3002.13 NC2803Bc Ann. T/7 HSC/67 2021 123 2314491-93-3
acarbose acarbose 2932.99 NC2004B1b Ann. O/6 HSC/53 2014 40 56180-94-0 HSC/11 (2932.90)
acasunlimab acasunlimab 3002.13 NC2930Bc Ann. P/25 HSC/69 2022 124 2253937-12-9
acavameran acavaméran 2934.99 NC2930Bc Ann. P/25 HSC/69 2022 124 2159155-74-3
acazicolcept acazicolcept 3002.13 NC2930Bc Ann. P/25 HSC/69 2022 124 2270247-50-0
acebilustat acébilustat 2934.99 NC2373B1b Ann. O/6 HSC/59 2017 114 943764-99-6
acemannan acémannan 3913.90 38.100 Ann. Q (No. 118) HSC/11 1993 64 110042-95-0
acetorphine acétorphine 2939.19 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 17 25333-77-1
acetylmethadol acétylméthadol 2922.19 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 5 509-74-0
aciclovir aciclovir 2933.59 38.100 Ann. Q (No. 119) HSC/11 1993 42 59277-89-3
acipimox acipimox 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 33 51037-30-0 HSC/11 (2933.90)
acitazanolast acitazanolast 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 72 114607-46-4 HSC/18 (2933.90)
acitretin acitrétine 2918.99 NC2373B1b Ann. O/12 HSC/59 2017 56 55079-83-9 HSC/11 (2918.90)
aclantate aclantate 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 27 39633-62-0 HSC/11 (2934.90)
aclerastide aclérastide 2933.29 NC2116B1b Ann. R/4 HSC/55 2015 110 227803-63-6
aclidinium bromide bromure d'aclidinium 2934.99 NC1178B1c Ann. O/5 HSC/39 2007 95 320345-99-1
aclimostat aclimostat 2934.99 NC2803Bc Ann. T/2 HSC/67 2021 120 2082752-83-6
acmucabtagene autoleucel acmucabtagène autoleucel 3002.51 NC2930Bc Ann. P/27 HSC/69 2022 125 no mention
acolbifene acolbifène 2934.99 NC0730B2 Ann. M/6 HSC/31 2003 86 182167-02-8
acorafloxacin acorafloxacine 2933.49 NC2004B1b Ann. O/5 HSC/53 2014 111 878592-87-1
acoramidis acoramidis 2933.19 NC2803Bc Ann. T/6 HSC/67 2021 122 1446711-81-4
acotiamide acotiamide 2934.10 NC0938B2b Ann. O/3 (II) HSC/35 2005 91 185106-16-5
acoziborole acoziborole 2934.99 NC2501B1b Ann. M/5 HSC/61 2018 116 1266084-51-8
acreozast acréozast 2926.90 42.100 Ann. O (VI) HSC/21 1998 77 123548-56-1
acrisorcin acrisorcine 2933.99 NC2116B1b Ann. R/6 HSC/55 2015 13 7527-91-5 HSC/11 (2933.90)
acrivastine acrivastine 2933.39 38.100 Ann. Q (No. 124) HSC/11 1993 51 87848-99-5
acrizanib acrizanib 2933.59 NC2501B1b Ann. M/5 HSC/61 2018 116 1229453-99-9
acrocinonide acrocinonide 2937.22 38.100 Ann. Q (No. 125) HSC/11 1993 27 28971-58-6
HSC/21 (2939.90)
acronine acronine 2939.79 NC2116B1b Ann. S/1 HSC/55 2015 22 7008-42-6
HSC/53 (2939.99)
actinium (225Ac) lintuzumab actinium (225Ac) lintuzumab
2844.42 NC2803Bc Ann. T/3 HSC/67 2021 121 2209911-94-2
satetraxetan satétraxétan
actoxumab actoxumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 107 1245634-25-6 HSC/51 (3002.10)
acumapimod acumapimod 2933.19 NC2116B1b Ann. R/5 HSC/55 2015 111 836683-15-9
adafosbuvir adafosbuvir 2934.99 NC2501B1b Ann. M/6 HSC/61 2018 117 1613589-09-5
adagrasib adagrasib 2933.59 NC2930Bc Ann. P/25 HSC/69 2022 124 2326521-71-3
adalimumab adalimumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 82 331731-18-1 HSC/27 (3002.10)
adalimumab beta adalimumab bêta 3002.13 NC2626B1b Ann. O/5 HSC/63 2019 118 1446410-95-2
adaprolol adaprolol 2922.19 40.260 Ann. L/2 (No. 38) HSC/17 1996 63 101479-70-3

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
adargileukin alfa adargileukine alfa 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 89 250710-65-7 HSC/47 (3002.10)
adarigiline adarigiline 2934.99 NC2501B1b Ann. M/6 HSC/61 2018 117 1124197-79-0
adarotene adarotène 2918.29 NC1500B1b Ann. K/6 HSC/44 2009 100 496868-77-0
adatanserin adatansérine 2933.59 40.600 Ann. D, par. 6 HSC/18 1996 70 127266-56-2
adavivint adavivint 2933.39 NC2501B1b Ann. M/6 HSC/61 2018 117 1467013-03-3
adavosertib adavosertib 2933.59 NC2501B1b Ann. M/6 HSC/61 2018 117 955365-80-7
adebrelimab adébrélimab 3002.13 NC2803Bc Ann. T/6 HSC/67 2021 122 2247114-85-6
adecatumumab adecatumumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 90 503605-66-1 HSC/35 (3002.10)
adefovir adéfovir 2933.59 40.600 Ann. D, par. 6 HSC/18 1996 72 106941-25-7
adegramotide adégramotide 3002.41 NC2803Bc Ann. T/4 HSC/67 2021 115 1252802-98-4 HSC/59 (3002.20)
adekalant adékalant 2933.39 NC0430B2 Ann. Q/1 (II) HSC/27 2001 83 227940-00-3
adelmidrol adelmidrol 2924.19 NC2004B1b Ann. O/6 HSC/53 2014 70 1675-66-7 HSC/18 (2924.10)
aderbasib aderbasib 2933.59 NC1443B1b Ann. P/6 HSC/43 2009 99 791828-58-5
adezmapimod adezmapimod 2933.39 NC2930Bc Ann. P/25 HSC/69 2022 124 152121-47-6
adibendan adibendan 2933.79 38.100 Ann. Q (No. 126) HSC/11 1993 57 100510-33-6
adimlecleucel adimlecleucel 3002.51 NC2803Bc Ann. T/4 HSC/67 2021 117 no mention HSC/61 (3002.90)
adintrevimab adintrévimab 3002.13 NC2930Bc Ann. P/27 HSC/69 2022 125 2516243-54-0
adipiplon adipiplon 2933.59 NC1443B1b Ann. P/5 HSC/43 2009 98 840486-93-3
adlinacogene civaparvovec adlinacogène civaparvovec 3002.49 NC2930Bc Ann. P/33 HSC/69 2022 120 2143579-02-4 HSC/67 (3002.90)
adomeglivant adoméglivant 2924.29 NC2373B1b Ann. O/7 HSC/59 2017 115 1488363-78-5
adomiparin sodium adomiparine sodique 3001.90 NC1760B1b Ann. N/7 HSC/49 2012 104 9041-08-1
adoprazine adoprazine 2934.99 NC1443B1b Ann. P/6 HSC/43 2009 99 222551-17-9
adrenomedullin pegol adrénomedulline pégol 2937.19 NC2803Bc Ann. T/7 HSC/67 2021 123 1432735-93-7
adriforant adriforant 2933.59 NC2626B1b Ann. O/6 HSC/63 2019 119 943057-12-3
adrogolide adrogolide 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 82 171752-56-0 HSC/27 (2934.90)
adrulipase alfa adrulipase alfa 3507.90 NC2930Bc Ann. P/27 HSC/69 2022 125 2488626-93-1
aducanumab aducanumab 3002.13 NC2237B1b Ann. T/13 HSC/57 2016 110 1384260-65-4 HSC/55 (3002.10)
afabicin afabicine 2934.99 NC2373B1b Ann. O/7 HSC/59 2017 115 1518800-35-5
afacifenacin afacifénacine 2933.59 NC1604B1b Ann. N/5 HSC/46 2010 101 877606-63-8
afamelanotide afamélanotide 2937.19 NC1553B1b Ann. O/7 HSC/45 2010 100 75921-69-6
afamitresgene autoleucel afamitresgène autoleucel 3002.51 NC2803Bc Ann. T/6 HSC/67 2021 122 no mention
HSC/57 (3002.10)
afasevikumab afasévikumab 3002.13 NC2237B1b Ann. T/11 HSC/57 2016 113 1589503-30-9
(S/9)
afatinib afatinib 2934.99 NC1604B1b Ann. N/6 HSC/46 2010 102 850140-72-6
afegostat afégostat 2933.39 NC1604B1b Ann. N/5 HSC/46 2010 101 169105-89-9
afeletecan afélétécan 2939.79 NC2237B1b Ann. T/12 HSC/57 2016 85 215604-75-4 HSC/29 (2939.99)
afelimomab afélimomab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 72 156227-98-4 HSC/18 (3002.10)
aficamten aficamtène 2934.99 NC2930Bc Ann. P/25 HSC/69 2022 124 2364554-48-1
afimetoran afimétoran 2933.39 NC2930Bc Ann. P/25 HSC/69 2022 124 2171019-55-7

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
afimoxifene afimoxifène 2922.19 NC1178B1c Ann. O/5 HSC/39 2007 95 68392-35-8
afizagabar afizagabar 2934.99 NC2803Bc Ann. T/2 HSC/67 2021 120 1398496-82-6
aflibercept aflibercept 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 95 862111-32-8 HSC/39 (3002.10)
afovirsen afovirsen 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 70 151356-08-0 HSC/18 (2934.90)
afoxolaner afoxolaner 2934.99 NC2004B1b Ann. O/4 HSC/53 2014 108 1093861-60-9
aftobetin aftobétine 2933.39 NC2004B1b Ann. O/5 HSC/53 2014 109 1208971-05-4
afuresertib afurésertib 2934.99 NC2004B1b Ann. O/4 HSC/53 2014 108 1047644-62-1
afutuzumab afutuzumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 99 949142-50-1 HSC/43 (3002.10)
agalsidase alfa agalsidase alfa 3507.90 NC0590B2 Ann. L/15 HSC/29 2002 84 104138-64-9
agalsidase beta agalsidase beta 3507.90 NC0590B2 Ann. L/15 HSC/29 2002 84 104138-64-9
aganepag aganépag 2934.99 NC1760B1b Ann. N/7 HSC/49 2012 104 910562-18-4
aganirsen aganirsen 2934.99 NC1604B1b Ann. N/5 HSC/46 2010 101 1146887-67-3
agatolimod agatolimod 2934.99 NC1443B1b Ann. P/5 HSC/43 2009 98 207623-20-9
agerafenib agérafénib 2934.99 NC2373B1b Ann. O/7 HSC/59 2017 115 1188910-76-0
aglatimagene besadenovec aglatimagène bésadénovec 3002.49 NC2930Bc Ann. P/33 HSC/69 2022 113 1621271-62-2 HSC/57 (3002.90)
aglepristone aglépristone 2922.50 42.100 Ann. O (VII) HSC/21 1998 70 124478-60-0
agomelatine agomélatine 2924.29 42.100 Ann. O (IV) HSC/21 1998 75 138112-76-2
alacizumab pegol alacizumab pégol 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 98 934216-54-3 HSC/43 (3002.10)
aladorian aladorian 2934.99 NC1874B1b Ann. O/2 HSC/51 2013 107 865433-00-7
alagebrium chloride chlorure d'alagébrium 2934.10 NC0938B2b Ann. O/3 (II) HSC/35 2005 91 341028-37-3
alalevonadifloxacin alalévonadifloxacine 2933.39 NC2373B1b Ann. O/6 HSC/59 2017 114 706809-20-3
alamifovir alamifovir 2933.59 NC0938B2b Ann. O/2 HSC/35 2005 89 193681-12-8
alatrofloxacin alatrofloxacine 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 75 157182-32-6 HSC/21 (2933.90)
albaconazole albaconazole 2933.59 NC0845B2 Ann. M/1 (II) HSC/33 2004 87 187949-02-6
albenatide albénatide 3002.12 NC2237B1b Ann. T/13 HSC/57 2016 111 1031700-39-6 HSC/55 (3002.10)
albiglutide albiglutide 2937.19 NC1310B1b Ann. N/4 HSC/41 2008 97 782500-75-8
albinterferon alfa-2b albinterféron alfa-2b 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 97 472960-22-8 HSC/41 (3002.10)
albitiazolium bromide bromure d'albitiazolium 2934.10 NC1604B1b Ann. N/5 HSC/46 2010 101 321915-72-4
albusomatropin albusomatropine 2937.11 NC2373B1b Ann. O/6 HSC/59 2017 114 1636119-82-8
albutrepenonacog alfa albutrépénonacog alfa 3002.12 NC2116B1b Ann. S/2 HSC/55 2015 108 1357448-54-4 HSC/53 (3002.10)
alcaftadine alcaftadine 2933.39 NC1178B1c Ann. O/3 HSC/39 2007 94 147084-10-4
alclofenac alclofénac 2918.99 NC2373B1b Ann. O/12 HSC/59 2017 23 22131-79-9 HSC/11 (2918.90)
aldafermin aldafermine 2937.19 NC2803Bc Ann. T/2 HSC/67 2021 120 1616639-03-2
aldesleukin aldesleukin 3504.00 38.100 Ann. Q (No. 128) HSC/11 1993 63 110942-02-4
aldoxorubicin aldoxorubicine 2941.90 NC2004B1b Ann. O/4 HSC/53 2014 108 1361644-26-9
aldumastat aldumastat 2933.59 NC2803Bc Ann. T/7 HSC/67 2021 123 1957278-93-1
alectinib alectinib 2934.99 NC2004B1b Ann. O/4 HSC/53 2014 108 1256580-46-7
alefacept aléfacept 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 84 222535-22-0 HSC/37 (3002.10)
aleglitazar aléglitazar 2934.99 NC1178B1c Ann. O/5 HSC/39 2007 95 475479-34-6

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
alemcinal alemcinal 2932.20 NC2004B1b Ann. O/6 HSC/53 2014 82 150785-53-8 HSC/29 (2932.29)
alemtuzumab alemtuzumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 83 216503-57-0 HSC/27 (3002.10)
aleplasinin aléplasinine 2933.99 NC1443B1b Ann. P/5 HSC/43 2009 98 481629-87-2
alfacalcidol alfacalcidol 2936.90 NC2004B1b Ann. O/6 HSC/53 2014 40 41294-56-8 HSC/11 (2936.10)
alfatradiol alfatradiol 2907.29 NC0730B2 Ann. M/4 HSC/31 2003 84 57-91-0
alfentanil alfentanil 2933.33 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 43 71195-58-9
alferminogene tadenovec alferminogène tadénovec 3002.49 NC2930Bc Ann. P/33 HSC/69 2022 95 473553-86-5 HSC/39 (3002.90)
alfimeprase alfiméprase 3507.90 NC0590B2 Ann. L/15 HSC/29 2002 85 259074-76-5
alglucosidase alfa alglucosidase alfa 3507.90 NC0938B2b Ann. O/3 (II) HSC/35 2005 91 420784-05-0
alicaforsen alicaforsen 2934.99 NC0730B2 Ann. M/4 (III) HSC/31 2003 85 185229-68-9
alicapistat alicapistat 2933.79 NC2373B1b Ann. O/7 HSC/59 2017 115 1254698-46-8
alicdamotide alicdamotide 3002.41 NC2803Bc Ann. T/4 HSC/67 2021 109 1201327-17-4 HSC/53 (3002.20)
alidornase alfa alidornase alfa 3507.90 NC2373B1b Ann. O/7 HSC/59 2017 115 1788036-49-6
aligomanuxic acid acide aligomanuxique 3913.90 NC2803Bc Ann. T/6 HSC/67 2021 122 105280-81-7
aliloxibic acid acide valiloxibique 2922.49 NC2803Bc Ann. T/7 HSC/67 2021 123 238401-16-6
alilusem alilusem 2933.49 NC0590B2 Ann. L/15 HSC/29 2002 85 144506-11-6
alinastine alinastine 2933.39 42.100 Ann. O (III) HSC/21 1998 74 154541-72-7
alipogene tiparvovec alipogène tiparvovec 3002.49 NC2930Bc Ann. P/33 HSC/69 2022 99 929881-05-0 HSC/43 (3002.90)
alirinetide alirinétide 2925.29 NC2501B1b Ann. M/6 HSC/61 2018 117 725715-18-4
alirocumab alirocumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 107 1245916-14-6 HSC/51 (3002.10)
alisertib alisertib 2933.59 NC1760B1b Ann. N/7 HSC/49 2012 104 1028486-01-2
aliskiren aliskirène 2924.29 NC0430B2 Ann. Q/1 (II) HSC/27 2001 83 173334-57-1
alisporivir alisporivir 2933.79 NC1553B1b Ann. O/7 HSC/45 2010 100 254435-95-5
alitretinoin alitrétinoïne 2936.21 NC0430B2 Ann. Q/1 (III) HSC/27 2001 80 1241893
allobarbital allobarbital 2933.53 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 1 52-43-7
allopurinol allopurinol 2933.59 38.100 Ann. Q (No. 131) HSC/11 1993 14 315-30-0
allylprodine allylprodine 2933.39 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 9 25384-17-2
almagate almagate 2842.90 38.100 Ann. Q (No. 132) HSC/11 1993 41 66827-12-1
almorexant almorexant 2933.49 NC1443B1b Ann. P/5 HSC/43 2009 98 871224-64-5
almotriptan almotriptan 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 76 154323-57-6 HSC/21 (2935.00)
almurtide almurtide 2932.99 42.100 Ann. O (III) HSC/21 1998 74 61136-12-7
alnespirone alnespirone 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 70 138298-79-0 HSC/18 (2934.90)
alniditan alniditan 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 72 152317-89-0 HSC/18 (2934.90)
alnuctamab alnuctamab 3002.13 NC2803Bc Ann. T/7 HSC/67 2021 123 2296827-07-9
alobresib alobrésib 2934.99 NC2501B1b Ann. M/6 HSC/61 2018 117 1637771-14-2
HSC/57 (2935.00)
alofanib alofanib 2935.90 NC2237B1b Ann. T/11 HSC/57 2016 113 1612888-66-0
(S/9)
alogabat alogabat 2934.99 NC2930Bc Ann. P/27 HSC/69 2022 125 2230009-48-8
alogliptin alogliptine 2933.59 NC1248B1b Ann. P/14 HSC/40 2007 96 850649-61-5

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
alomfilimab alomfilimab 3002.13 NC2930Bc Ann. P/25 HSC/69 2022 124 2378692-24-9
aloxistatin aloxistatine 2924.29 38.100 Ann. Q (No. 133) HSC/11 1993 57 88321-09-9
alpelisib alpélisib 2934.10 NC2116B1b Ann. R/4 HSC/55 2015 110 1217486-61-7
alpertine alpertine 2933.59 38.100 Ann. Q (No. 134) HSC/11 1993 34 27076-46-6
alphacetylmethadol alphacétylméthadol 2922.19 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 5 17199-58-5
alphameprodine alphaméprodine 2933.39 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 1 468-51-9
alphamethadol alphaméthadol 2922.19 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 5 17199-54-1
alphaprodine alphaprodine 2933.39 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 1 77-20-3
alprafenone alprafénone 2922.19 40.260 Ann. L/2 (No. 39) HSC/17 1996 62 124316-02-5
alprazolam alprazolam 2933.91 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 30 28981-97-7
alprenolol alprénolol 2922.19 40.260 Ann. L/2 (No. 40) HSC/17 1996 19 13655-52-2
alrefimotide alréfimotide 3002.41 NC2930Bc Ann. P/27 HSC/69 2022 125 1331848-79-3
alrizomadlin alrizomadline 2933.79 NC2930Bc Ann. P/27 HSC/69 2022 125 1818393-16-6
alsactide alsactide 2937.19 NC2004B1b Ann. O/6 HSC/53 2014 45 34765-96-3 HSC/21 (2937.10)
alsevalimab alsévalimab 3002.13 NC2803Bc Ann. T/6 HSC/67 2021 122 2254029-91-7
altapizone altapizone 2933.59 38.100 Ann. Q (No. 135) HSC/11 1993 55 93277-96-4
alteminostat altéminostat 2933.59 NC2626B1b Ann. O/6 HSC/63 2019 119 1246374-97-9
altinicline altinicline 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 82 179120-92-4 HSC/27 (2933.90)
altiratinib altiratinib 2933.39 NC2237B1b Ann. S/9 HSC/57 2016 113 1345847-93-9
altizide altizide 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 13 5588-16-9 HSC/11 (2935.00)
altumomab altumomab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 68 156586-92-4 HSC/16 (3002.10)
alunacedase alfa alunacédase alfa 3507.90 NC2803Bc Ann. T/11 HSC/67 2021
124 COVID-19
2416824-55-8
alvameline alvaméline 2933.39 NC0090B2 Ann. M/1 (II) HSC/23 1999 79 120241-31-8
alvelestat alvélestat 2933.79 NC1760B1b Ann. N/7 HSC/49 2012 104 848141-11-7
alvespimycin alvespimycine 2941.90 NC1553B1b Ann. O/1 HSC/45 2010 96 467214-20-6
alvimopan alvimopan 2933.39 NC0845B2 Ann. M/1 (II) HSC/33 2004 87 156053-89-3
alvocidib alvocidib 2934.99 NC0845B2 Ann. M/2 HSC/33 2004 88 146426-40-6
amadinone amadinone 2937.23 NC2004B1b Ann. O/6 HSC/53 2014 25 30781-27-2 HSC/21 (2937.92)
amatuximab amatuximab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 104 931402-35-6 HSC/49 (3002.10)
ambasilide ambasilide 2933.39 38.100 Ann. Q (No. 137) HSC/11 1993 59 83991-25-7
ambrisentan ambrisentan 2933.59 NC0590B2 Ann. L/15 HSC/29 2002 85 177036-94-1
ambruticin ambruticine 2941.90 38.100 Ann. Q (No. 138) HSC/11 1993 39 58857-02-6
amcasertib amcasertib 2934.10 NC2237B1b Ann. S/9 HSC/57 2016 113 1129403-56-0
amcenestrant amcénestrant 2933.99 NC2803Bc Ann. T/6 HSC/67 2021 122 2114339-57-8
amcinafal amcinafal 2937.22 38.100 Ann. Q (No. 139) HSC/11 1993 25 3924-70-7
amcinafide amcinafide 2937.22 38.100 Ann. Q (No. 140) HSC/11 1993 25 7332-27-6
amcinonide amcinonide 2937.22 38.100 Ann. Q (No. 141) HSC/11 1993 33 51022-69-6
amcipatricin amcipatricine 2941.90 NC2803Bc Ann. T/2 HSC/67 2021 120 143483-67-4
amdakefalin amdakéfaline 2933.59 NC2803Bc Ann. T/6 HSC/67 2021 122 2253747-71-4

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
amdizalisib amdizalisib 2933.59 NC2930Bc Ann. P/27 HSC/69 2022 125 1894229-05-0
amdoxovir amdoxovir 2934.99 NC0590B2 Ann. L/15 HSC/29 2002 85 145514-04-1
amebucort amébucort 2937.29 38.100 Ann. Q (No. 142) HSC/11 1993 54 83625-35-8
amediplase amédiplase 3507.90 NC0090B2 Ann. M/1 (II) HSC/23 1999 79 151912-11-7
amelometasone amélométasone 2937.22 42.100 Ann. O (III) HSC/21 1998 74 123013-22-9
amelparib amelparib 2934.99 NC2626B1b Ann. O/6 HSC/63 2019 119 1227156-72-0
amelubant amélubant 2925.29 NC2004B1b Ann. O/6 HSC/53 2014 85 346735-24-8 HSC/31 (2925.20)
amenamevir aménamévir 2934.99 NC1500B1b Ann. K/6 HSC/44 2009 100 841301-32-4
amfepramone amfépramone 2922.31 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 13 90-84-6
amfetamine amfétamine 2921.46 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 55 300-62-9
amfomycin amfomycine 2941.90 38.100 Ann. Q (No. 143) HSC/11 1993 13 1402-82-0
amibegron amibégron 2922.50 NC1178B1c Ann. O/3 HSC/39 2007 94 121524-08-1
amifampridine amifampridine 2933.39 NC1310B1b Ann. N/10 HSC/41 2008 96 54-96-6
amiglumide amiglumide 2924.29 NC0430B2 Ann. Q/1 (I) HSC/27 2001 82 119363-62-1
amilintide amilintide 2937.19 NC1760B1b Ann. N/3 HSC/49 2012 76 122384-88-7
amilomotide amilomotide 3002.41 NC2803Bc Ann. T/4 HSC/67 2021 105 1238372-23-0 HSC/49 (3002.20)
amiloxate amiloxate 2918.99 NC2373B1b Ann. O/12 HSC/59 2017 83 71617-10-2 HSC/27 (2918.90)
aminoethyl nitrate nitrate d'aminoéthyle 2922.50 38.100 Ann. Q (No. 144) HSC/11 1993 1 646-02-6
aminorex aminorex 2934.91 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 14 2207-50-3
amiselimod amisélimod 2922.50 NC2237B1b Ann. S/8 HSC/57 2016 112 942399-20-4
amitifadine amitifadine 2933.99 NC1874B1b Ann. O/1 HSC/51 2013 106 410074-73-6
amitriptylinoxide amitriptylinoxyde 2929.90 40.260 Ann. L/2 (No. 10) HSC/17 1996 36 4317-14-0
amivantamab amivantamab 3002.13 NC2803Bc Ann. T/3 HSC/67 2021 121 2171511-58-1
amlintide amlintide 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 76 122384-88-7 HSC/21 (2934.90)
amlitelimab amlitélimab 3002.13 NC2930Bc Ann. P/25 HSC/69 2022 124 2378692-15-8
amlivirsen amlivirsen 2934.99 NC2626B1b Ann. O/6 HSC/63 2019 119 1637640-12-0
amobarbital amobarbital 2933.53 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 1 57-43-2
amolimogene bepiplasmid amolimogène bépiplasmide 2934.99 NC1443B1b Ann. P/5 HSC/43 2009 98 870524-46-2
amopyroquine amopyroquine 2933.49 NC2004B1b Ann. O/6 HSC/53 2014 8 550-81-2 HSC/11 (2933.40)
amotosalen amotosalène 2932.20 NC2004B1b Ann. O/6 HSC/53 2014 85 161262-29-9 HSC/29 (2932.29)
amoxydramine camsilate camsilate d'amoxydramine 2929.90 40.260 Ann. L/2 (No. 11) HSC/17 1996 15 15350-99-9
amphenidone amphénidone 2933.79 38.100 Ann. Q (No. 146) HSC/11 1993 10 134-37-2
ampreloxetine ampréloxétine 2933.39 NC2626B1b Ann. O/6 HSC/63 2019 119 1227056-84-9
amprenavir amprénavir 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 79 161814-49-9 HSC/23 (2935.00)
amsilarotene amsilarotène 2931.90 NC2373B1b Ann. O/12 HSC/59 2017 98 125973-56-0 HSC/43 (2931.00)
amubarvimab amubarvimab 3002.13 NC2930Bc Ann. P/27 HSC/69 2022 125 2509447-07-6
amuvatinib amuvatinib 2934.99 NC1649B3b Ann. R/14 HSC/47 2011 103 850879-09-3
amylmetacresol amylmétacrésol 2907.19 38.100 Ann. Q (No. 147) HSC/11 1993 55 1300-94-3
anacetrapib anacétrapib 2934.99 NC1443B1b Ann. P/5 HSC/43 2009 98 875446-37-0

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
anagestone anagestone 2937.23 NC2004B1b Ann. O/6 HSC/53 2014 16 2740-52-5 HSC/11 (2937.92)
anagliptin anagliptine 2933.59 NC1649B3b Ann. R/14 HSC/47 2011 103 739366-20-2
anakinra anakinra 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 70 143090-92-0 HSC/18 (3002.10)
anamorelin anamoréline 2933.39 NC1310B1b Ann. N/4 HSC/41 2008 97 249921-19-5
anaritide anaritide 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 57 95896-08-5 HSC/11 (2934.90)
anastrozole anastrozole 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 72 120511-73-1 HSC/18 (2933.90)
anatibant anatibant 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 88 209733-45-9 HSC/33 (2935.00)
anatumomab mafenatox anatumomab mafénatox 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 79 0-00-0 HSC/23 (3002.10)
anaxirone anaxirone 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 52 77658-97-0 HSC/11 (2934.90)
anazocine anazocine 2933.39 38.100 Ann. Q (No. 151) HSC/11 1993 30 15378-99-1
anbenitamab anbénitamab 3002.13 NC2930Bc Ann. P/25 HSC/69 2022 124 2367012-88-0
ancestim ancestim 3002.13 NC2373B1b Ann. O/8 HSC/59 2017 79 163545-26-4 HSC/23 (3002.10)
ancremonam ancrémonam 2941.90 NC2803Bc Ann. T/7 HSC/67 2021 123 1810051-96-7
ancriviroc ancriviroc 2933.39 NC1004B1b Ann. L/11 HSC/36 2005 92 370893-06-4
ancrod ancrod 3507.90 38.100 Ann. Q (No. 152) HSC/11 1993 23 9046-56-4
andecaliximab andécaliximab 3002.13 NC2373B1b Ann. O/7 HSC/59 2017 115 1518996-49-0
andexanet alfa andexanet alfa 3002.13 NC2237B1b Ann. T/13 HSC/57 2016 110 1262449-58-0 HSC/55 (3002.10)
anecortave anécortave 2915.39 NC0430B2 Ann. Q/1 (III) HSC/27 2001 80 7753-60-8
anetumab corixetan anétumab corixétan 3002.13 NC2803Bc Ann. T/3 HSC/67 2021 121 2222980-98-3
anetumab ravtansine anétumab ravtansine 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 109 1375258-01-7 HSC/53 (3002.10)
angiotensinamide angiotensinamide 2933.29 38.100 Ann. Q (No. 153) HSC/11 1993 12 53-73-6
anidulafungin anidulafungine 2941.90 NC0430B2 Ann. Q/1 (III) HSC/27 2001 81 166663-25-8
anifrolumab anifrolumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 109 1326232-46-5 HSC/53 (3002.10)
anileridine aniléridine 2933.33 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 5 144-14-9
anisperimus anispérimus 2925.29 NC2004B1b Ann. O/6 HSC/53 2014 82 170368-04-4 HSC/27 (2925.20)
anistreplase anistreplase 3507.90 38.100 Ann. Q (No. 154) HSC/11 1993 59 81669-57-0
anivamersen anivamersen 2934.99 NC1760B1b Ann. N/8 HSC/49 2012 105 959716-29-1
anrukinzumab anrukinzumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 98 910649-32-0 HSC/43 (3002.10)
anseculin anséculine 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 75 155773-59-4 HSC/21 (2934.90)
anselamimab ansélamimab 3002.13 NC2930Bc Ann. P/27 HSC/69 2022 125 2414866-63-8
ansuvimab ansuvimab 3002.13 NC2930Bc Ann. P/25 HSC/69 2022 124 2375952-29-5
antazonite antazonite 2934.10 38.100 Ann. Q (No. 155) HSC/11 1993 15 25422-75-7
antithrombin alfa antithrombine alfa 3002.12 NC2116B1b Ann. S/2 HSC/55 2015 93 84720-88-7 HSC/37 (3002.10)
antithrombin gamma antithrombine gamma 3002.12 NC2116B1b Ann. S/2 HSC/55 2015 107 1311281-25-0 HSC/51 (3002.10)
anumigilimab anumigilimab 3002.13 NC2930Bc Ann. P/27 HSC/69 2022 125 2416593-08-1
apabetalone apabétalone 2933.59 NC2116B1b Ann. R/4 HSC/55 2015 110 1044870-39-4
apadamtase alfa apadamtase alfa 3507.90 NC2626B1b Ann. O/5 HSC/63 2019 118 2086325-24-6
apadenoson apadénoson 2934.99 NC1123B1b Ann. N/1 HSC/38 2006 94 250386-15-3
apadoline apadoline 2934.30 42.100 Ann. O (III) HSC/21 1998 74 135003-30-4

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
HSC/18 (2903.30)
apaflurane apaflurane 2903.46 NC2803Bc Ann. T/4 HSC/67 2021 73 431-89-0
HSC/53 (2903.39)
apalutamide apalutamide 2933.39 NC2237B1b Ann. S/9 HSC/57 2016 113 956104-40-8
apararenone apararénone 2935.90 NC2373B1b Ann. O/7 HSC/59 2017 115 945966-46-1
apatorsen apatorsen 2934.99 NC2116B1b Ann. R/4 HSC/55 2015 110 1002331-21-6
apaxifylline apaxifylline 2939.59 NC2004B1b Ann. O/6 HSC/53 2014 71 151581-23-6 HSC/18 (2939.50)
apaziquone apaziquone 2933.99 NC0730B2 Ann. M/7 HSC/31 2003 87 114560-48-4
apilimod apilimod 2934.99 NC1178B1c Ann. O/5 HSC/39 2007 95 541550-19-0
apimostinel apimostinel 2933.99 NC2373B1b Ann. O/7 HSC/59 2017 115 1421866-48-9
apitegromab apitégromab 3002.13 NC2803Bc Ann. T/7 HSC/67 2021 123 2278276-46-1
apitolisib apitolisib 2934.99 NC2004B1b Ann. O/4 HSC/53 2014 108 1032754-93-0
apixaban apixaban 2933.79 NC1059B2b Ann. O/5 HSC/37 2006 93 503612-47-3
aplaviroc aplaviroc 2933.79 NC1178B1c Ann. O/3 HSC/39 2007 94 461443-59-4
aplindore aplindore 2934.99 NC0730B2 Ann. M/7 HSC/31 2003 92 189681-70-7
apolizumab apolizumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 87 267227-08-7 HSC/31 (3002.10)
apraglutide apraglutide 2937.19 NC2626B1b Ann. O/5 HSC/63 2019 118 1295353-98-8
apratastat apratastat 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 93 287405-51-0 HSC/37 (2935.00)
apremilast aprémilast 2930.90 NC1310B1b Ann. N/4 HSC/41 2008 97 608141-41-9
aprepitant aprépitant 2934.99 NC0590B2 Ann. L/15 HSC/29 2002 84 170729-80-3
apricitabine apricitabine 2934.99 NC1178B1c Ann. O/5 HSC/39 2007 95 160707-69-7
apricoxib apricoxib 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 99 197904-84-0 HSC/43 (2935.00)
aprinocarsen aprinocarsen 2934.99 NC0938B2b Ann. O/2 HSC/35 2005 89 151879-73-1
aprocitentan aprocitentan 2933.59 NC2501B1b Ann. M/5 HSC/61 2018 116 1103522-45-7
aprutumab aprutumab 3002.13 NC2373B1b Ann. O/7 HSC/59 2017 115 1634620-63-5
aprutumab ixadotin aprutumab ixadotine 3002.13 NC2373B1b Ann. O/7 HSC/59 2017 115 1708947-48-1
aptazapine aptazapine 2933.59 38.100 Ann. Q (No. 156) HSC/11 1993 50 71576-40-4
aptiganel aptiganel 2925.29 NC2004B1b Ann. O/6 HSC/53 2014 72 137159-92-3 HSC/18 (2925.20)
aramisulpride aramisulpride 2933.99 NC2803Bc Ann. T/6 HSC/67 2021 122 71675-90-6
arasertaconazole arasertaconazole 2934.99 NC1059B2b Ann. O/5 HSC/37 2006 93 583057-48-1
arazasetron arazasétron 2934.99 NC2626B1b Ann. O/5 HSC/63 2019 118 2025360-90-9
arbaclofen arbaclofène 2922.49 NC1760B1b Ann. N/7 HSC/49 2012 104 69308-37-8
arbaclofen placarbil arbaclofène placarbil 2924.29 NC1310B1b Ann. N/4 HSC/41 2008 97 847353-30-4
arbekacin arbékacine 2941.90 38.100 Ann. Q (No. 157) HSC/11 1993 56 51025-85-5
arcitumomab arcitumomab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 74 154361-48-5 HSC/21 (3002.10)
ardenermin ardénermine 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 88 305391-49-5 HSC/47 (3002.10)
ardeparin sodium ardéparine sodique 3001.90 NC1553B1b Ann. O/5 HSC/45 2010 68 9041-08-1
arfalasin arfalasine 2933.29 38.100 Ann. Q (No. 158) HSC/11 1993 37 60173-73-1
arfolitixorin arfolitixorine 2933.59 NC2501B1b Ann. M/6 HSC/61 2018 117 316901-11-6
arformoterol arformotérol 2924.29 NC0938B2b Ann. O/3 (I) HSC/35 2005 90 67346-49-0

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
arginine arginine 2925.29 NC2004B1b Ann. O/6 HSC/53 2014 14 74-79-3 HSC/11 (2925.20)
argipressin argipressine 2937.19 NC2004B1b Ann. O/6 HSC/53 2014 13 113-79-1 HSC/17 (2937.99)
argiprestocin argiprestocine 2937.19 NC2004B1b Ann. O/6 HSC/53 2014 13 113-80-4 HSC/18 (2937.99)
arhalofenate arhalofénate 2924.29 NC1649B3b Ann. R/12 HSC/47 2011 101 24136-23-0
arimoclomol arimoclomol 2933.39 NC0845B2 Ann. M/2 HSC/33 2004 88 289893-25-0
aripiprazole aripiprazole 2933.79 42.100 Ann. O (IV) HSC/21 1998 75 129722-12-9
arlipoic acid acide arlipoïque 2934.99 NC2803Bc Ann. T/3 HSC/67 2021 121 1200-22-2
armodafinil armodafinil 2930.90 NC0938B2b Ann. O/3 (II) HSC/35 2005 91 112111-43-0
arnolol arnolol 2922.19 38.100 Ann. Q (No. 160) HSC/11 1993 56 87129-71-3
arofylline arofylline 2939.59 NC2004B1b Ann. O/6 HSC/53 2014 75 136145-07-8 HSC/21 (2939.50)
arotinolol arotinolol 2934.10 38.100 Ann. Q (No. 161) HSC/11 1993 48 68377-92-4
arpraziquantel arpraziquantel 2933.59 NC2803Bc Ann. T/3 HSC/67 2021 121 57452-98-9
arprinocid arprinocide 2933.59 38.100 Ann. Q (No. 162) HSC/11 1993 38 55779-18-5
artefenomel artéfénomel 2934.99 NC2004B1b Ann. O/5 HSC/53 2014 109 1029939-86-3
arteflene artéflène 2932.99 40.600 Ann. D, par. 6 HSC/18 1996 70 123407-36-3
artemisone artémisone 2934.99 NC1059B2b Ann. O/4 HSC/37 2006 92 255730-18-8
artemotil artémotil 2932.99 NC0090B2 Ann. M/5 HSC/23 1999 80 75887-54-6
artenimol arténimol 2932.99 NC0250B2 Ann. P/1 (II) HSC/25 2000 81 81496-81-3
arterolane artérolane 2932.99 NC1310B1b Ann. N/4 HSC/41 2008 97 664338-39-0
arundic acid acide arundique 2915.90 NC0845B2 Ann. M/2 HSC/33 2004 88 185517-21-9
arzoxifene arzoxifène 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 80 182133-25-1 HSC/23 (2934.90)
asalhydromorphone asalhydromorphone 2939.19 NC2626B1b Ann. O/6 HSC/63 2019 119 1431529-94-0
asapiprant asapiprant 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 109 932372-01-5 HSC/53 (2935.00)
asciminib asciminib 2933.39 NC2373B1b Ann. O/7 HSC/59 2017 115 1492952-76-7
ascorbyl gamolenate gamolénate d'ascorbyl 2932.20 NC2004B1b Ann. O/6 HSC/53 2014 79 109791-32-4 HSC/23 (2932.29)
HSC/57 (3002.10)
ascrinvacumab ascrinvacumab 3002.13 NC2237B1b Ann. T/11 HSC/57 2016 113 1463459-96-2
(S/9)
aselizumab asélizumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 88 395639-53-9 HSC/33 (3002.10)
asenapine asénapine 2934.99 NC0730B2 Ann. M/7 HSC/31 2003 87 65576-45-6
aseripide aséripide 2934.10 42.100 Ann. O (VI) HSC/21 1998 77 153242-02-5
asfotase alfa asfotase alfa 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 104 1174277-80-5 HSC/49 (3002.10)
asimadoline asimadoline 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 74 153205-46-0 HSC/21 (2933.90)
asivatrep asivatrep 2935.90 NC2501B1b Ann. M/6 HSC/61 2018 117 1005168-10-4
asobamast asobamast 2934.10 38.100 Ann. Q (No. 163) HSC/11 1993 63 104777-03-9
asoprisnil asoprisnil 2937.29 NC0938B2b Ann. O/1 HSC/35 2005 86 199396-76-4
asoprisnil ecamate ecamate d'asoprisnil 2937.29 NC0938B2b Ann. O/1 HSC/35 2005 88 222732-94-7
aspacytarabine aspacytarabine 2934.99 NC2803Bc Ann. T/2 HSC/67 2021 120 2098942-53-9
astegolimab astégolimab 3002.13 NC2803Bc Ann. T/3 HSC/67 2021 121 2173054-79-8
astemizole astémizole 2933.39 38.100 Ann. Q (No. 164) HSC/11 1993 42 68844-77-9

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
astodrimer astodrimère 2924.29 NC2116B1b Ann. R/4 HSC/55 2015 110 1379746-42-5
asudemotide asudémotide 3002.41 NC2803Bc Ann. T/4 HSC/67 2021 107 1018833-53-8 HSC/51 (3002.20)
asunaprevir asunaprévir 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 105 630420-16-5 HSC/49 (2935.00)
asundexian asundexian 2933.79 NC2803Bc Ann. T/7 HSC/67 2021 123 2064121-65-7
asunercept asunercept 3002.13 NC2237B1b Ann. T/10 HSC/57 2016 114 1450882-18-4 (List 112 asinercept)
asvasiran asvasiran 2934.99 NC2116B1b Ann. R/5 HSC/55 2015 111 870094-26-1
atabecestat atabécestat 2934.99 NC2501B1b Ann. M/6 HSC/61 2018 117 1200493-78-2
atacicept atacicept 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 95 845264-92-8 HSC/39 (3002.10)
ataciguat ataciguat 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 88 254877-67-3 HSC/33 (2935.00)
atagabalin atagabaline 2922.49 NC1604B1b Ann. N/6 HSC/46 2010 102 223445-75-8
ataluren ataluren 2934.99 NC1604B1b Ann. N/5 HSC/46 2010 101 775304-57-9
atamestane atamestane 2937.29 NC2004B1b Ann. O/6 HSC/53 2014 54 96301-34-7 HSC/11 (2937.99)
atamparib atamparib 2933.59 NC2930Bc Ann. P/25 HSC/69 2022 124 2381037-82-5
ataquimast ataquimast 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 82 182316-31-0 HSC/27 (2933.90)
atazanavir atazanavir 2933.39 NC0845B2 Ann. M/2 HSC/33 2004 88 198904-31-3
atecegatran atécégatran 2933.99 NC1649B3b Ann. R/14 HSC/47 2011 103 917904-13-3
atecegatran fexenetil atécégatran fexénétil 2933.99 NC1649B3b Ann. R/14 HSC/47 2011 103 433937-93-0
atelocantel atélocantel 2933.39 NC2501B1b Ann. M/5 HSC/61 2018 116 1370540-16-1
atesidorsen atésidorsen 2934.99 NC2501B1b Ann. M/5 HSC/61 2018 116 872063-57-5
atexakin alfa atexakine alfa 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 72 143631-61-2 HSC/18 (3002.10)
HSC/57 (3002.10)
atezolizumab atézolizumab 3002.13 NC2237B1b Ann. T/10 HSC/57 2016 112 1380723-44-3
(S/8)
atibeprone atibéprone 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 72 153420-96-3 HSC/18 (2934.90)
atibuclimab atibuclimab 3002.13 NC2803Bc Ann. T/11 HSC/67 2021
124 COVID-19
2417175-94-9
aticaprant aticaprant 2933.99 NC2626B1b Ann. O/6 HSC/63 2019 119 1174130-61-0
atidarsagene autotemcel atidarsagène autotemcel 3002.51 NC2803Bc Ann. T/7 HSC/67 2021 123 no mention
atidortoxumab atidortoxumab 3002.13 NC2501B1b Ann. M/6 HSC/61 2018 117 1939108-95-8
atigliflozin atigliflozine 2940.00 NC1553B1b Ann. O/7 HSC/45 2010 100 647834-15-9
atilmotin atilmotine 2933.99 NC1059B2b Ann. O/4 HSC/37 2006 92 533927-56-9
atinumab atinumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 104 1226761-65-4 HSC/49 (3002.10)
atiprimod atiprimod 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 75 123018-47-3 HSC/21 (2933.90)
atiprosin atiprosine 2933.59 38.100 Ann. Q (No. 166) HSC/11 1993 54 89303-63-9
atiratecan atiratécan 2939.79 NC2237B1b Ann. T/12 HSC/57 2016 101 867063-97-6 HSC/47 (2939.99)
atizoram atizoram 2933.59 42.100 Ann. O (III) HSC/21 1998 74 135637-46-6
atleradstrocel atléradstrocel 3002.51 NC2803Bc Ann. T/3 HSC/67 2021 121 no mention
atliprofen atliprofène 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 77 108912-17-0 HSC/21 (2934.90)
atocalcitol atocalcitol 2909.49 NC0938B2b Ann. O/1 HSC/35 2005 88 302904-82-1
atogepant atogépant 2933.79 NC2501B1b Ann. M/5 HSC/61 2018 116 1374248-81-3
atoltivimab atoltivimab 3002.13 NC2803Bc Ann. T/2 HSC/67 2021 120 2135632-29-8

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
atopaxar atopaxar 2934.99 NC1760B1b Ann. N/7 HSC/49 2012 104 751475-53-3
atorolimumab atorolimumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 80 202833-08-7 HSC/23 (3002.10)
atorvastatin atorvastatine 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 71 134523-00-5 HSC/18 (2933.90)
atrasentan atrasentan 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 83 195733-43-8 HSC/27 (2934.90)
atreleuton atréleuton 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 78 154355-76-7 HSC/22 (2934.90)
atrimustine atrimustine 2922.49 40.260 Ann. L/2 (No. 42) HSC/17 1996 61 75219-46-4
HSC/11 (2939.90)
atromepine atromépine 2939.79 NC2116B1b Ann. S/1 HSC/55 2015 15 428-07-9
HSC/53 (2939.99)
atuliflapon atuliflapon 2933.59 NC2930Bc Ann. P/27 HSC/69 2022 125 2041075-86-7
atuveciclib atuvéciclib 2933.69 NC2373B1b Ann. O/7 HSC/59 2017 115 1414943-94-4
atuzabrutinib atuzabrutinib 2933.59 NC2930Bc Ann. P/27 HSC/69 2022 125 1581714-49-9
atuzaginstat atuzaginstat 2924.29 NC2930Bc Ann. P/25 HSC/69 2022 124 2211981-76-7
audencel audencel 3002.51 NC2803Bc Ann. T/4 HSC/67 2021 115 no mention HSC/61 (3002.90)
aumolertinib aumolertinib 2933.59 NC2930Bc Ann. P/25 HSC/69 2022 124 1899-21-05-1
auriclosene auriclosène 2929.90 NC1874B1b Ann. O/2 HSC/51 2013 107 846056-87-9
autogene cevumeran autogène cévuméran 3002.41 NC2930Bc Ann. P/28 HSC/69 2022 122 2365453-34-3
avacincaptad pegol avacincaptad pégol 3907.29 NC2803Bc Ann. T/4 HSC/67 2021 113 1613641-69-2 HSC/57 (3907.20)
avacopan avacopan 2933.39 NC2373B1b Ann. O/6 HSC/59 2017 114 1346623-17-3
avadomide avadomide 2933.59 NC2501B1b Ann. M/6 HSC/61 2018 117 1015474-32-4
avagacestat avagacestat 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 104 1146699-66-2 HSC/49 (2935.00)
avalglucosidase alfa avalglucosidase alfa 3507.90 NC2501B1b Ann. M/6 HSC/61 2018 117 1802558-87-7
avalotcagene ontaparvovec avalotcagène ontaparvovec 3002.49 NC2930Bc Ann. P/33 HSC/69 2022 121 2227000-30-6 HSC/67 (3002.90)
avanafil avanafil 2933.59 NC1004B1b Ann. L/11 HSC/36 2005 92 330784-47-9
avanbulin avanbuline 2934.99 NC2803Bc Ann. T/2 HSC/67 2021 120 798577-91-0
avapritinib avapritinib 2933.59 NC2501B1b Ann. M/6 HSC/61 2018 117 1703793-34-3
avasimibe avasimibe 2929.90 NC0430B2 Ann. Q/1 (III) HSC/27 2001 80 166518-60-1
avasopasem manganese avasopasem manganèse 2933.39 NC2626B1b Ann. O/6 HSC/63 2019 120 435327-40-5 (List 119)
avatrombopag avatrombopag 2934.10 NC1874B1b Ann. O/2 HSC/51 2013 107 570406-98-3
avdoralimab avdoralimab 3002.13 NC2803Bc Ann. T/3 HSC/67 2021 121 2226393-85-5
HSC/57 (3002.10)
avelumab avélumab 3002.13 NC2237B1b Ann. T/11 HSC/57 2016 113 1537032-82-8
(S/9)
avexitide avexitide 2937.19 NC2803Bc Ann. T/2 HSC/67 2021 120 133514-43-9
avibactam avibactam 2933.39 NC1649B3b Ann. R/14 HSC/47 2011 103 1192500-31-4
avipendekin pegol avipendékine pégol 3002.13 NC2803Bc Ann. T/7 HSC/67 2021 123 2361317-09-9
aviptadil aviptadil 2933.29 42.750 Ann. O HSC/22 1998 78 40077-57-4
aviscumine aviscumine 3002.49 NC2803Bc Ann. T/9 HSC/67 2021 84 223577-45-5 HSC/31 (3002.90)
avitriptan avitriptan 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 76 151140-96-4 HSC/21 (2935.00)
avizakimab avizakimab 3002.13 NC2803Bc Ann. T/3 HSC/67 2021 121 2229685-51-0
avoplacel avoplacel 3002.51 NC2803Bc Ann. T/4 HSC/67 2021 119 no mention HSC/63 (3002.90)

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
avoralstat avoralstat 2933.39 NC2237B1b Ann. S/8 HSC/57 2016 112 918407-35-9
avorelin avoréline 2937.19 NC2004B1b Ann. O/6 HSC/53 2014 74 140703-49-7 HSC/21 (2937.99)
avosentan avosentan 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 93 290815-26-8 HSC/37 (2935.00)
avotaciclib avotaciclib 2933.59 NC2803Bc Ann. T/7 HSC/67 2021 123 1983983-41-0
avotermin avotermine 2934.99 NC1649B3b Ann. R/10 HSC/47 2011 77 182212-66-4
axalimogene filolisbac axalimogén filolisbac 3002.49 NC2930Bc Ann. P/33 HSC/69 2022 112 No mention. HSC/57 (3002.90)
axatilimab axatilimab 3002.13 NC2803Bc Ann. T/3 HSC/67 2021 121 2155851-88-8
axelopran axélopran 2933.39 NC2004B1b Ann. O/5 HSC/53 2014 109 949904-48-7
axicabtagene ciloleucel axicabtagène ciloleucel 3002.51 NC2803Bc Ann. T/4 HSC/67 2021 117 no mention HSC/61 (3002.90)
axitinib axitinib 2933.39 NC1178B1c Ann. O/3 HSC/39 2007 94 319460-85-0
axitirome axitirome 2924.29 NC0430B2 Ann. Q/1 (I) HSC/27 2001 82 156740-57-7
axomadol axomadol 2922.50 NC0730B2 Ann. M/7 HSC/31 2003 87 187219-95-0
azabon azabon 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 16 1150-20-5 HSC/11 (2935.00)
azalanstat azalanstat 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 73 143393-27-5 HSC/18 (2934.90)
azamidugene autotemcel azamidugène autotemcel 3002.51 NC2930Bc Ann. P/27 HSC/69 2022 125 no mention
azatadine azatadine 2933.39 38.100 Ann. Q (No. 170) HSC/11 1993 18 3964-81-6
azathioprine azathioprine 2933.59 38.100 Ann. Q (No. 171) HSC/11 1993 12 446-86-6
azelaprag azélaprag 2935.90 NC2626B1b Ann. O/6 HSC/63 2019 119 2049980-18-7
azeliragon azéliragon 2933.29 NC2116B1b Ann. R/5 HSC/55 2015 111 603148-36-3
azeloprazole azéloprazole 2934.99 NC2501B1b Ann. M/5 HSC/61 2018 116 955095-45-1
azemiglitazone azémiglitazone 2934.10 NC2803Bc Ann. T/6 HSC/67 2021 122 1133819-87-0
azercabtagene zapreleucel azercabtagène zapréleucel 3002.51 NC2803Bc Ann. T/7 HSC/67 2021 123 no mention
azetirelin azétiréline 2937.19 NC2004B1b Ann. O/6 HSC/53 2014 60 95729-65-0 HSC/11 (2937.99)
azilsartan azilsartan 2934.99 NC1178B1c Ann. O/5 HSC/39 2007 95 147403-03-0
azilsartan medoxomil azilsartan médoxomil 2934.99 NC1310B1b Ann. N/4 HSC/41 2008 97 863031-21-4
azimilide azimilide 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 72 149908-53-2 HSC/18 (2934.90)
azintuxizumab azintuxizumab 3002.13 NC2501B1b Ann. M/5 HSC/61 2018 116 1826819-57-1
azintuxizumab vedotin azintuxizumab védotine 3002.13 NC2501B1b Ann. M/5 HSC/61 2018 116 1826819-58-2
azoximer bromide bromure d'azoximère 3911.90 NC1443B1b Ann. P/4 HSC/43 2009 97 892497-01-7
bacmecillinam bacmécillinam 2941.90 42.100 Ann. O (II) HSC/21 1998 38 50846-45-2
bafetinib bafétinib 2933.59 NC1443B1b Ann. P/6 HSC/43 2009 99 859212-16-1
bafisontamab bafisontamab 3002.13 NC2930Bc Ann. P/27 HSC/69 2022 125 2437210-79-0
balaglitazone balaglitazone 2934.10 NC0590B2 Ann. L/15 HSC/29 2002 84 199113-98-9
balamapimod balamapimod 2933.49 NC1310B1b Ann. N/10 HSC/41 2008 96 863029-99-6
balapiravir balapiravir 2934.99 NC1500B1b Ann. K/6 HSC/44 2009 100 690270-29-2
balazipone balazipone 2926.90 40.600 Ann. D, par. 6 HSC/18 1996 71 137109-71-8
balicatib balicatib 2933.59 NC1004B1b Ann. L/11 HSC/36 2005 92 354813-19-7
baliforsen baliforsén 2934.99 NC2501B1b Ann. M/5 HSC/61 2018 116 1698048-23-5
balipodect balipodect 2933.19 NC2501B1b Ann. M/5 HSC/61 2018 116 1238697-26-1

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
balixafortide balixafortide 2934.99 NC2237B1b Ann. S/8 HSC/57 2016 112 1051366-32-5
balofloxacin balofloxacine 2933.49 NC2004B1b Ann. O/6 HSC/53 2014 71 127294-70-6 HSC/18 (2933.40)
baloramotide baloramotide 3002.41 NC2803Bc Ann. T/2 HSC/67 2021 120 2207581-19-7
balovaptan balovaptan 2933.39 NC2501B1b Ann. M/5 HSC/61 2018 116 1228088-30-9
baloxavir marboxil baloxavir marboxil 2934.99 NC2501B1b Ann. M/5 HSC/61 2018 116 1985606-14-1
balstilimab balstilimab 3002.13 NC2803Bc Ann. T/2 HSC/67 2021 120 2148321-77-9
baltaleucel baltaleucel 3002.51 NC2803Bc Ann. T/4 HSC/67 2021 116 no mention HSC/61 (3002.90)
balugrastim balugrastim 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 107 527698-09-5 HSC/51 (3002.10)
bamadutide bamadutide 2937.19 NC2626B1b Ann. O/6 HSC/63 2019 119 1596343-09-7
bamaquimast bamaquimast 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 76 135779-82-7 HSC/21 (2933.90)
baminercept baminercept 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 98 909110-25-4 HSC/43 (3002.10)
bamirastine bamirastine 2933.39 NC0938B2b Ann. O/3 (II) HSC/35 2005 91 215529-47-8
bamlanivimab bamlanivimab 3002.13 NC2803Bc Ann. T/11 HSC/67 2021
124 COVID-19
2423943-37-5
bamocaftor bamocaftor 2935.90 NC2803Bc Ann. T/3 HSC/67 2021 121 2204245-48-5
bamosiran bamosiran 2934.99 NC1874B1b Ann. O/1 HSC/51 2013 106 1337968-84-9
banoxantrone banoxantrone 2929.90 NC0938B2b Ann. O/3 (I) HSC/35 2005 90 136470-65-0
bapineuzumab bapineuzumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 93 648895-38-9 HSC/37 (3002.10)
bapotulimab bapotulimab 3002.13 NC2803Bc Ann. T/7 HSC/67 2021 123 2359413-58-2
barasertib barasertib 2933.59 NC1649B3b Ann. R/13 HSC/47 2011 102 722543-31-9
barbital barbital 2933.53 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 4 57-44-3
bardoxolone bardoxolone 2926.90 NC1649B3b Ann. R/12 HSC/47 2011 101 218600-44-3
barecetamab barécétamab 3002.13 NC2803Bc Ann. T/7 HSC/67 2021 123 2275727-74-5
baricitinib baricitinib 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 107 1187594-09-7 HSC/51 (2935.00)
barixibat barixibat 2933.39 NC0845B2 Ann. M/2 HSC/33 2004 88 263562-28-3
barusiban barusiban 2934.99 NC0845B2 Ann. M/2 HSC/33 2004 88 285571-64-4
barzolvolimab barzolvolimab 3002.13 NC2930Bc Ann. P/27 HSC/69 2022 125 2438203-51-9
basifungin basifungine 2941.90 40.600 Ann. D, par. 6 HSC/18 1996 72 127785-64-2
basiliximab basiliximab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 76 179045-86-4 HSC/21 (3002.10)
basimglurant basimglurant 2933.39 NC2004B1b Ann. O/5 HSC/53 2014 109 802906-73-6
basmisanil basmisanil 2934.99 NC2116B1b Ann. R/5 HSC/55 2015 111 1159600-41-5
batabulin batabuline 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 90 195533-53-0 HSC/35 (2935.00)
batefenterol batéfentérol 2933.79 NC2116B1b Ann. R/4 HSC/55 2015 110 743461-65-6
batimastat batimastat 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 70 130370-60-4 HSC/18 (2934.90)
batiraxcept batiraxcept 3002.13 NC2803Bc Ann. T/7 HSC/67 2021 123 2268717-61-7
batoclimab batoclimab 3002.13 NC2803Bc Ann. T/3 HSC/67 2021 121 2187430-05-1
bavdegalutamide bavdégalutamide 2933.59 NC2930Bc Ann. P/27 HSC/69 2022 125 2222112-77-6
bavisant bavisant 2934.99 NC1649B3b Ann. R/14 HSC/47 2011 103 929622-08-2
bavituximab bavituximab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 95 648904-28-3 HSC/39 (3002.10)
baxdrostat baxdrostat 2933.79 NC2930Bc Ann. P/27 HSC/69 2022 125 1428652-17-8

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
bazedoxifene bazédoxifène 2933.99 NC0730B2 Ann. M/6 HSC/31 2003 86 198481-32-2
bazlitoran bazlitoran 2934.99 NC2373B1b Ann. O/6 HSC/59 2017 114 1378549-07-5
becampanel bécampanel 2933.99 NC0938B2b Ann. O/3 (I) HSC/35 2005 90 188696-80-2
becaplermin bécaplermine 2937.19 NC2004B1b Ann. O/6 HSC/53 2014 74 165101-51-9 HSC/21 (2937.99)
becatecarin becatecarine 2941.90 NC1178B1c Ann. O/2 HSC/39 2007 92 119673-08-4
beclanorsen béclanorsen 2934.99 NC1604B1b Ann. N/5 HSC/46 2010 101 1072859-54-1
beclavubir béclavubir 2933.59 NC2116B1b Ann. R/5 HSC/55 2015 111 958002-33-0
becocalcidiol bécocalcidiol 2906.19 NC1059B2b Ann. O/4 HSC/37 2006 92 524067-21-8
bectumomab bectumomab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 75 158318-63-9 HSC/21 (3002.10)
bedaquiline bédaquiline 2933.49 NC1649B3b Ann. R/14 HSC/47 2011 103 843663-66-1
bederocin bédérocine 2934.99 NC1553B1b Ann. O/4 HSC/45 2010 99 757942-43-1
bedinvetmab bédinvetmab 3002.13 NC2803Bc Ann. T/2 HSC/67 2021 120 2171034-69-6
bedoradrine bédoradrine 2924.29 NC1178B1c Ann. O/5 HSC/39 2007 95 194785-19-8
befetupitant béfétupitant 2934.99 NC0938B2b Ann. O/3 (II) HSC/35 2005 91 290296-68-3
befiradol béfiradol 2933.39 NC1443B1b Ann. P/6 HSC/43 2009 99 208110-64-9
befotertinib béfotertinib 2933.59 NC2803Bc Ann. T/7 HSC/67 2021 123 1835667-63-4
befovacimab béfovacimab 3002.13 NC2803Bc Ann. T/3 HSC/67 2021 121 2156634-62-5
begacestat bégacestat 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 97 769169-27-9 HSC/41 (2935.00)
begelomab bégélomab 3002.13 NC2237B1b Ann. T/13 HSC/57 2016 111 1403744-56-8 HSC/55 (3002.10)
beinaglutide béinaglutide 2937.19 NC2501B1b Ann. M/6 HSC/61 2018 117 123475-27-4
belantamab bélantamab 3002.13 NC2626B1b Ann. O/5 HSC/63 2019 118 2061894-48-0
belantamab mafodotin belantamab mafodotine 3002.13 NC2626B1b Ann. O/5 HSC/63 2019 118 2050232-20-5
belaperidone bélapéridone 2933.59 42.100 Ann. O (V) HSC/21 1998 78 156862-51-0
belatacept belatacept 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 93 706808-37-9 HSC/37 (3002.10)
belcesiran belcésiran 2934.99 NC2930Bc Ann. P/27 HSC/69 2022 125 2375562-54-0
belinostat bélinostat 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 97 414864-00-9 HSC/41 (2935.00)
belizatinib bélizatinib 2933.39 NC2237B1b Ann. S/9 HSC/57 2016 113 1357920-84-3
belnacasan belnacasan 2934.99 NC2004B1b Ann. O/4 HSC/53 2014 108 273404-37-8
beloranib béloranib 2922.19 NC1553B1b Ann. O/7 HSC/45 2010 100 251111-30-5
belotecan bélotécan 2939.79 NC2116B1b Ann. S/1 HSC/55 2015 91 256411-32-2 HSC/35 (2939.99)
beloxepin béloxépine 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 75 135928-30-2 HSC/21 (2934.90)
beludavimab béludavimab 3002.13 NC2930Bc Ann. P/27 HSC/69 2022 125 2423016-74-2
belumosudil bélumosudil 2933.59 NC2803Bc Ann. T/7 HSC/67 2021 123 911417-87-3
belvarafenib belvarafénib 2934.99 NC2626B1b Ann. O/5 HSC/63 2019 118 1446113-23-0
belzupacap sarotalocan belzupacap sarotalocan 3204.90 NC2803Bc Ann. T/6 HSC/67 2021 122 2390462-37-8
belzutifan belzutifan 2930.90 NC2803Bc Ann. T/6 HSC/67 2021 122 1672668-24-4
bemarituzumab bémarituzumab 3002.13 NC2501B1b Ann. M/6 HSC/61 2018 117 1952272-74-0
bemcentinib bemcentinib 2933.99 NC2501B1b Ann. M/6 HSC/61 2018 117 1037624-75-1
beminafil béminafil 2934.99 NC0938B2b Ann. O/3 (I) HSC/35 2005 90 566906-50-1

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
bemiparin sodium bémiparine sodique 3001.90 NC1553B1b Ann. O/5 HSC/45 2010 75 9041-08-1
bemnifosbuvir bemnifosbuvir 2934.99 NC2930Bc Ann. P/27 HSC/69 2022 125 1998705-64-8
bemotrizinol bémotrizinol 2933.69 NC1004B1b Ann. L/11 HSC/36 2005 92 187393-00-6
bempedoic acid acide bempedoïque 2918.19 NC2116B1b Ann. R/4 HSC/55 2015 110 738606-46-7
bempegaldesleukin bempégaldesleukine 3002.13 NC2626B1b Ann. O/6 HSC/63 2019 119 1939126-74-5
benfurodil hemisuccinate hémisuccinate de benfurodil 2932.20 NC2004B1b Ann. O/6 HSC/53 2014 16 3447-95-8 HSC/11 (2932.29)
benolizime bénolizime 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 45 61864-30-0 HSC/11 (2933.90)
benperidol benpéridol 2933.39 38.100 Ann. Q (No. 175) HSC/11 1993 14 2062-84-2
benralizumab benralizumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 102 1044511-01-4 HSC/46 (3002.10)
bentamapimod bentamapimod 2934.20 NC1443B1b Ann. P/5 HSC/43 2009 98 848344-36-5
bentemazole bentémazole 2933.29 38.100 Ann. Q (No. 176) HSC/11 1993 40 63927-95-7
bentracimab bentracimab 3002.13 NC2803Bc Ann. T/7 HSC/67 2021 123 2260568-31-6
benufutamab bénufutamab 3002.13 NC2803Bc Ann. T/3 HSC/67 2021 121 2109730-69-8
benzalkonium chloride chlorure de benzalkonium 3402.41 NC2803Bc Ann. T/4 HSC/67 2021 1 8001-54-5 HSC/11 (3402.12)
benzethidine benzéthidine 2933.39 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 9 3691-78-9
benzfetamine benzfétamine 2921.46 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 55 156-08-1
benzhydrocodone benzhydrocodone 2939.19 NC2116B1b Ann. R/5 HSC/55 2015 111 1259440-61-3
benzindopyrine benzindopyrine 2933.39 38.100 Ann. Q (No. 177) HSC/11 1993 13 16571-59-8
benzodrocortisone benzodrocortisone 2937.29 NC2501B1b Ann. M/5 HSC/61 2018 116 28956-89-0
benzonatate benzonatate 3402.42 NC2803Bc Ann. T/4 HSC/67 2021 6 104-31-4 HSC/18 (3402.13)
benzopyrronium bromide bromure de benzopyrronium 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 12 13696-15-6 HSC/11 (2933.90)
benzpiperylone benzpipérylone 2933.39 38.100 Ann. Q (No. 55) HSC/11 1993 13 53-89-4
beperminogene perplasmid béperminogène perplasmide 2934.99 NC1310B1b Ann. N/7 HSC/41 2008 95 627861-07-8
bepirovirsen bépirovirsen 2934.99 NC2803Bc Ann. T/7 HSC/67 2021 123 1403787-62-1
bepotastine bépotastine 2933.39 42.750 Ann. O HSC/22 1998 78 125602-71-3
bepranemab bépranémab 3002.13 NC2803Bc Ann. T/6 HSC/67 2021 122 2244960-75-4
berdazimer sodium berdazimère sodique 3910.00 NC2501B1b Ann. M/6 HSC/61 2018 117 1846565-00-1
beremagene geperpavec bérémagène géperpavec 3002.49 NC2930Bc Ann. P/33 HSC/69 2022 123 2241888-62-8 HSC/67 (3002.90)
berlafenone berlafénone 2922.19 40.260 Ann. L/2 (No. 43) HSC/17 1996 63 18965-97-4
berlimatoxumab berlimatoxumab 3002.13 NC2501B1b Ann. M/6 HSC/61 2018 117 1939109-24-6
bermekimab bermékimab 3002.13 NC2803Bc Ann. T/2 HSC/67 2021 120 1401965-15-8
beroctocog alfa béroctocog alfa 3002.12 NC2116B1b Ann. S/2 HSC/55 2015 95 9001-27-8 HSC/41 (3002.10)
berotralstat bérotralstat 2933.19 NC2803Bc Ann. T/2 HSC/67 2021 120 1809010-50-1
bersacapavir bersacapavir 2935.90 NC2803Bc Ann. T/6 HSC/67 2021 122 1638266-40-6
bersanlimab bersanlimab 3002.13 NC2626B1b Ann. O/5 HSC/63 2019 118 1987854-08-9
bertilimumab bertilimumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 88 375348-49-5 HSC/33 (3002.10)
berubicin bérubicine 2941.90 NC1553B1b Ann. O/3 HSC/45 2010 98 677017-23-1
berupipam bérupipam 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 71 150490-85-0 HSC/18 (2934.90)
bervastatin bervastatine 2932.99 40.600 Ann. D, par. 6 HSC/18 1996 72 132017-01-7

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
berzosertib berzosertib 2934.99 NC2501B1b Ann. M/6 HSC/61 2018 117 1232416-25-9
besifloxacin bésifloxacine 2933.49 NC1443B1b Ann. P/5 HSC/43 2009 98 141388-76-3
besifovir bésifovir 2933.59 NC1760B1b Ann. N/8 HSC/49 2012 105 441785-25-7
besilesomab besilesomab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 92 537694-98-7 HSC/37 (3002.10)
besipirdine bésipirdine 2933.39 40.600 Ann. D, par. 6 HSC/18 1996 70 119257-34-0
betacetylmethadol bétacétylméthadol 2922.19 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 5 17199-59-6
betameprodine bétaméprodine 2933.39 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 1 468-50-8
betamethadol bétaméthadol 2922.19 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 5 17199-55-2
betamicin bétamicine 2941.90 42.100 Ann. O (II) HSC/21 1998 38 36889-15-3
betaprodine bétaprodine 2933.39 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 5 468-59-7
betasizofiran bétasizofiran 3913.90 40.600 Ann. D, par. 6 HSC/18 1996 72 39464-87-4
betaxolol bétaxolol 2922.19 40.260 Ann. L/2 (No. 44) HSC/17 1996 40 63659-18-7
betiatide bétiatide 2930.90 38.100 Ann. Q (No. 179) HSC/11 1993 58 103725-47-9
betibeglogene autotemcel bétibéglogène autotemcel 3002.51 NC2803Bc Ann. T/3 HSC/67 2021 121 no mention
betibeglogene darolentivec bétibéglogène darolentivec 3002.49 NC2930Bc Ann. P/33 HSC/69 2022 116 1905394-85-5 HSC/61 (3002.90)
betoxycaine bétoxycaïne 2922.50 40.260 Ann. L/2 (No. 9) HSC/17 1996 13 3818-62-0
betrixaban bétrixaban 2933.39 NC1443B1b Ann. P/5 HSC/43 2009 98 330942-05-7
bevacizumab bevacizumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 83 216974-75-3 HSC/27 (3002.10)
bevacizumab beta bévacizumab bêta 3002.13 NC2373B1b Ann. O/6 HSC/59 2017 114 1438851-35-4
bevasiranib bévasiranib 2934.99 NC1443B1b Ann. P/6 HSC/43 2009 99 959961-96-7
bevenopran bévénopran 2934.99 NC1874B1b Ann. O/2 HSC/51 2013 107 676500-67-7
bevifimod bévifimod 2933.29 NC2626B1b Ann. O/6 HSC/63 2019 119 2223113-32-2
bevirimat bévirimat 2918.19 NC1310B1b Ann. N/10 HSC/41 2008 96 174022-42-5
bevufenogene nofeparvovec bévufénogène noféparvovec 3002.49 NC2930Bc Ann. P/25 HSC/69 2022 124 2374772-30-0
bevurogant bévurogant 2933.59 NC2930Bc Ann. P/27 HSC/69 2022 125 1817773-66-2
bexaglifozin bexaglifozine 2932.99 NC2237B1b Ann. S/9 HSC/57 2016 113 1118567-05-7
bexarotene bexarotène 2916.39 NC0090B2 Ann. M/5 HSC/23 1999 80 153559-49-0
bexlosteride bexlostéride 2933.79 NC0250B2 Ann. P/1 (II) HSC/25 2000 81 148905-78-6
bexmarilimab bexmarilimab 3002.13 NC2803Bc Ann. T/6 HSC/67 2021 122 2259301-27-2
bezafibrate bézafibrate 2924.29 38.100 Ann. Q (No. 180) HSC/11 1993 35 41859-67-0
bezitramide bézitramide 2933.33 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 15 15301-48-1
bezlotoxumab bezlotoxumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 107 1246264-45-8 HSC/51 (3002.10)
biapenem biapénem 2941.90 39.600 Ann. D/1, par. 15 HSC/16 1995 69 120410-24-4
bibapcitide bibapcitide 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 78 153507-46-1 HSC/22 (2934.90)
bicalutamide bicalutamide 2930.90 40.600 Ann. D, par. 6 HSC/18 1996 70 90357-06-5
bictegravir bictégravir 2934.99 NC2237B1b Ann. S/9 HSC/57 2016 113 1611493-60-7
bidridistrogene xeboparvovec bidridistrogène xéboparvovec 3002.49 NC2930Bc Ann. P/27 HSC/69 2022 125 2365142-14-7
bifarcept bifarcept 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 86 163796-60-9 HSC/47 (3002.10)
bifeprunox biféprunox 2934.99 NC0730B2 Ann. M/7 HSC/31 2003 87 350992-10-8

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
bifikafusp alfa bifikafusp alfa 3002.13 NC2626B1b Ann. O/5 HSC/63 2019 118 1957239-90-5
bilastine bilastine 2933.39 NC0430B2 Ann. Q/1 (I) HSC/27 2001 82 202189-78-4
bimagrumab bimagrumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 108 1356922-05-8 HSC/53 (3002.10)
bimatoprost bimatoprost 2937.50 NC0730B2 Ann. M/4 (III) HSC/31 2003 85 155206-00-1
bimekizumab bimékizumab 3002.13 NC2237B1b Ann. T/13 HSC/57 2016 110 1418205-77-2 HSC/55 (3002.10)
bimiralisib bimiralisib 2934.99 NC2501B1b Ann. M/5 HSC/61 2018 116 1225037-39-7
bimoclomol bimoclomol 2933.39 42.100 Ann. O (V) HSC/21 1998 76 130493-03-7
bimosiamose bimosiamose 2940.00 NC0590B2 Ann. L/15 HSC/29 2002 84 187269-40-5
binetrakin binétrakine 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 82 207137-56-2 HSC/27 (3002.10)
binfloxacin binfloxacine 2933.49 NC2004B1b Ann. O/6 HSC/53 2014 60 108437-28-1 HSC/11 (2933.40)
binimetinib binimétinib 2933.99 NC2004B1b Ann. O/5 HSC/53 2014 109 606143-89-9
binizolast binizolast 2933.59 38.100 Ann. Q (No. 182) HSC/11 1993 60 86662-54-6
binodenoson binodénoson 2934.99 NC0938B2b Ann. O/3 (I) HSC/35 2005 90 144348-08-3
bintrafusp alfa bintrafusp alfa 3002.13 NC2626B1b Ann. O/6 HSC/63 2019 119 1918149-01-5
birabresib birabrésib 2934.99 NC2373B1b Ann. O/7 HSC/59 2017 115 202590-98-5
biricodar biricodar 2933.39 42.750 Ann. O HSC/22 1998 78 159997-94-1
birinapant birinapant 2933.99 NC1874B1b Ann. O/2 HSC/51 2013 107 1260251-31-7
biriperone biripérone 2933.59 40.260 Ann. L/2 (No. 21) HSC/17 1996 51 41510-23-0
birtamimab birtamimab 3002.13 NC2626B1b Ann. O/6 HSC/63 2019 119 1608108-91-3
bisaramil bisaramil 2933.39 38.100 Ann. Q (No. 183) HSC/11 1993 60 89194-77-4
bisegliptin biségliptine 2933.99 NC1760B1b Ann. N/7 HSC/49 2012 104 862501-61-9
bisnafide bisnafide 2925.19 40.600 Ann. D, par. 6 HSC/18 1996 73 144849-63-8
bisoctrizole bisoctrizole 2933.99 NC1004B1b Ann. L/11 HSC/36 2005 92 103597-45-1
bisoprolol bisoprolol 2922.19 40.260 Ann. L/2 (No. 45) HSC/17 1996 48 66722-44-9
bivalirudin bivalirudine 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 72 128270-60-0 HSC/18 (2933.90)
bivatuzumab bivatuzumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 83 214559-60-1 HSC/27 (3002.10)
bixalomer bixalomère 3911.90 NC1760B1b Ann. N/3 HSC/49 2012 101 851373-13-2
bizalimogene ralaplasmid bizalimogène ralaplasmide 2934.99 NC2626B1b Ann. O/5 HSC/63 2019 118 1977488-08-6
blarcamesine blarcamésine 2932.19 NC2803Bc Ann. T/2 HSC/67 2021 120 195615-83-9
HSC/57 (3002.10)
bleselumab blésélumab 3002.13 NC2237B1b Ann. T/11 HSC/57 2016 113 1453067-91-8
(S/9)
blinatumomab blinatumomab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 100 853426-35-4 HSC/44 (3002.10)
blisibimod blisibimod 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 107 1236126-45-6 HSC/51 (3002.10)
blonanserin blonansérine 2933.59 42.100 Ann. O (V) HSC/21 1998 76 132810-10-7
blontuvetmab blontuvetmab 3002.13 NC2373B1b Ann. O/6 HSC/59 2017 114 1608112-78-2
blosozumab blosozumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 105 1132758-87-2 HSC/49 (3002.10)
boceprevir bocéprévir 2933.99 NC1310B1b Ann. N/4 HSC/41 2008 97 394730-60-0
bococizumab bococizumab 3002.13 NC2237B1b Ann. T/13 HSC/57 2016 110 1407495-02-6 HSC/55 (3002.10)
bofelisimer bofélisimère 3908.90 NC2930Bc Ann. P/27 HSC/69 2022 125 2485035-32-1

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
bomedemstat bomédemstat 2933.59 NC2803Bc Ann. T/6 HSC/67 2021 122 1990504-34-1
bomtabegagene bavoparvovec bomtabégagène bavoparvovec 3002.49 NC2930Bc Ann. P/27 HSC/69 2022 125 2364477-20-1
bornaprolol bornaprolol 2922.19 40.260 Ann. L/2 (No. 46) HSC/17 1996 46 66451-06-7
borofalan (10B) borofalan (10B) 2845.20 NC2803Bc Ann. T/4 HSC/67 2021 118 80994-59-8 HSC/63 (2845.90)
bortezomib bortezomib 2933.99 NC0845B2 Ann. M/2 HSC/33 2004 88 179324-69-7
bosentan bosentan 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 70 147536-97-8 HSC/18 (2935.00)
bosutinib bosutinib 2933.59 NC1178B1c Ann. O/3 HSC/39 2007 94 380843-75-4
botensilimab botensilimab 3002.13 NC2930Bc Ann. P/25 HSC/69 2022 124 2408310-37-0
bovhyaluronidase azoximer bovhyaluronidase azoximère 3507.90 NC2237B1b Ann. S/8 HSC/57 2016 112 1383710-57-3
bradanicline bradanicline 2934.99 NC2116B1b Ann. R/5 HSC/55 2015 111 639489-84-2
branaplam branaplam 2933.39 NC2373B1b Ann. O/7 HSC/59 2017 115 1562338-42-4
branebrutinib branébrutinib 2933.39 NC2803Bc Ann. T/3 HSC/67 2021 121 1912445-55-6
brasofensine brasofensine 2933.39 42.100 Ann. O (V) HSC/21 1998 76 171655-91-7
brazergoline brazergoline 2939.69 NC2004B1b Ann. O/6 HSC/53 2014 37 60019-20-7 HSC/11 (2939.60)
brazikumab brazikumab 3002.13 NC2373B1b Ann. O/7 HSC/59 2017 115 1610353-18-8
brecanavir brécanavir 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 94 313682-08-5 HSC/39 (2935.00)
bremazocine brémazocine 2933.39 38.100 Ann. Q (No. 185) HSC/11 1993 43 71990-00-6
bremelanotide brémélanotide 2933.79 NC1178B1c Ann. O/5 HSC/39 2007 95 189691-06-3
brensocatib brensocatib 2934.99 NC2803Bc Ann. T/3 HSC/67 2021 121 1802148-05-5
brentuximab vedotin brentuximab védotine 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 103 914088-09-08 HSC/47 (3002.10)
brepocitinib brépocitinib 2933.59 NC2803Bc Ann. T/3 HSC/67 2021 121 1883299-62-4
brexanolone brexanolone 2914.40 NC2501B1b Ann. M/6 HSC/61 2018 117 516-54-1
brexpiprazole brexpiprazole 2934.99 NC1874B1b Ann. O/1 HSC/51 2013 106 913611-97-9
brexucabtagene autoleucel bréxucabtagène autoleucel 3002.51 NC2930Bc Ann. P/27 HSC/69 2022 125 no mention
briakinumab briakinumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 101 339308-60-0 HSC/46 (3002.10)
briciclib briciclib 2930.90 NC2116B1b Ann. R/5 HSC/55 2015 111 865783-99-9
brifentanil brifentanil 2933.34 NC2803Bc Ann. T/4 HSC/67 2021 63 101345-71-5 HSC/11 (2933.39)
brigatinib brigatinib 2933.59 NC2237B1b Ann. S/9 HSC/57 2016 113 1197953-54-0
brilacidin brilacidine 2933.59 NC2004B1b Ann. O/4 HSC/53 2014 108 1224095-98-0
brilanestrant brilanestrant 2933.99 NC2373B1b Ann. O/7 HSC/59 2017 115 1365888-06-7
brilaroxazine brilaroxazine 2934.99 NC2626B1b Ann. O/6 HSC/63 2019 119 1239729-06-6
brimapitide brimapitide 2933.99 NC2373B1b Ann. O/6 HSC/59 2017 114 1445179-97-4
brincidofovir brincidofovir 2933.59 NC2116B1b Ann. R/4 HSC/55 2015 110 444805-28-1
brinzolamide brinzolamide 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 76 138890-62-7 HSC/21 (2935.00)
briobacept briobacept 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 98 869881-54-9 HSC/43 (3002.10)
brivanib alaninate brivanib alaninate 2933.99 NC1310B1b Ann. N/4 HSC/41 2008 97 649735-63-7
brivaracetam brivaracetam 2933.79 NC1059B2b Ann. O/5 HSC/37 2006 93 357336-20-0
brivoligide brivoligide 2934.99 NC2501B1b Ann. M/5 HSC/61 2018 116 1803075-42-4
brobactam brobactam 2941.90 42.100 Ann. O (II) HSC/21 1998 53 26631-90-3

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
brodalumab brodalumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 105 1174395-19-7 HSC/49 (3002.10)
brolamfetamine brolamfétamine 2922.29 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 55 64638-07-9
HSC/57 (3002.10)
brolucizumab brolucizumab 3002.13 NC2237B1b Ann. T/10 HSC/57 2016 112 1531589-13-5
(S/8)
bromazepam bromazépam 2933.33 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 22 1812-30-2
bromerguride bromerguride 2939.69 NC2004B1b Ann. O/6 HSC/53 2014 51 83455-48-5 HSC/11 (2939.69)
brometenamine brométénamine 2933.69 40.260 Ann. L/2 (No. 22) HSC/17 1996 12 15585-71-4
bromhexine bromhexine 2921.59 38.100 Ann. Q (No. 188) HSC/11 1993 20 3572-43-8
bromindione bromindione 2914.79 NC2116B1b Ann. S/1 HSC/55 2015 12 1146-98-1 HSC/11 (2914.70)
brontictuzumab brontictuzumab 3002.13 NC2237B1b Ann. T/13 HSC/57 2016 111 1447814-75-6 HSC/55 (3002.10)
broperamole bropéramole 2933.39 38.100 Ann. Q (No. 190) HSC/11 1993 42 33144-79-5
brostallicin brostallicine 2933.99 NC0590B2 Ann. L/15 HSC/29 2002 84 203258-60-0
brotizolam brotizolam 2934.91 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 40 57801-81-7
bucelipase alfa bucélipase alfa 3507.90 NC1178B1c Ann. O/5 HSC/39 2007 95 9026-00-0
buciclovir buciclovir 2933.59 38.100 Ann. Q (No. 191) HSC/11 1993 52 86304-28-1
budesonide budésonide 2937.29 38.100 Ann. Q (No. 192) HSC/11 1993 37 51333-22-3
budigalimab budigalimab 3002.13 NC2626B1b Ann. O/6 HSC/63 2019 119 2098225-93-3
budiodarone budiodarone 2932.99 NC1604B1b Ann. N/5 HSC/46 2010 101 335148-45-3
budotitane budotitane 2914.40 NC2004B1b Ann. O/6 HSC/53 2014 56 85969-07-9 HSC/11 (2914.49)
bulaquine bulaquine 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 82 223661-25-4 HSC/27 (2934.90)
bulevirtide bulévirtide 2933.29 NC2626B1b Ann. O/5 HSC/63 2019 118 2012558-47-1
bumepidil bumépidil 2933.59 38.100 Ann. Q (No. 194) HSC/11 1993 44 62052-97-5
bunaprolast bunaprolast 2915.39 38.100 Ann. Q (No. 195) HSC/11 1993 60 99107-52-5
bunazosin bunazosine 2933.59 38.100 Ann. Q (No. 196) HSC/11 1993 50 80755-51-7
bunolol bunolol 2922.19 40.260 Ann. L/2 (No. 47) HSC/17 1996 22 27591-01-1
buparlisib buparlisib 2934.99 NC1874B1b Ann. O/1 HSC/51 2013 106 944396-07-0
bupranolol bupranolol 2922.19 40.260 Ann. L/2 (No. 48) HSC/17 1996 27 14556-46-8
buprenorphine buprénorphine 2939.11 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 29 52485-79-7
buquiterine buquitérine 2933.59 38.100 Ann. Q (No. 197) HSC/11 1993 53 76536-74-8
burapitant burapitant 2934.99 NC1604B1b Ann. N/5 HSC/46 2010 101 537034-22-3
burixafor burixafor 2933.59 NC1760B1b Ann. N/7 HSC/49 2012 104 1191448-17-5
burlulipase burlulipase 3507.90 NC1874B1b Ann. O/2 HSC/51 2013 107 1261982-91-5
burosumab burosumab 3002.13 NC2373B1b Ann. O/7 HSC/59 2017 115 1610833-03-8
buserelin buséréline 2937.19 NC2004B1b Ann. O/6 HSC/53 2014 36 57982-77-1 HSC/11 (2937.99)
busulfan busulfan 2905.39 42.100 Ann. O (I) HSC/21 1998 6 55-98-1
butalbital butalbital 2933.53 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 4 77-26-9
butamirate butamirate 2922.19 40.260 Ann. L/2 (No. 49) HSC/17 1996 22 18109-80-3
buthalital sodium buthalital sodique 2933.59 38.100 Ann. Q (No. 199) HSC/11 1993 8 510-90-7
butixocort butixocort 2937.29 38.100 Ann. Q (No. 200) HSC/11 1993 63 120815-74-9

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
butofilolol butofilolol 2922.19 40.260 Ann. L/2 (No. 50) HSC/17 1996 40 64552-17-6
butorphanol butorphanol 2933.49 NC2004B1b Ann. O/6 HSC/53 2014 33 42408-82-2 HSC/13 (2933.40)
HSC/11 (2939.90)
butropium bromide bromure de butropium 2939.79 NC2116B1b Ann. S/1 HSC/55 2015 30 29025-14-7
HSC/53 (2939.99)
butylphthalide butylphthalide 2932.20 NC2116B1b Ann. R/5 HSC/55 2015 111 6066-49-5
cabazitaxel cabazitaxel 2932.99 NC1443B1b Ann. P/5 HSC/43 2009 98 183133-96-2
cabiotraxetan cabiotraxétan 2934.99 NC1604B1b Ann. N/6 HSC/46 2010 102 451478-45-8
cabiralizumab cabiralizumab 3002.13 NC2373B1b Ann. O/6 HSC/59 2017 114 1613144-80-1
cabotegravir cabotégravir 2934.99 NC2116B1b Ann. R/5 HSC/55 2015 111 1051375-10-0
cabozantinib cabozantinib 2933.49 NC1760B1b Ann. N/8 HSC/49 2012 105 849217-68-1
cadalimogene ixalentivec cadalimogène ixalentivec 3002.49 NC2930Bc Ann. P/33 HSC/69 2022 120 2137091-21-3 HSC/67 (3002.90)
cadazolid cadazolid 2934.99 NC1760B1b Ann. N/7 HSC/49 2012 104 1025097-10-2
cadonilimab cadonilimab 3002.13 NC2930Bc Ann. P/25 HSC/69 2022 124 2394841-59-7
cadrofloxacin cadrofloxacine 2933.59 NC0250B2 Ann. P/1 (II) HSC/25 2000 81 153808-85-6
caficrestat caficrestat 2934.20 NC2930Bc Ann. P/25 HSC/69 2022 124 1355612-71-3
cagrilintide cagrilintide 2937.19 NC2803Bc Ann. T/7 HSC/67 2021 123 1415456-99-3
calaspargase pegol calaspargase pégol 3507.90 NC1760B1b Ann. N/8 HSC/49 2012 105 941577-06-6
calcium carbimide carbimide calcique 3102.90 NC2004B1b Ann. O/6 HSC/53 2014 10 156-62-7 HSC/11 (3102.70)
calcobutrol calcobutrol 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 79 151878-23-8 HSC/25 (2933.90)
caldaret caldaret 2933.59 NC0590B2 Ann. L/15 HSC/29 2002 85 133804-44-1
caloxetic acid acide caloxétique 2922.50 NC0250B2 Ann. P/1 (II) HSC/25 2000 81 135306-78-4
camazepam camazépam 2933.91 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 30 36104-80-0
camicinal camicinal 2933.59 NC1874B1b Ann. O/1 HSC/51 2013 106 923565-21-3
camidanlumab camidanlumab 3002.13 NC2501B1b Ann. M/6 HSC/61 2018 117 921618-45-3
camidanlumab tesirine camidanlumab tésirine 3002.13 NC2501B1b Ann. M/6 HSC/61 2018 117 1853239-04-9
camizestrant camizestrant 2933.39 NC2930Bc Ann. P/27 HSC/69 2022 125 2222844-89-3
camobucol camobucol 2930.90 NC1178B1c Ann. O/5 HSC/39 2007 95 216167-92-9
camrelizumab camrélizumab 3002.13 NC2373B1b Ann. O/7 HSC/59 2017 115 1798286-48-2
camsirubicin camsirubicine 2941.90 NC2626B1b Ann. O/6 HSC/63 2019 119 236095-26-4
canagliflozin canagliflozine 2934.99 NC1604B1b Ann. N/6 HSC/46 2010 102 842133-18-0
402710-27-4 (light
canakinumab canakinumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 97 chain) 402710-25- HSC/41 (3002.10)
2 (heavy chain)
candesartan candésartan 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 71 139481-59-7 HSC/18 (2933.90)
candocuronium iodide iodure de candocuronium 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 70 54278-85-2 HSC/18 (2933.90)
canerpaturev canerpaturev 3002.49 NC2930Bc Ann. P/33 HSC/69 2022 117 1662666-66-1 HSC/61 (3002.90)
canertinib canertinib 2934.99 NC0730B2 Ann. M/7 HSC/31 2003 87 267243-28-7
canfosfamide canfosfamide 2930.90 NC1059B2b Ann. O/4 HSC/37 2006 92 158382-37-7
cangrelor cangrélor 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 82 163706-06-7 HSC/27 (2934.90)

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
cannabidiol cannabidiol 2907.29 NC2373B1b Ann. O/7 HSC/59 2017 115 13956-29-1
canoctakin canoctakine 3002.13 NC2237B1b Ann. T/13 HSC/57 2016 110 1019859-03-0 HSC/55 (3002.10)
canosimibe canosimibe 2933.79 NC1500B1b Ann. K/6 HSC/44 2009 100 768394-99-6
cantharidin cantharidine 2932.19 NC2803Bc Ann. T/7 HSC/67 2021 123 56-25-7
cantuzumab ravtansine cantuzumab ravtansine 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 105 868747-45-9 HSC/49 (3002.10)
capadenoson capadénoson 2934.10 NC1178B1c Ann. O/5 HSC/39 2007 95 544417-40-5
capecitabine capécitabine 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 72 154361-50-9 HSC/18 (2934.90)
capeserod capésérod 2934.99 NC1123B1b Ann. N/1 HSC/38 2006 94 769901-96-4
capivasertib capivasertib 2933.59 NC2501B1b Ann. M/6 HSC/61 2018 117 1143532-39-1
caplacizumab caplacizumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 106 915810-67-2 HSC/51 (3002.10)
capmatinib capmatinib 2933.49 NC2116B1b Ann. R/5 HSC/55 2015 111 1029712-80-8
capravirine capravirine 2933.39 NC0430B2 Ann. Q/1 (II) HSC/27 2001 83 178979-85-6
capromab capromab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 70 151763-64-3 HSC/18 (3002.10)
capromorelin capromoréline 2933.99 NC1874B1b Ann. O/3 HSC/51 2013 83 193273-66-4 HSC/27 (2933.90)
HSC/57 (2933.99)
capsaicin capsaïcine 2939.79 NC2237B1b Ann. T/11 HSC/57 2016 113 404-86-4
(S/9)
carabersat carabersat 2932.99 NC0090B2 Ann. M/5 HSC/23 1999 80 184653-84-7
carafiban carafiban 2933.29 42.750 Ann. O HSC/22 1998 78 177563-40-5
carbaldrate carbaldrate 2842.90 40.260 Ann. L/2 (No. 4) HSC/17 1996 53 41342-54-5
carbasalate calcium carbasalate calcique 2924.29 38.100 Ann. Q (No. 202) HSC/11 1993 27 5749-67-7
carbazocine carbazocine 2933.49 NC2004B1b Ann. O/6 HSC/53 2014 16 15686-38-1 HSC/11 (2933.40)
carbetimer carbétimère 3911.90 38.100 Ann. Q (No. 204) HSC/11 1993 50 82230-03-3
carboplatin carboplatine 2843.90 38.100 Ann. Q (No. 205) HSC/11 1993 48 41575-94-4
carfenazine carfénazine 2934.30 38.100 Ann. Q (No. 206) HSC/11 1993 12 2622-30-2
carfilzomib carfilzomib 2934.99 NC1310B1b Ann. N/4 HSC/41 2008 97 868540-17-4
carfloglitazar carfloglitazar 2933.99 NC2803Bc Ann. T/7 HSC/67 2021 123 2213406-75-6
carglumic acid acide carglumique 2924.19 NC0590B2 Ann. L/15 HSC/29 2002 84 1188-38-1
caricotamide caricotamide 2933.39 NC1059B2b Ann. O/5 HSC/37 2006 93 64881-21-6
cariporide cariporide 2930.90 42.100 Ann. O (III) HSC/21 1998 74 159138-80-4
cariprazine cariprazine 2933.59 NC1443B1b Ann. P/5 HSC/43 2009 98 839712-12-8
carisbamate carisbamate 2924.29 NC1310B1b Ann. N/10 HSC/41 2008 96 194085-75-1
carlumab carlumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 104 915404-94-3 HSC/49 (3002.10)
carmegliptin carmégliptine 2933.79 NC1443B1b Ann. P/5 HSC/43 2009 98 813452-18-5
carmofur carmofur 2933.59 38.100 Ann. Q (No. 207) HSC/11 1993 45 61422-45-5
carmoterol carmotérol 2933.79 NC0938B2b Ann. O/3 (II) HSC/35 2005 91 147568-66-9
carotegrast carotégrast 2933.59 NC1604B1b Ann. N/6 HSC/46 2010 102 401904-75-4
carotuximab carotuximab 3002.13 NC2373B1b Ann. O/6 HSC/59 2017 114 1268714-50-6
cartasteine cartastéine 2934.10 40.600 Ann. D, par. 6 HSC/18 1996 72 149079-51-6
carumonam carumonam 2941.90 38.100 Ann. Q (No. 208) HSC/11 1993 51 87638-04-8

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
casimersen casimersen 2934.99 NC2447B1b Ann. N/2 HSC/60 2017 115 1422958-19-7
casirivimab casirivimab 3002.13 NC2803Bc Ann. T/11 HSC/67 2021
124 COVID-19
2415933-42-3
casopitant casopitant 2933.59 NC1178B1c Ann. O/3 HSC/39 2007 94 414910-27-3
caspofungin caspofungine 2941.90 NC0250B2 Ann. P/1 (I) HSC/25 2000 80 162808-62-0
catequentinib catéquentinib 2933.49 NC2803Bc Ann. T/3 HSC/67 2021 121 1058156-90-3
cathine cathine 2939.43 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 44 492-39-7
cathinone cathinone 2939.79 NC2116B1b Ann. S/1 HSC/55 2015 44 71031-15-7 HSC/25 (2939.99)
catramilast catramilast 2933.29 NC1178B1c Ann. O/5 HSC/39 2007 95 183659-72-5
catridecacog catridécacog 3002.12 NC2116B1b Ann. S/2 HSC/55 2015 99 606138-08-3 HSC/43 (3002.10)
catumaxomab catumaxomab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 93 509077-98-9 HSC/37 (3002.10)
cavosonstat cavosonstat 2933.49 NC2501B1b Ann. M/5 HSC/61 2018 116 1371587-51-7
cavrotolimod cavrotolimod 2934.99 NC2930Bc Ann. P/25 HSC/69 2022 124 2378664-12-9
cebranopadol cébranopadol 2934.99 NC1874B1b Ann. O/2 HSC/51 2013 107 863513-91-1
ceclazepide céclazépide 2933.39 NC2501B1b Ann. M/5 HSC/61 2018 116 1801749-44-9
cedazuridine cédazuridine 2934.99 NC2626B1b Ann. O/5 HSC/63 2019 118 1141397-80-9
cedelizumab cédélizumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 77 156586-90-2 HSC/21 (3002.10)
cediranib cédiranib 2933.59 NC1178B1c Ann. O/5 HSC/39 2007 95 288383-20-0
cedirogant cédirogant 2933.39 NC2803Bc Ann. T/7 HSC/67 2021 123 2055496-11-0
cefiderocol céfidérocol 2941.90 NC2373B1b Ann. O/6 HSC/59 2017 114 1225208-94-5
cefilavancin céfilavancine 2941.90 NC2116B1b Ann. R/5 HSC/55 2015 111 722454-12-8
cefluprenam céfluprénam 2941.90 40.600 Ann. D, par. 6 HSC/18 1996 71 116853-25-9
cefmatilen cefmatilène 2941.90 NC0250B2 Ann. P/1 (II) HSC/25 2000 81 140128-74-1
cefoselis céfosélis 2941.90 40.600 Ann. D, par. 6 HSC/18 1996 71 122841-10-5
cefovecin céfovécine 2941.90 NC0730B2 Ann. M/7 HSC/31 2003 87 234096-34-5
cefquinome cefquinome 2941.90 38.100 Ann. Q (No. 209) HSC/11 1993 59 84957-30-2
ceftaroline fosamil ceftaroline fosamil 2941.90 NC1310B1b Ann. N/4 HSC/41 2008 97 229016-73-3
cefteram ceftéram 2941.90 38.100 Ann. Q (No. 210) HSC/11 1993 55 82547-58-8
ceftizoxime alapivoxil ceftizoxime alapivoxil 2941.90 42.100 Ann. O (VI) HSC/21 1998 77 135821-54-4
ceftobiprole ceftobiprole 2941.90 NC1004B1b Ann. L/11 HSC/36 2005 92 209467-52-7
ceftobiprole medocaril ceftobiprole médocaril 2941.90 NC1004B1b Ann. L/11 HSC/36 2005 92 376653-43-9
ceftolozane ceftolozane 2941.90 NC1760B1b Ann. N/8 HSC/49 2012 105 689293-68-3
cefuzonam céfuzonam 2941.90 38.100 Ann. Q (No. 211) HSC/11 1993 55 82219-78-1
celecoxib célécoxib 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 80 169590-42-5 HSC/23 (2935.00)
celgosivir celgosivir 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 77 121104-96-9 HSC/21 (2933.90)
celivarone célivarone 2932.99 NC1123B1b Ann. N/1 HSC/38 2006 94 401925-43-7
cemadotin cémadotine 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 75 159776-69-9 HSC/21 (2933.90)
cemdisiran cemdisiran 2934.99 NC2373B1b Ann. O/6 HSC/59 2017 114 1639264-46-2
cemiplimab cémiplimab 3002.13 NC2626B1b Ann. O/6 HSC/63 2019 119 1801342-60-8
cendakimab cendakimab 3002.13 NC2803Bc Ann. T/2 HSC/67 2021 120 2151032-62-9

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
cenderitide cendéritide 2937.19 NC1760B1b Ann. N/8 HSC/49 2012 105 507289-11-4
cenegermin cénégermine 3002.13 NC2373B1b Ann. O/7 HSC/59 2017 115 1772578-74-1
cenerimod cénérimod 2934.99 NC2237B1b Ann. S/9 HSC/57 2016 113 1262414-04-9
cenersen cénersen 2934.99 NC1310B1b Ann. N/4 HSC/41 2008 97 872847-66-0
cenicriviroc cénicriviroc 2933.29 NC1649B3b Ann. R/14 HSC/47 2011 103 497223-25-3
cenisertib cénisertib 2933.59 NC1760B1b Ann. N/7 HSC/49 2012 104 871357-89-0
cenobamate cénobamate 2933.99 NC2237B1b Ann. S/9 HSC/57 2016 113 913088-80-9
cenplacel cenplacel 3002.51 NC2803Bc Ann. T/4 HSC/67 2021 115 no mention HSC/61 (3002.90)
censavudine censavudine 2934.99 NC2116B1b Ann. R/4 HSC/55 2015 110 634907-30-5
centanafadine centanafadine 2933.99 NC2237B1b Ann. S/8 HSC/57 2016 112 924012-43-1
centhaquine centhaquine 2933.59 NC2803Bc Ann. T/3 HSC/67 2021 121 57961-90-7
cenupatide cénupatide 2925.29 NC2626B1b Ann. O/6 HSC/63 2019 119 1006388-38-0
cepeginterferon alfa-2b cépeginterféron alfa-2b 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 105 1192706-52-7 HSC/49 (3002.10)
ceralasertib céralasertib 2934.99 NC2626B1b Ann. O/6 HSC/63 2019 119 1352226-88-0
ceralifimod céralifimod 2933.99 NC2004B1b Ann. O/5 HSC/53 2014 109 891859-12-4
cerdulatinib cerdulatinib 2935.90 NC2237B1b Ann. T/12 HSC/57 2016 111 1198300-79-6 HSC/55 (2935.00)
HSC/57 (3002.10)
cergutuzumab amunaleukin cergutuzumab amunaleukine 3002.13 NC2237B1b Ann. T/11 HSC/57 2016 113 1509916-03-3
(S/9)
ceritinib céritinib 2933.59 NC2004B1b Ann. O/5 HSC/53 2014 109 1032900-25-6
cerivastatin cérivastatine 2933.39 42.100 Ann. O (III) HSC/21 1998 74 145599-86-6
cerlapirdine cerlapirdine 2933.99 NC1874B1b Ann. O/1 HSC/51 2013 106 925448-93-7
cerliponase alfa cerliponase alfa 3507.90 NC2116B1b Ann. R/5 HSC/55 2015 111 151662-36-1
certolizumab pegol certolizumab pegol 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 90 428863-50-7 HSC/35 (3002.10)
certoparin sodium certoparine sodique 3001.90 NC1553B1b Ann. O/5 HSC/45 2010 70 0-00-0
ceruletide cérulétide 2933.79 40.260 Ann. L/2 (No. 23) HSC/17 1996 34 17650-98-5
HSC/21 (2937.99)
cetermin cétermine 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 74 157238-32-9
HSC/47 (3002.10)
cethromycin céthromycine 2941.90 NC0845B2 Ann. M/1 (II) HSC/33 2004 87 205110-48-1
cetilistat cétilistat 2934.99 NC0938B2b Ann. O/3 (II) HSC/35 2005 91 282526-98-1
cetrelimab cétrélimab 3002.13 NC2626B1b Ann. O/5 HSC/63 2019 118 2050478-92-5
cetrimide cétrimide 3808.94 NC2004B1b Ann. O/6 HSC/53 2014 46 505-86-2 HSC/17 (3808.40)
cetuximab cétuximab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 82 205923-56-4 HSC/27 (3002.10)
cetuximab sarotalocan cétuximab sarotalocan 3002.13 NC2803Bc Ann. T/2 HSC/67 2021 120 2166339-33-7
cevaretigene ritoparvovec cévarétigène ritoparvovec 3002.49 NC2930Bc Ann. P/33 HSC/69 2022 123 2247971-00-0 HSC/67 (3002.90)
cevidoplenib cévidoplénib 2934.99 NC2626B1b Ann. O/5 HSC/63 2019 118 1703788-21-9
cevimeline céviméline 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 76 107233-08-9 HSC/21 (2934.90)
cevipabulin cévipabulin 2933.59 NC1310B1b Ann. N/10 HSC/41 2008 96 849550-05-6
cevoglitazar cévoglitazar 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 94 839673-52-8 HSC/39 (2935.00)
cevostamab cévostamab 3002.13 NC2803Bc Ann. T/6 HSC/67 2021 122 2249888-53-5

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
chloralodol chloralodol 2911.00 42.100 Ann. O (I) HSC/21 1998 12 3563-58-4
chlordiazepoxide chlordiazépoxide 2933.91 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 11 58-25-3
chlorotrianisene chlorotrianisène 2909.30 38.100 Ann. Q (No. 212) HSC/11 1993 6 569-57-3
choline fenofibrate fénofibrate de choline 2923.10 NC1310B1b Ann. N/4 HSC/41 2008 97 856676-23-8
choriogonadotropin alfa choriogonadotropine alfa 2937.19 NC2004B1b Ann. O/6 HSC/53 2014 75 177073-44-8 HSC/21 (2937.10)
choriogonadotropin beta choriogonadotropine bêta 2937.19 NC2803Bc Ann. T/2 HSC/67 2021 120 2170458-11-2
ciaftalan zinc ciaftalane zinc 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 74 14320-04-8 HSC/21 (2933.90)
cibinetide cibinétide 2933.79 NC2373B1b Ann. O/6 HSC/59 2017 114 1208243-50-8
cibisatamab cibisatamab 3002.13 NC2626B1b Ann. O/5 HSC/63 2019 118 1855925-27-7
ciclesonide ciclésonide 2937.29 38.100 Ann. Q (No. 213) HSC/11 1993 74 141845-82-1
cicloprolol cicloprolol 2922.19 40.260 Ann. L/2 (No. 51) HSC/17 1996 48 63659-12-1
ciclosporin ciclosporine 3002.13 NC2570B1b Ann. M/19 HSC/62 2018 46 59865-13-3 HSC/17 (2941.90)
cidofovir cidofovir 2933.59 40.600 Ann. D, par. 6 HSC/18 1996 72 113852-37-2
ciforadenant ciforadénant 2934.99 NC2626B1b Ann. O/5 HSC/63 2019 118 1202402-40-1
cilengitide cilengitide 2933.79 NC0250B2 Ann. P/1 (II) HSC/25 2000 81 188968-51-6
cilgavimab cilgavimab 3002.13 NC2803Bc Ann. T/11 HSC/67 2021
124 COVID-19
2420563-99-9
cilmostim cilmostim 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 71 148637-05-2 HSC/18 (3002.10)
cilobradine cilobradine 2933.79 38.100 Ann. Q (No. 214) HSC/11 1993 66 109859-78-1
cilofexor cilofexor 2934.99 NC2626B1b Ann. O/5 HSC/63 2019 118 1418274-28-8
cilofungin cilofungine 2941.90 38.100 Ann. Q (No. 215) HSC/11 1993 60 79404-91-4
cilomilast cilomilast 2926.90 NC0430B2 Ann. Q/1 (I) HSC/27 2001 82 153259-65-5
ciltacabtagene autoleucel ciltacabtagène autoleucel 3002.51 NC2803Bc Ann. T/6 HSC/67 2021 122 no mention
ciluprevir ciluprévir 2934.10 NC0938B2b Ann. O/3 (I) HSC/35 2005 90 300832-84-2
cimaglermin alfa cimaglermine alfa 2934.99 NC2116B1b Ann. R/4 HSC/55 2015 110 1350717-96-2
cimdelirsen cimdélirsen 2934.99 NC2930Bc Ann. P/27 HSC/69 2022 125 2131025-82-4
cimlanod cimlanod 2935.90 NC2626B1b Ann. O/6 HSC/63 2019 119 1620330-72-4
cimpuciclib cimpuciclib 2933.59 NC2930Bc Ann. P/25 HSC/69 2022 124 2202767-78-8
cinacalcet cinacalcet 2921.49 NC0845B2 Ann. M/2 HSC/33 2004 88 226256-56-0
cinaciguat cinaciguat 2922.50 NC1310B1b Ann. N/4 HSC/41 2008 97 329773-35-5
cinalukast cinalukast 2934.10 40.600 Ann. D, par. 6 HSC/18 1996 70 128312-51-6
cinamolol cinamolol 2922.19 40.260 Ann. L/2 (No. 52) HSC/17 1996 44 39099-98-4
cinaxadamtase alfa cinaxadamtase alfa 3507.90 NC2930Bc Ann. P/27 HSC/69 2022 125 2406308-29-8
cindunistat cindunistat 2930.90 NC1874B1b Ann. O/2 HSC/51 2013 107 364067-22-1
cinhyaluronate sodium cinhyaluronate de sodium 3913.90 NC2237B1b Ann. S/9 HSC/57 2016 113 1372784-20-7
cinpanemab cinpanémab 3002.13 NC2803Bc Ann. T/2 HSC/67 2021 120 2094516-02-4
cinrebafusp alfa cinrébafusp alfa 3002.13 NC2803Bc Ann. T/3 HSC/67 2021 121 2218515-90-1
cintirorgon cintirorgon 2935.90 NC2626B1b Ann. O/6 HSC/63 2019 119 1227156-72-0
cintredekin besudotox cintrédékine bésudotox 3002.49 NC2803Bc Ann. T/9 HSC/67 2021 92 372075-36-0 HSC/39 (3002.90)
cipaglucosidase alfa cipaglucosidase alfa 3507.90 NC2803Bc Ann. T/7 HSC/67 2021 123 2359727-71-0

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
cipamfylline cipamfylline 2939.59 NC2004B1b Ann. O/6 HSC/53 2014 71 132210-43-6 HSC/18 (2939.50)
cipargamin cipargamine 2933.79 NC2116B1b Ann. R/4 HSC/55 2015 110 1193314-23-6
cipemastat cipémastat 2933.39 NC0250B2 Ann. P/1 (II) HSC/25 2000 81 190648-49-8
cipralisant cipralisant 2933.29 NC0590B2 Ann. L/15 HSC/29 2002 85 213027-19-1
ciraparantag ciraparantag 2933.59 NC2237B1b Ann. S/9 HSC/57 2016 113 1438492-26-2
cirtuvivint cirtuvivint 2933.59 NC2803Bc Ann. T/7 HSC/67 2021 123 2143917-62-6
cisatracurium besilate bésilate de cisatracurium 2933.49 NC2004B1b Ann. O/6 HSC/53 2014 73 96946-42-8 HSC/18 (2933.40)
cismadinone cismadinone 2937.23 NC2004B1b Ann. O/6 HSC/53 2014 12 54063-31-9 HSC/11 (2937.92)
citarinostat citarinostat 2933.59 NC2501B1b Ann. M/5 HSC/61 2018 116 1316215-12-9
citatuzumab bogatox citatuzumab bogatox 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 99 945228-49-9 HSC/45 (3002.10)
cixutumumab cixutumumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 100 947687-12-9 HSC/44 (3002.10)
cizolirtine cizolirtine 2933.19 42.100 Ann. O (V) HSC/21 1998 76 142155-43-9
clamikalant clamikalant 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 81 158751-64-5 HSC/25 (2935.00)
clascoterone clascotérone 2937.29 NC2803Bc Ann. T/2 HSC/67 2021 120 19608-29-8
clazakizumab clazakizumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 107 1236278-28-6 HSC/51 (3002.10)
clazosentan clazosentan 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 90 180384-56-9 HSC/35 (2935.00)
clenoliximab clénoliximab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 77 182912-58-9 HSC/21 (3002.10)
clervonafusp alfa clervonafusp alfa 3002.13 NC2930Bc Ann. P/30 HSC/69 2022 120 2145123-44-8 HSC/67 (3507.90)
clesacostat clésacostat 2933.39 NC2930Bc Ann. P/25 HSC/69 2022 124 1370448-25-1
clevidipine clévidipine 2933.39 42.100 Ann. O (IV) HSC/21 1998 75 167221-71-8
clevudine clévudine 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 78 163252-36-6 HSC/22 (2934.90)
cligosiban cligosiban 2933.39 NC2626B1b Ann. O/5 HSC/63 2019 118 900510-03-4
cliropamine cliropamine 2922.50 38.100 Ann. Q (No. 217) HSC/11 1993 59 109525-44-2
HSC/57 (3002.10)
clivatuzumab tetraxetan clivatuzumab tétraxétan 3002.13 NC2237B1b Ann. T/11 HSC/57 2016 113 943976-23-6
(S/9)
clobazam clobazam 2933.72 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 25 22316-47-8
clofarabine clofarabine 2934.99 NC0938B2b Ann. O/3 (I) HSC/35 2005 90 123318-82-1
clofenoxyde clofénoxyde 2914.79 NC2116B1b Ann. S/1 HSC/55 2015 14 3030-53-3 HSC/21 (2914.70)
clomifenoxide clomifènoxide 2929.90 40.260 Ann. L/2 (No. 12) HSC/17 1996 54 97642-74-5
clonazepam clonazépam 2933.91 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 22 1622-61-3
clonitazene clonitazène 2933.99 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 11 3861-76-5
cloprednol cloprednol 2937.22 42.100 Ann. O (I) HSC/21 1998 31 5251-34-3
cloranolol cloranolol 2922.19 40.260 Ann. L/2 (No. 53) HSC/17 1996 41 39563-28-5
clotiazepam clotiazépam 2934.91 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 30 33671-46-4
cloxazolam cloxazolam 2934.91 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 29 24166-13-0
cloxestradiol cloxestradiol 2937.23 NC2004B1b Ann. O/6 HSC/53 2014 12 54063-33-1 HSC/11 (2937.92)
cobicistat cobicistat 2934.10 NC1649B3b Ann. R/14 HSC/47 2011 103 1004316-88-4
cobimetinib cobimétinib 2933.39 NC1874B1b Ann. O/2 HSC/51 2013 107 934660-93-2
cobiprostone cobiprostone 2937.50 NC1443B1b Ann. P/5 HSC/43 2009 98 333963-42-1

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
cobitolimod cobitolimod 2934.99 NC2237B1b Ann. S/9 HSC/57 2016 113 1226822-98-5
coblopasvir coblopasvir 2934.99 NC2626B1b Ann. O/6 HSC/63 2019 119 1312608-46-0
cobolimab cobolimab 3002.13 NC2803Bc Ann. T/2 HSC/67 2021 120 2022215-65-0
cobomarsen cobomarsen 2934.99 NC2501B1b Ann. M/6 HSC/61 2018 117 1848257-52-2
codactide codactide 2937.19 NC2004B1b Ann. O/6 HSC/53 2014 24 22572-04-9 HSC/21 (2937.10)
codoxime codoxime 2939.19 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 15 7125-76-0
codrituzumab codrituzumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 109 1365267-33-9 HSC/53 (3002.10)
cofetuzumab cofétuzumab 3002.13 NC2501B1b Ann. M/6 HSC/61 2018 117 1869928-62-0
cofetuzumab pelidotin cofétuzumab pélidotine 3002.13 NC2501B1b Ann. M/6 HSC/61 2018 117 1869937-48-3
cofirasersen cofirasersen 2934.99 NC2930Bc Ann. P/25 HSC/69 2022 124 2247669-96-9
coleneuramide coléneuramide 2932.99 NC1553B1b Ann. O/7 HSC/45 2010 100 204200-47-5
colesevelam colésévélam 3911.90 42.100 Ann. O (VI) HSC/21 1998 77 182815-43-6
colestilan colestilan 3911.90 40.600 Ann. D, par. 6 HSC/18 1996 74 95522-45-5
colimecycline colimécycline 2941.30 40.260 Ann. L/2 (No. 5) HSC/17 1996 33 58298-92-3
coltuximab ravtansine coltuximab ravtansine 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 109 1269764-99-9 HSC/53 (3002.10)
coluracetam coluracétam 2934.99 NC0730B2 Ann. M/6 HSC/31 2003 86 135463-81-9
conatumumab conatumumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 99 896731-82-1 HSC/43 (3002.10)
conbercept conbercept 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 105 1227158-72-6 HSC/49 (3002.10)
concizumab concizumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 108 1312299-39-0 HSC/53 (3002.10)
condoliase condoliase 3507.90 NC1604B1b Ann. N/6 HSC/46 2010 102 9024-13-9
conendostatin conendostatine 2934.99 NC2803Bc Ann. T/6 HSC/67 2021 122 2202745-12-6
conestat alfa conestat alfa 3002.12 NC2116B1b Ann. S/2 HSC/55 2015 98 80295-38-1 HSC/47 (3002.10)
conivaptan conivaptan 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 82 210101-16-9 HSC/27 (2933.90)
conteltinib conteltinib 2935.90 NC2626B1b Ann. O/5 HSC/63 2019 118 1384860-29-0
contezolid contézolid 2934.99 NC2626B1b Ann. O/5 HSC/63 2019 118 1112968-42-9
contusugene ladenovec contusugène ladénovec 3002.49 NC2930Bc Ann. P/33 HSC/69 2022 97 600735-73-7 HSC/41 (3002.90)
copanlisib copanlisib 2934.99 NC2004B1b Ann. O/4 HSC/53 2014 108 1032568-63-0
coprelotamab coprélotamab 3002.13 NC2803Bc Ann. T/7 HSC/67 2021 123 2348469-84-9
corifollitropin alfa corifollitropine alfa 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 80 195962-23-3 HSC/27 (2934.90)
cortodoxone cortodoxone 2937.29 NC2004B1b Ann. O/6 HSC/53 2014 15 152-58-9 HSC/11 (2914.49)
cosdosiran cosdosiran 2934.99 NC2501B1b Ann. M/5 HSC/61 2018 116 1834560-88-1
cosfroviximab cosfroviximab 3002.13 NC2501B1b Ann. M/5 HSC/61 2018 116 1792982-57-0
cosibelimab cosibélimab 3002.13 NC2803Bc Ann. T/3 HSC/67 2021 121 2216751-26-5
cositecan cositécan 2939.79 NC2116B1b Ann. S/1 HSC/55 2015 100 203923-89-1 HSC/46 (2939.99)
cotadutide cotadutide 2937.19 NC2626B1b Ann. O/6 HSC/63 2019 119 1686108-82-6
cotoretigene toliparvovec cotoretigène toliparvovec 3002.49 NC2930Bc Ann. P/33 HSC/69 2022 123 2246424-95-1 HSC/67 (3002.90)
cotosudil cotosudil 2935.90 NC2803Bc Ann. T/7 HSC/67 2021 123 1258833-31-6
crenezumab crénezumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 105 1095207-05-8 HSC/49 (3002.10)
crenigacestat crénigacestat 2933.79 NC2501B1b Ann. M/6 HSC/61 2018 117 1421438-81-4

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
crenolanib crénolanib 2934.99 NC1760B1b Ann. N/8 HSC/49 2012 105 670220-88-9
cridanimod cridanimod 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 83 38609-97-1 HSC/27 (2933.90)
crilvastatin crilvastatine 2933.79 38.100 Ann. Q (No. 221) HSC/11 1993 63 120551-59-9
crinecerfont crinécerfont 2934.10 NC2803Bc Ann. T/2 HSC/67 2021 120 752253-39-7
crisaborole crisaborole 2934.99 NC2237B1b Ann. S/8 HSC/57 2016 112 906673-24-3
crisantaspase crisantaspase 3507.90 NC1874B1b Ann. O/2 HSC/51 2013 107 1349719-22-7
crisdesalazine crisdésalazine 2922.50 NC2803Bc Ann. T/2 HSC/67 2021 120 927685-43-6
crisnatol crisnatol 2922.19 38.100 Ann. Q (No. 222) HSC/11 1993 58 96389-68-3
crizanlizumab crizanlizumab 3002.13 NC2373B1b Ann. O/7 HSC/59 2017 115 1690318-25-2
crizotinib crizotinib 2933.39 NC1649B3b Ann. R/14 HSC/47 2011 103 877399-52-5
crobenetine crobénétine 2933.39 NC0430B2 Ann. Q/1 (I) HSC/27 2001 82 221019-25-6
crolibulin crolibuline 2932.99 NC1760B1b Ann. N/7 HSC/49 2012 104 1000852-17-4
cromakalim cromakalim 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 58 94470-67-4 HSC/11 (2934.90)
cromoglicate lisetil cromoglicate lisétil 2932.99 40.600 Ann. D, par. 6 HSC/18 1996 72 110816-79-0
crotedumab crotédumab 3002.13 NC2373B1b Ann. O/6 HSC/59 2017 114 1452387-69-7
crotoniazide crotoniazide 2933.39 38.100 Ann. Q (No. 224) HSC/11 1993 11 7007-96-7
crovalimab crovalimab 3002.13 NC2626B1b Ann. O/6 HSC/63 2019 119 1917321-26-6
cudarolimab cudarolimab 3002.13 NC2803Bc Ann. T/6 HSC/67 2021 122 2244739-29-3
cupabimod cupabimod 2934.99 NC2373B1b Ann. O/7 HSC/59 2017 115 297774-48-2
cusatuzumab cusatuzumab 3002.13 NC2626B1b Ann. O/5 HSC/63 2019 118 1864871-20-4
custirsen custirsen 2934.99 NC1443B1b Ann. P/6 HSC/43 2009 99 903916-27-8
cutamesine cutamésine 2933.59 NC1500B1b Ann. K/6 HSC/44 2009 100 165377-43-5
cyclobarbital cyclobarbital 2933.53 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 1 52-31-3
cyclopentolate cyclopentolate 2922.19 40.260 Ann. L/2 (No. 54) HSC/17 1996 39 512-15-2
cystine cystine 2930.90 NC0430B2 Ann. Q/1 (I) HSC/27 2001 82 56-89-3
cytisinicline cytisinicline 2933.79 NC2803Bc Ann. T/2 HSC/67 2021 120 485-35-8
dabelotine dabélotine 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 74 118976-38-8 HSC/21 (2934.90)
dabigatran dabigatran 2933.39 NC0430B2 Ann. Q/1 (II) HSC/27 2001 83 211914-51-1
dabigatran etexilate dabigatran étexilate 2933.39 NC0730B2 Ann. M/7 HSC/31 2003 87 211915-06-9
dabocemagene autoficel dabocémagène autoficel 3002.51 NC2930Bc Ann. P/27 HSC/69 2022 125 2365353-63-3
dabrafenib dabrafénib 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 105 1195765-45-7 HSC/49 (2935.00)
dacetuzumab dacétuzumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 98 880486-59-9 HSC/43 (3002.10)
daclatasvir daclatasvir 2933.29 NC1760B1b Ann. N/8 HSC/49 2012 107 1099119-64-5
daclizumab daclizumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 78 152923-56-3 HSC/18 (3002.10)
daclizumab beta daclizumab bêta 3002.13 NC2373B1b Ann. O/6 HSC/59 2017 114 152923-56-3
dacomitinib dacomitinib 2933.59 NC1649B3b Ann. R/14 HSC/47 2011 103 1110813-31-4
dactolisib dactolisib 2933.49 NC1874B1b Ann. O/2 HSC/51 2013 107 915019-65-7
dafsolimab dafsolimab 3002.13 NC2803Bc Ann. T/7 HSC/67 2021 123 2367001-71-4
dafsolimab setaritox dafsolimab sétaritox 3002.13 NC2803Bc Ann. T/7 HSC/67 2021 123 2361013-28-5

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
daglutril daglutril 2933.79 NC0938B2b Ann. O/3 (I) HSC/35 2005 90 182821-27-8
dagrocorat dagrocorat 2933.39 NC2116B1b Ann. R/5 HSC/55 2015 111 1044535-52-5
dalantercept dalantercept 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 105 1186210-24-1 HSC/49 (3002.10)
dalatazide dalatazide 3002.49 NC2803Bc Ann. T/9 HSC/67 2021 111 1081110-69-1 HSC/55 (3002.90)
dalbavancin dalbavancine 2941.90 NC0590B2 Ann. L/15 HSC/29 2002 85 171500-79-1
dalbraminol dalbraminol 2933.19 38.100 Ann. Q (No. 225) HSC/11 1993 58 81528-80-5
dalcetrapib dalcétrapib 2930.90 NC1310B1b Ann. N/10 HSC/41 2008 96 211513-37-0
dalcinonacog alfa dalcinonacog alfa 3002.12 NC2626B1b Ann. O/5 HSC/63 2019 118 2055206-13-6
dalcotidine dalcotidine 2933.39 42.100 Ann. O (V) HSC/21 1998 76 120958-90-9
dalosirvat dalosirvat 2932.99 NC2803Bc Ann. T/7 HSC/67 2021 123 1360540-81-3
dalotuzumab dalotuzumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 102 1005389-60-5 HSC/46 (3002.10)
dalpiciclib dalpiciclib 2933.79 NC2803Bc Ann. T/7 HSC/67 2021 123 1637781-04-4
dalteparin sodium daltéparine sodique 3001.90 NC1553B1b Ann. O/5 HSC/45 2010 64 9041-08-1
dalutrafusp alfa dalutrafusp alfa 3002.13 NC2930Bc Ann. P/27 HSC/69 2022 125 2419918-89-9
damoctocog alfa pegol damoctocog alfa pégol 3002.12 NC2116B1b Ann. S/2 HSC/55 2015 109 1363853-26-2 HSC/53 (3002.10)
danaparoid sodium danaparoïde sodique 3913.90 42.100 Ann. O (III) HSC/21 1998 74 83513-48-8
danavorexton danavorexton 2935.90 NC2803Bc Ann. T/7 HSC/67 2021 123 2114324-48-8
danegaptide danégaptide 2933.99 NC1604B1b Ann. N/5 HSC/46 2010 101 943134-39-2
danicamtiv danicamtiv 2934.99 NC2803Bc Ann. T/2 HSC/67 2021 120 1970972-74-7
danicopan danicopan 2933.59 NC2626B1b Ann. O/6 HSC/63 2019 119 1903768-17-1
daniplestim daniplestim 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 76 161753-30-6 HSC/21 (3002.10)
daniquidone daniquidone 2933.79 38.100 Ann. Q (No. 226) HSC/11 1993 62 67199-66-0
danirixin danirixine 2933.39 NC1874B1b Ann. O/2 HSC/51 2013 107 954126-98-8
danoprevir danoprévir 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 102 916881-67-9 HSC/47 (2935.00)
danuglipron danuglipron 2934.99 NC2930Bc Ann. P/25 HSC/69 2022 124 2230198-02-2
danusertib danusertib 2933.59 NC1443B1b Ann. P/6 HSC/43 2009 99 827318-97-8
danvatirsen danvatirsen 2934.99 NC2501B1b Ann. M/6 HSC/61 2018 117 1402100-56-4
dapabutan dapabutan 2922.49 40.600 Ann. D, par. 6 HSC/18 1996 70 6582-31-6
dapaconazole dapaconazole 2933.29 NC2116B1b Ann. R/5 HSC/55 2015 111 1269726-67-1
dapagliflozin dapagliflozine 2932.99 NC1310B1b Ann. N/4 HSC/41 2008 97 461432-26-8
dapansutrile dapansutrile 2930.90 NC2373B1b Ann. O/6 HSC/59 2017 114 54863-37-5
dapatifagene navolactibac dapatifagène navolactibac 3002.49 NC2930Bc Ann. P/33 HSC/69 2022 122 no mention HSC/67 (3002.90)
dapiclermin dapiclermine 2933.29 NC1059B2b Ann. O/5 HSC/37 2006 93 444069-80-1
dapiglutide dapiglutide 2937.19 NC2803Bc Ann. T/7 HSC/67 2021 123 2296814-85-0
dapirolizumab pegol dapirolizumab pégol 3002.13 NC2237B1b Ann. T/13 HSC/57 2016 110 1416147-64-2 HSC/55 (3002.10)
dapitant dapitant 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 74 153438-49-4 HSC/21 (2933.90)
dapivirine dapivirine 2933.59 NC0730B2 Ann. M/6 HSC/31 2003 86 244767-67-7
daplusiran daplusiran 2934.99 NC2803Bc Ann. T/7 HSC/67 2021 123 2202783-38-6
daporinad daporinad 2933.39 NC1443B1b Ann. P/5 HSC/43 2009 98 201034-75-5

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
daprodustat daprodustat 2933.54 NC2237B1b Ann. S/9 HSC/57 2016 113 960539-70-2
darapladib darapladib 2933.59 NC1178B1c Ann. O/3 HSC/39 2007 94 356057-34-6
daratumumab daratumumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 101 945721-28-8 HSC/46 (3002.10)
darbepoetin alfa darbépoétine alfa 3002.12 NC2116B1b Ann. S/2 HSC/55 2015 85 209810-58-2 HSC/31 (3002.10)
darbufelone darbufélone 2934.10 NC0250B2 Ann. P/1 (I) HSC/25 2000 80 139226-28-1
darexaban darexaban 2933.99 NC1604B1b Ann. N/5 HSC/46 2010 104 365462-23-3
darglitazone darglitazone 2934.10 39.600 Ann. D/1, par. 15 HSC/16 1995 69 141200-24-0
daridorexant daridorexant 2933.99 NC2626B1b Ann. O/5 HSC/63 2019 120 1505484-82-1 (List 118 nemorexant)
darifenacin darifénacine 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 70 133099-04-4 HSC/18 (2934.90)
darigabat darigabat 2933.99 NC2803Bc Ann. T/7 HSC/67 2021 123 1614245-70-3
darinaparsin darinaparsine 2930.90 NC1443B1b Ann. P/5 HSC/43 2009 98 69819-86-9
darolutamide darolutamide 2933.19 NC2373B1b Ann. O/7 HSC/59 2017 115 1297538-32-9
darotropium bromide bromure de darotropium 2939.79 NC2116B1b Ann. S/1 HSC/55 2015 99 850607-58-8 HSC/45 (2933.99)
darovasertib darovasertib 2933.39 NC2803Bc Ann. T/7 HSC/67 2021 123 1874276-76-2
darsidormine darsidomine 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 74 137500-42-6 HSC/18 (2934.90)
darunavir darunavir 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 88 206361-99-1 HSC/33 (2935.00)
darusentan darusentan 2933.59 NC0430B2 Ann. Q/1 (I) HSC/27 2001 82 171714-84-4
darvadstrocel darvadstrocel 3002.51 NC2803Bc Ann. T/4 HSC/67 2021 117 no mention HSC/63 (3002.90)
dasabuvir dasabuvir 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 109 1132935-63-7 HSC/53 (2935.00)
dasantafil dasantafil 2933.59 NC0938B2b Ann. O/3 (II) HSC/35 2005 91 569351-91-3
dasatinib dasatinib 2934.10 NC1178B1c Ann. O/3 HSC/39 2007 94 302962-49-8
dasiglucagon dasiglucagon 2937.19 NC2501B1b Ann. M/5 HSC/61 2018 116 1544300-84-6
dasolampanel dasolampanel 2933.49 NC1760B1b Ann. N/8 HSC/49 2012 105 503294-13-1
dasotraline dasotraline 2921.49 NC2116B1b Ann. R/4 HSC/55 2015 110 675126-05-3
HSC/21 (2939.90)
datelliptium chloride chlorure de datelliptium 2939.79 NC2116B1b Ann. S/1 HSC/55 2015 57 105118-14-7
HSC/53 (2933.99)
datopotamab datopotamab 3002.13 NC2803Bc Ann. T/6 HSC/67 2021 122 2267989-53-5
datopotamab deruxtecan datopotamab déruxtécan 3002.13 NC2803Bc Ann. T/6 HSC/67 2021 122 2238831-60-0
davalintide davalintide 2937.19 NC1649B3b Ann. R/12 HSC/47 2011 101 863919-85-1
davamotecan pegadexamer davamotécan pégadexamère 2939.79 NC2501B1b Ann. M/6 HSC/61 2018 117 1883668-61-8
davasaicin davasaïcine 2924.29 NC1178B1c Ann. O/2 HSC/39 2007 92 147497-64-1
davoceticept davocéticept 3002.13 NC2930Bc Ann. P/27 HSC/69 2022 125 2307144-64-3
davunetide davunétide 2933.99 NC1553B1b Ann. O/7 HSC/45 2010 100 211439-12-2
daxalipram daxalipram 2934.99 NC0938B2b Ann. O/3 (II) HSC/35 2005 91 189940-24-7
daxdilimab daxdilimab 3002.13 NC2803Bc Ann. T/7 HSC/67 2021 123 2245966-28-1
dazcapistat dazcapistat 2934.99 NC2803Bc Ann. T/11 HSC/67 2021
124 COVID-19
2221010-42-8
dazodalibep dazodalibep 2934.99 NC2803Bc Ann. T/7 HSC/67 2021 123 2245953-10-8
dazucorilant dazucorilant 2935.90 NC2930Bc Ann. P/27 HSC/69 2022 125 1496508-34-9
decernotinib décernotinib 2933.59 NC2004B1b Ann. O/4 HSC/53 2014 110 944842-54-0

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
HSC/11 (2939.90)
decitropine décitropine 2939.79 NC2116B1b Ann. S/1 HSC/55 2015 18 1242-69-9
HSC/53 (2939.99)
declenperone déclenpérone 2933.39 38.100 Ann. Q (No. 228) HSC/11 1993 42 63388-37-4
declopramide déclopramide 2924.29 42.750 Ann. O HSC/22 1998 78 891-60-1
decoglurant décoglurant 2933.59 NC2004B1b Ann. O/5 HSC/53 2014 109 911115-16-7
decominol décominol 2922.19 40.260 Ann. L/2 (No. 55) HSC/17 1996 45 60812-35-3
HSC/57 (3002.10)
dectrekumab dectrékumab 3002.13 NC2237B1b Ann. T/10 HSC/57 2016 112 1528523-94-5
(S/8)
defactinib défactinib 2935.90 NC2237B1b Ann. T/12 HSC/57 2016 111 1073154-85-4 HSC/55 (2935.00)
deferasirox déférasirox 2933.99 NC0730B2 Ann. M/6 HSC/31 2003 86 201530-41-8
deferitazole déféritazole 2934.10 NC2004B1b Ann. O/4 HSC/53 2014 108 945635-15-4
deferitrin déféritrine 2934.10 NC1004B1b Ann. L/11 HSC/36 2005 92 239101-33-8
deflazacort déflazacort 2937.29 38.100 Ann. Q (No. 229) HSC/11 1993 39 14484-47-0
defosbarasertib défosbarasertib 2933.59 NC2930Bc Ann. P/25 HSC/69 2022 124 722544-51-6
defoslimod défoslimod 2932.99 NC0430B2 Ann. Q/1 (III) HSC/27 2001 79 171092-39-0
degarelix dégarélix 2937.19 NC0730B2 Ann. M/6 HSC/31 2003 86 214766-78-6
delafloxacin délafloxacine 2933.49 NC1553B1b Ann. O/7 HSC/45 2010 100 189279-58-1
delamanid délamanid 2934.99 NC1760B1b Ann. N/7 HSC/49 2012 104 681492-22-8
delandistrogene moxeparvovec délandistrogène moxéparvovec 3002.49 NC2930Bc Ann. P/25 HSC/69 2022 124 2305040-16-6
delanzomib délanzomib 2933.39 NC1760B1b Ann. N/8 HSC/49 2012 105 847499-27-8
delavirdine délavirdine 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 71 136817-59-9 HSC/18 (2935.00)
delcasertib delcasertib 2934.99 NC1760B1b Ann. N/8 HSC/49 2012 105 949100-39-4
deldeprevir deldéprévir 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 110 1229626-28-1 HSC/51 (2935.00)
deleobuvir déléobuvir 2933.59 NC2004B1b Ann. O/4 HSC/53 2014 108 863884-77-9
delequamine déléquamine 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 73 119905-05-4 HSC/18 (2935.00)
delgocitinib delgocitinib 2933.59 NC2501B1b Ann. M/6 HSC/61 2018 117 1263774-59-9
deligoparin sodium déligoparine sodique 3001.90 NC1553B1b Ann. O/5 HSC/45 2010 89 9041-08-1
delimotecan délimotécan 2939.79 NC2237B1b Ann. T/12 HSC/57 2016 97 187852-63-7 HSC/43 (2939.99)
delmitide delmitide 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 92 287096-87-1 HSC/47 (3002.10)
delolimogene mupadenorepvec délolimogène mupadénorépvec 3002.49 NC2930Bc Ann. P/33 HSC/69 2022 118 2061938-98-3 HSC/63 (3002.90)
delorazepam délorazépam 2933.91 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 40 2894-67-9
deloxolone déloxolone 2918.19 38.100 Ann. Q (No. 230) HSC/11 1993 51 68635-50-7
delparantag delparantag 2924.29 NC2004B1b Ann. O/4 HSC/53 2014 108 872454-31-4
delpazolid delpazolid 2934.99 NC2501B1b Ann. M/5 HSC/61 2018 116 1219707-39-7
deltibant deltibant 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 75 140661-97-8 HSC/21 (2933.90)
delucemine délucémine 2921.49 NC0730B2 Ann. M/7 HSC/31 2003 87 186495-49-8
dematirsen dématirsen 2934.99 NC2501B1b Ann. M/5 HSC/61 2018 116 1802465-55-9
demcizumab demcizumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 107 1243262-17-0 HSC/51 (3002.10)
demegestone démégestone 2937.23 NC2004B1b Ann. O/6 HSC/53 2014 24 10116-22-0 HSC/11 (2937.92)

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
demiditraz demiditraz 2933.29 NC1443B1b Ann. P/6 HSC/43 2009 99 944263-65-4
demplatin pegraglumer demplatine pégraglumère 2843.90 NC2501B1b Ann. M/6 HSC/61 2018 117 1009838-50-9
demupitamab démupitamab 3002.13 NC2803Bc Ann. T/6 HSC/67 2021 122 2249926-74-5
denagliptin dénagliptine 2933.99 NC1123B1b Ann. N/1 HSC/38 2006 94 483369-58-0
denaverine dénavérine 2922.19 40.260 Ann. L/2 (No. 56) HSC/17 1996 25 3579-62-2
denbufylline denbufylline 2939.59 NC2004B1b Ann. O/6 HSC/53 2014 55 57076-71-8 HSC/11 (2939.50)
denenicokin dénénicokine 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 99 716840-32-3 HSC/43 (3002.10)
denibulin dénibuline 2933.99 NC1178B1c Ann. O/5 HSC/39 2007 95 284019-34-7
denifanstat dénifanstat 2933.39 NC2930Bc Ann. P/27 HSC/69 2022 125 1399177-37-7
denileukin diffitox dénileukine diftitox 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 78 173146-27-5 HSC/25 (3002.10)
denintuzumab mafodotine dénintuzumab mafodotine 3002.13 NC2237B1b Ann. T/13 HSC/57 2016 111 1399672-02-6 HSC/55 (3002.10)
denosumab dénosumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 94 615258-40-7 HSC/38 (3002.10)
denotivir dénotivir 2934.10 40.600 Ann. D, par. 6 HSC/18 1996 70 51287-57-1
denufosol dénufosol 2934.99 NC0938B2b Ann. O/3 (II) HSC/35 2005 91 211448-85-0
deoxycholic acid acide désoxycholique 2918.19 NC1874B1B Ann. O/1 HSC/51 2013 106 83-44-3
depatuxizumab dépatuxizumab 3002.13 NC2373B1b Ann. O/7 HSC/59 2017 115 1471999-69-5
depatuxizumab mafodotin dépatuxizumab mafodotine 3002.13 NC2373B1b Ann. O/7 HSC/59 2017 115 1585973-65-4
depelestat dépélestat 2934.99 NC0938B2b Ann. O/3 (II) HSC/35 2005 91 506433-25-6
depemokimab dépémokimab 3002.13 NC2803Bc Ann. T/7 HSC/67 2021 123 2243274-14-6
depreotide dépréotide 2933.79 NC0250B2 Ann. P/1 (I) HSC/25 2000 80 161982-62-3
HSC/11 (2939.90)
deptropine deptropine 2939.79 NC2116B1b Ann. S/1 HSC/55 2015 12 604-51-3
HSC/53 (2939.99)
deracoxib déracoxib 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 80 169590-41-4 HSC/25 (2935.00)
derazantinib dérazantinib 2933.59 NC2501B1b Ann. M/5 HSC/61 2018 116 1234356-69-4
derenofylline dérénofylline 2933.59 NC1604B1b Ann. N/6 HSC/46 2010 102 251945-92-3
derpanicate derpanicate 2933.39 38.100 Ann. Q (No. 233) HSC/11 1993 58 99518-29-3
derquantel derquantel 2934.99 NC1443B1b Ann. P/6 HSC/43 2009 99 187865-22-1
dersalazine dersalazine 2933.39 NC0730B2 Ann. M/6 HSC/31 2003 86 188913-58-8
dersimelagon dersimélagon 2933.39 NC2626B1b Ann. O/6 HSC/63 2019 119 1835256-48-8
desaspidin désaspidine 2914.50 42.100 Ann. O (I) HSC/21 1998 15 114-43-2
desciclovir desciclovir 2933.59 38.100 Ann. Q (No. 234) HSC/11 1993 55 84408-37-7
descinolone descinolone 2937.22 38.100 Ann. Q (No. 235) HSC/11 1993 17 595-52-8
desfesoterodine desfésotérodine 2922.50 NC2237B1b Ann. S/8 HSC/57 2016 112 207679-81-0
desidustat désidustat 2933.79 NC2501B1b Ann. M/6 HSC/61 2018 117 1616690-16-4
desirudin désirudine 3001.90 40.600 Ann. D, par. 6 HSC/18 1996 70 120993-53-5
deslanoside deslanoside 2938.90 38.100 Ann. Q (No. 236) HSC/11 1993 14 17598-65-1
desloratadine desloratadine 2933.39 NC0090B2 Ann. M/5 HSC/23 1999 80 100643-71-8
desmeninol desméninol 2930.90 40.600 Ann. D, par. 6 HSC/18 1996 70 583-91-5
desmetramadol desmétramadol 2922.50 NC2501B1b Ann. M/6 HSC/61 2018 117 80456-81-1

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
desmopressin desmopressine 2937.19 NC2004B1b Ann. O/6 HSC/53 2014 33 16679-58-6 HSC/11 (2937.99)
desmoteplase desmoteplase 3507.90 NC0250B2 Ann. P/1 (I) HSC/25 2000 80 145137-38-8
desomorphine désomorphine 2939.19 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 5 427-00-9
desoximetasone désoximétasone 2937.22 38.100 Ann. Q (No. 238) HSC/11 1993 20 382-67-2
detanosal détanosal 2922.19 40.260 Ann. L/2 (No. 57) HSC/17 1996 23 23573-66-2
detiviciclovir détiviciclovir 2933.59 NC0730B2 Ann. M/6 HSC/31 2003 86 220984-26-9
detumomab détumomab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 70 145832-33-3 HSC/18 (3002.10)
deucravacitinib deucravacitinib 2845.90 NC2803Bc Ann. T/7 HSC/67 2021 123 1609392-27-9
deudextromethorphan deudextromethorphane 2845.90 NC2373B1b Ann. O/6 HSC/59 2017 114 1079043-55-2
deudomperidone deudompéridone 2845.90 NC2930Bc Ann. P/25 HSC/69 2022 124 2121525-08-2
deuruxolitinib deuruxolitinib 2845.90 NC2930Bc Ann. P/25 HSC/69 2022 124 1513883-39-0
deutarserine deutarsérine 2845.90 NC2930Bc Ann. P/25 HSC/69 2022 124 103292-62-2
deutetrabenazine deutétrabénazine 2845.90 NC2237B1b Ann. S/8 HSC/57 2016 112 1392826-25-3
deutivacaftor deutivacaftor 2845.90 NC2626B1b Ann. O/5 HSC/63 2019 118 1413431-07-8
deutolperisone deutolpérisone 2845.90 NC1059B2b Ann. O/4 HSC/37 2006 92 474641-19-5
devafidugene civaparvovec devafidugène civaparvovec 3002.49 NC2930Bc Ann. P/33 HSC/69 2022 120 2143580-11-2 HSC/67 (3002.90)
devimistat dévimistat 2930.90 NC2803Bc Ann. T/2 HSC/67 2021 120 95809-78-2
dexamethasone cipecilate cipécilate de dexaméthasone 2937.22 NC1178B1c Ann. O/3 HSC/39 2007 94 132245-57-9
dexamfetamine dexamfétamine 2921.46 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 55 51-64-9
dexbudesonide dexbudésonide 2932.99 NC0250B2 Ann. P/1 (I) HSC/25 2000 80 51372-29-3
dexecadotril dexécadotril 2930.90 40.600 Ann. D, par. 6 HSC/18 1996 73 112573-72-5
dexefaroxan dexéfaroxan 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 76 143249-88-1 HSC/21 (2934.90)
dexelvucitabine dexelvucitabine 2934.99 NC1178B1c Ann. O/5 HSC/39 2007 95 134379-77-4
dexepicatechin dexépicatéchine 2932.99 NC2930Bc Ann. P/27 HSC/69 2022 125 35323-91-2
dexisometheptene dexisométhéptène 2921.19 NC2373B1b Ann. O/7 HSC/59 2017 115 1620401-56-0
dexketoprofen dexkétoprofène 2918.30 40.600 Ann. D, par. 6 HSC/18 1996 70 22161-81-5
dexlansoprazole dexlansoprazole 2933.39 NC1059B2b Ann. O/5 HSC/37 2006 93 138530-94-6
dexmecamylamine dexmécamylamine 2921.30 NC1874B1b Ann. O/1 HSC/51 2013 106 107538-05-6
dexmethylphenidate dexméthylphénidate 2933.39 NC0845B2 Ann. M/2 HSC/33 2004 88 40431-64-9
dexnebivolol dexnébivolol 2932.99 NC1443B1b Ann. P/5 HSC/43 2009 98 118457-15-1
dexpemedolac dexpémédolac 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 71 114030-44-3 HSC/18 (2934.90)
dexpramipexole dexpramipexole 2934.20 NC1649B3b Ann. R/14 HSC/47 2011 103 104632-28-2
dexpropranolol dexpropranolol 2922.19 40.260 Ann. L/2 (No. 58) HSC/17 1996 21 5051-22-9
dexsotalol dexsotalol 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 74 30236-32-9 HSC/21 (2935.00)
dextiopronin dextiopronine 2930.90 NC0090B2 Ann. M/1 (II) HSC/23 1999 79 29335-92-0
dextofisopam dextofisopam 2933.99 NC0938B2b Ann. O/3 (I) HSC/35 2005 90 82059-50-5
dextromethorphan dextrométhorphane 2933.49 NC2004B1b Ann. O/6 HSC/53 2014 1 125-71-3 HSC/11 (2933.40)
dextromoramide dextromoramide 2934.91 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 6 357-56-2
dextropropoxyphene dextropropoxyphène 2922.14 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 7 469-62-5

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
dextrorphan dextrorphane 2933.49 NC2004B1b Ann. O/6 HSC/53 2014 1 125-73-5 HSC/11 (2933.40)
dezaguanine dézaguanine 2933.79 38.100 Ann. Q (No. 241) HSC/11 1993 51 41729-52-6
dezamizumab dézamizumab 3002.13 NC2373B1b Ann. O/7 HSC/59 2017 115 1662664-56-3
dezapelisib dézapélisib 2934.99 NC2501B1b Ann. M/5 HSC/61 2018 116 1262440-25-4
diampromide diampromide 2924.29 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 10 552-25-0
dianexin dianexine 3002.12 NC2373B1b Ann. O/12 HSC/59 2017 109 1352413-49-0 HSC/57 (3002.10)
dianhydrogalactitol dianhydrogalactitol 2910.90 NC2116B1b Ann. R/5 HSC/55 2015 111 23261-20-3
dianicline dianicline 2934.99 NC1059B2b Ann. O/5 HSC/37 2006 93 292634-27-6
diaplasinin diaplasinine 2933.99 NC1123B1b Ann. N/1 HSC/38 2006 94 481631-45-2
diazepam diazépam 2933.91 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 12 439-14-5
dibotermin alfa dibotermine alfa 2933.29 NC0938B2b Ann. O/2 HSC/35 2005 89 246539-15-1
dibunate dibunate 2904.10 38.100 Ann. Q (No. 69) HSC/11 1993 48 no mention
dichlorisone dichlorisone 2937.22 38.100 Ann. Q (No. 242) HSC/11 1993 10 7008-26-6
diciferron diciferron 2931.90 NC2373B1b Ann. O/12 HSC/59 2017 44 65606-61-3 HSC/11 (2931.00)
dicirenone dicirénone 2937.29 NC2004B1b Ann. O/6 HSC/53 2014 50 41020-79-5 HSC/11 (2937.99)
diclofenac etalhyaluronate étalhyaluronate de diclofénac 3913.90 NC2116B1b Ann. R/5 HSC/55 2015 111 1608089-20-8
dicobalt edetate édétate dicobaltique 2922.49 38.100 Ann. Q (No. 245) HSC/11 1993 45 36499-65-7
dienestrol diènestrol 2907.29 38.100 Ann. Q (No. 246) HSC/11 1993 1 84-17-3
dienogest diénogest 2937.23 NC2004B1b Ann. O/6 HSC/53 2014 49 65928-58-7 HSC/11 (2907.29)
diethylstilbestrol diéthylstilbestrol 2907.29 38.100 Ann. Q (No. 248) HSC/11 1993 4 56-53-1
diethylthiambutene diéthylthiambutène 2934.99 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 3 86-14-6
dietifen diétifène 2922.19 40.260 Ann. L/2 (No. 59) HSC/17 1996 22 3686-78-0
difamilast difamilast 2934.99 NC2626B1b Ann. O/5 HSC/63 2019 118 937782-05-3
difelikefalin difélikéfaline 2933.39 NC2237B1b Ann. S/9 HSC/57 2016 113 1024828-77-0
difemerine difémérine 2922.19 40.260 Ann. L/2 (No. 60) HSC/17 1996 17 80387-96-8
difenoximide difénoximide 2933.39 38.100 Ann. Q (No. 249) HSC/11 1993 32 47806-92-8
difenoxin difénoxine 2933.33 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 25 28782-42-5
difeterol difétérol 2922.19 40.260 Ann. L/2 (No. 61) HSC/17 1996 36 14587-50-9
diflomotecan diflomotécan 2934.99 NC2237B1b Ann. S/11 HSC/57 2016 84 220997-97-7 HSC/31 (2939,99)
difluprednate difluprednate 2937.22 38.100 Ann. Q (No. 250) HSC/11 1993 21 23674-86-4
dihydrocodeine dihydrocodéine 2939.11 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 8 125-28-0
dilanubicel dilanubicel 3002.51 NC2803Bc Ann. T/4 HSC/67 2021 119 no mention HSC/63 (3002.90)
dilmapimod dilmapimod 2933.79 NC1649B3b Ann. R/13 HSC/47 2011 102 444606-18-2
dilopetine dilopétine 2934.99 NC1123B1b Ann. N/1 HSC/38 2006 94 247046-52-2
dilpacimab dilpacimab 3002.13 NC2626B1b Ann. O/6 HSC/63 2019 119 1791420-09-1
diltiazem diltiazem 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 30 42399-41-7 HSC/11 (2934.90)
dimabefylline dimabéfylline 2939.59 NC2004B1b Ann. O/6 HSC/53 2014 19 1703-48-6 HSC/11 (2939.50)
dimadectin dimadectine 2941.90 40.600 Ann. D, par. 6 HSC/18 1996 73 156131-91-8
dimelazine dimélazine 2934.30 38.100 Ann. Q (No. 253) HSC/11 1993 14 15302-12-2

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
dimenoxadol diménoxadol 2922.19 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 7 509-78-4 HSC/17 (2922.19)
dimepheptanol dimépheptanol 2922.19 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 5 545-90-4
dimesone dimésone 2937.22 38.100 Ann. Q (No. 254) HSC/11 1993 23 25092-07-3
dimethylthiambutene diméthylthiambutène 2934.99 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 3 524-84-5
dinaciclib dinaciclib 2933.59 NC1649B3b Ann. R/13 HSC/47 2011 102 779353-01-4
dinalbuphine sebacate sébacate de dinalbuphine 2939.19 NC2373B1b Ann. O/6 HSC/59 2017 116 311768-81-7 (List 114 nalbuphine sebacate)
dinutuximab dinutuximab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 109 1363687-32-4 HSC/53 (3002.10)
HSC/57 (3002.10)
dinutuximab beta dinutuximab bêta 3002.13 NC2237B1b Ann. T/11 HSC/57 2016 113 1613303-02-8
(S/9)
dioxaphetyl butyrate butyrate de dioxaphétyl 2934.99 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 5 467-86-7
diphenoxylate diphénoxylate 2933.33 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 10 915-30-0
dipipanone dipipanone 2933.33 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 5 467-83-4
diprafenone diprafénone 2922.19 40.260 Ann. L/2 (No. 63) HSC/17 1996 48 81447-80-5
dipraglurant dipraglurant 2933.39 NC1604B1b Ann. N/6 HSC/46 2010 102 872363-17-2
diprogulic acid acide diprogulique 2932.99 NC2004B1b Ann. O/6 HSC/53 2014 35 18467-77-1 HSC/11 (2932.90)
diridavumab diridavumab 3002.13 NC2237B1b Ann. T/13 HSC/57 2016 111 1393659-46-5 HSC/55 (3002.10)
dirithromycin dirithromycine 2941.50 38.100 Ann. Q (No. 256) HSC/11 1993 53 62013-04-1
dirloctocogene samoparvovec dirloctocogène samoparvovec 3002.49 NC2930Bc Ann. P/33 HSC/69 2022 121 2163074-23-3 HSC/67 (3002.90)
dirlotapide dirlotapide 2933.99 NC0938B2b Ann. O/3 (II) HSC/35 2005 91 481658-94-0
dirocaftor dirocaftor 2933.49 NC2803Bc Ann. T/7 HSC/67 2021 123 2137932-23-9
diroleuton diroleuton 2916.19 NC2626B1b Ann. O/5 HSC/63 2019 118 1783-84-2
diroximel fumarate fumarate de diroximel 2925.19 NC2373B1b Ann. O/7 HSC/59 2017 115 1577222-14-0
dirucotide dirucotide 2933.29 NC1553B1b Ann. O/7 HSC/45 2010 100 152074-97-0
disitamab disitamab 3002.13 NC2803Bc Ann. T/2 HSC/67 2021 120 2185868-98-6
disitamab vedotin disitamab védotine 3002.13 NC2803Bc Ann. T/2 HSC/67 2021 120 2136633-23-1
disitertide disitertide 2933.99 NC1443B1b Ann. P/6 HSC/43 2009 99 272105-42-7
disogluside disogluside 2938.90 38.100 Ann. Q (No. 257) HSC/11 1993 47 14144-06-0
disomotide disomotide 3002.41 NC2803Bc Ann. T/4 HSC/67 2021 94 181477-43-0 HSC/40 (3002.20)
disufenton sodium disufenton sodique 2929.90 NC0845B2 Ann. M/2 HSC/33 2004 88 168021-79-2
disulergine disulergine 2939.69 42.100 Ann. O (I) HSC/21 1998 45 59032-40-5
disulfiram disulfirame 2930.30 38.100 Ann. Q (No. 258) HSC/11 1993 1 97-77-8
disuprazole disuprazole 2933.39 38.100 Ann. Q (No. 259) HSC/11 1993 56 99499-40-8
ditekiren ditékirène 2933.39 38.100 Ann. Q (No. 260) HSC/11 1993 84 103336-05-6
ditercalinium chloride chlorure de ditercalinium 2933.39 38.100 Ann. Q (No. 261) HSC/11 1993 49 74517-42-3
dithranol dithranol 2914.50 38.100 Ann. Q (No. 262) HSC/11 1993 4 480-22-8
divaplon divaplone 2933.59 38.100 Ann. Q (No. 263) HSC/11 1993 61 90808-12-1
divozilimab divozilimab 3002.13 NC2803Bc Ann. T/7 HSC/67 2021 123 2254061-60-2
dizocilpine dizocilpine 2933.49 NC2004B1b Ann. O/6 HSC/53 2014 60 77086-21-6 HSC/11 (2933.40)
docaravimab docaravimab 3002.13 NC2803Bc Ann. T/6 HSC/67 2021 122 2247196-23-0

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
docetaxel docétaxel 2932.99 NC2004B1b Ann. O/6 HSC/53 2014 71 114977-28-5 HSC/11 (2932.90)
dociparstat sodium dociparstat sodique 3913.90 NC2373B1b Ann. O/6 HSC/59 2017 114 177021-00-0
dofequidar doféquidar 2933.59 NC0845B2 Ann. M/2 HSC/33 2004 88 129716-58-1
dolcanatide dolcanatide 2937.19 NC2501B1b Ann. M/3 HSC/61 2018 114 1092457-65-2
dolutegravir dolutégravir 2934.99 NC1760B1b Ann. N/8 HSC/49 2012 105 1051375-16-6
domagrozumab domagrozumab 3002.13 NC2373B1b Ann. O/6 HSC/59 2017 114 1629605-31-7
domatinostat domatinostat 2935.90 NC2626B1b Ann. O/5 HSC/63 2019 118 910462-43-0
domitroban domitroban 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 73 112966-96-8 HSC/18 (2935.00)
domofenogene zalfaparvovec domofénogène zalfaparvovec 3002.49 NC2930Bc Ann. P/27 HSC/69 2022 125 2382896-04-8
domoprednate domoprednate 2937.29 38.100 Ann. Q (No. 266) HSC/11 1993 47 66877-67-6
domperidone dompéridone 2933.39 38.100 Ann. Q (No. 267) HSC/11 1993 36 57808-66-9
domvanalimab domvanalimab 3002.13 NC2930Bc Ann. P/25 HSC/69 2022 124 2368219-35-4
donanemab donanémab 3002.13 NC2803Bc Ann. T/2 HSC/67 2021 120 1931944-80-7
donaperminogène
donaperminogene seltoplasmid 2934.99 NC2501B1b Ann. M/5 HSC/61 2018 116 1787232-87-4
seltoplasmide
donepezil donépézil 2933.39 42.100 Ann. O (IV) HSC/21 1998 75 120014-06-4
donidalorsen donidalorsen 2934.99 NC2930Bc Ann. P/25 HSC/69 2022 124 2304692-48-4
donitriptan donitriptan 2933.59 NC0430B2 Ann. Q/1 (I) HSC/27 2001 82 170912-52-4
doqualast doqualast 2933.59 38.100 Ann. Q (No. 268) HSC/11 1993 48 64019-03-0
doramapimod doramapimod 2934.99 NC0845B2 Ann. M/2 HSC/33 2004 88 285983-48-4
doramectin doramectine 2941.90 38.100 Ann. Q (No. 269) HSC/11 1993 65 117704-25-3
doranidazole doranidazole 2933.29 NC0938B2b Ann. O/3 (I) HSC/35 2005 90 149838-23-3
dorastine dorastine 2933.39 38.100 Ann. Q (No. 270) HSC/11 1993 23 21228-13-7
doravirine doravirine 2933.79 NC2004B1b Ann. O/5 HSC/53 2014 109 1338225-97-0
doripenem doripénem 2941.90 NC0590B2 Ann. L/10 HSC/29 2002 83 148016-81-3
dornase alfa dornase alfa 3507.90 40.600 Ann. D, par. 6 HSC/18 1996 70 143831-71-4
doruxapapogene ralaplasmid doruxapapogène ralaplasmide 2934.99 NC2930Bc Ann. P/27 HSC/69 2022 125 2416305-95-6
dorzagliatin dorzagliatine 2933.79 NC2501B1b Ann. M/5 HSC/61 2018 116 1191995-00-2
dosergoside dosergoside 2939.69 NC2004B1b Ann. O/6 HSC/53 2014 54 87178-42-5 HSC/11 (2939.60)
dostarlimab dostarlimab 3002.13 NC2626B1b Ann. O/6 HSC/63 2019 119 2022215-59-2
dotinurad dotinurad 2934.20 NC2501B1b Ann. M/5 HSC/61 2018 116 1285572-51-1
dovanvetmab dovanvetmab 3002.13 NC2803Bc Ann. T/3 HSC/67 2021 121 2171034-71-0
dovitinib dovitinib 2933.79 NC1310B1b Ann. N/4 HSC/41 2008 97 405169-16-6
doxecitine doxécitine 2934.99 NC2930Bc Ann. P/27 HSC/69 2022 125 951-77-9
doxercalciferol doxercalciférol 2936.29 NC0430B2 Ann. Q/1 (I) HSC/27 2001 82 54573-75-0
doxribtimine doxribtimine 2934.99 NC2930Bc Ann. P/27 HSC/69 2022 125 50-89-5
draquinolol draquinolol 2933.79 38.100 Ann. Q (No. 272) HSC/11 1993 54 67793-71-9
dresbuxelimab dresbuxélimab 3002.13 NC2930Bc Ann. P/27 HSC/69 2022 125 2550560-20-6
drinabant drinabant 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 99 358970-97-5 HSC/43 (2935.00)

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
drisapersen drisapersen 2934.99 NC1874B1b Ann. O/1 HSC/51 2013 106 1251830-50-8
droloxifene droloxifène 2922.19 40.260 Ann. L/2 (No. 64) HSC/17 1996 53 82413-20-5
dronedarone dronédarone 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 75 141626-36-0 HSC/21 (2935.00)
drospirenone drospirénone 2937.29 NC2004B1b Ann. O/6 HSC/53 2014 63 67392-87-4 HSC/11 (2932.29)
drotebanol drotébanol 2933.49 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 24 3176-03-2
drotrecogin alfa (activated) drotrécogine alfa (activé) 3002.12 NC2116B1b Ann. S/2 HSC/55 2015 86 98530-76-8 HSC/31 (3002.10)
droxinavir droxinavir 2924.21 42.100 Ann. O (III) HSC/21 1998 74 159910-86-8
drozitumab drozitumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 103 912628-39-8 HSC/47 (3002.10)
dubermatinib dubermatinib 2935.90 NC2803Bc Ann. T/2 HSC/67 2021 120 1341200-45-0
dulaglutide dulaglutide 2937.19 NC1649B3b Ann. R/14 HSC/47 2011 103 923950-08-7
dulanermin dulanermine 2933.29 NC1443B1b Ann. P/6 HSC/43 2009 99 867153-61-5
duligotumab duligotumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 107 1314238-96-4 HSC/51 (3002.10)
dupilumab dupilumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 108 1190264-60-8 HSC/53 (3002.10)
durlobactam durlobactam 2933.39 NC2626B1b Ann. O/6 HSC/63 2019 119 1467829-71-5
HSC/57 (3002.10)
durvalumab durvalumab 3002.13 NC2237B1b Ann. T/10 HSC/57 2016 112 1428935-60-7
(S/8)
dusigitumab dusigitumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 108 1204390-13-5 HSC/53 (3002.10)
dusquetide dusquétide 2933.99 NC2237B1b Ann. S/9 HSC/57 2016 113 931395-42-5
dutacatib dutacatib 2933.59 NC1123B1b Ann. N/1 HSC/38 2006 94 501000-36-8
dutasteride dutastéride 2937.29 NC2116B1b Ann. R/7 HSC/55 2015 78 164656-23-9 HSC/22 (2933.79)
duteplase dutéplase 3507.90 38.100 Ann. Q (No. 275) HSC/11 1993 62 120608-46-0
dutogliptin dutogliptine 2933.99 NC1500B1b Ann. K/6 HSC/44 2009 100 852329-66-9
duvelisib duvélisib 2933.79 NC2116B1b Ann. R/4 HSC/55 2015 110 1201438-56-3
duvoglustat duvoglustat 2933.39 NC1604B1b Ann. N/6 HSC/46 2010 102 19130-96-2
duvortuxizumab duvortuxizumab 3002.13 NC2501B1b Ann. M/5 HSC/61 2018 116 1831098-91-9
ebalzotan ébalzotan 2932.99 40.600 Ann. D, par. 6 HSC/18 1996 72 149494-37-1
ebaresdax ébaresdax 2934.10 NC2930Bc Ann. P/25 HSC/69 2022 124 1334471-39-4
ebdarokimab ebdarokimab 3002.13 NC2930Bc Ann. P/25 HSC/69 2022 124 2393651-11-9
eblasakimab éblasakimab 3002.13 NC2930Bc Ann. P/27 HSC/69 2022 125 2445460-16-0
ebopiprant ébopiprant 2935.90 NC2803Bc Ann. T/6 HSC/67 2021 122 2005486-31-5
ebronucimab ébronucimab 3002.13 NC2803Bc Ann. T/7 HSC/67 2021 123 2304800-90-4
ebvaciclib ebvaciclib 2935.90 NC2930Bc Ann. P/25 HSC/69 2022 124 2185857-97-8
ecalcidene ecalcidene 2933.39 NC0590B2 Ann. L/15 HSC/29 2002 85 150337-94-3
ecallantide ecallantide 2934.99 NC1059B2b Ann. O/5 HSC/37 2006 93 460738-38-9
ecamsule écamsule 2914.79 NC2116B1b Ann. S/1 HSC/55 2015 75 92761-26-7 HSC/21 (2914.70)
ecenofloxacin écénofloxacine 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 78 162301-05-5 HSC/22 (2933.90)
ecipramidil écipramidil 2922.19 40.260 Ann. L/2 (No. 65) HSC/17 1996 40 64552-16-5
ecleralimab écléralimab 3002.13 NC2930Bc Ann. P/27 HSC/69 2022 125 2415207-91-7
eclitasertib éclitasertib 2934.99 NC2803Bc Ann. T/11 HSC/67 2021
124 COVID-19
2125450-76-0

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
ecogramostim écogramostim 3504.00 38.100 Ann. Q (No. 276) HSC/11 1993 62 123120-99-0
ecomustine écomustine 2932.99 NC2004B1b Ann. O/6 HSC/53 2014 61 98383-18-7 HSC/11 (2932.90)
ecopipam ecopipam 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 80 112108-01-7 HSC/23 (2933.90)
ecopladib ecopladib 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 90 381683-92-7 HSC/35 (2935.00)
ecraprost ecraprost 2937.50 NC2116B1b Ann. R/7 HSC/55 2015 83 136892-64-3 HSC/27 (2918.19)
ecromeximab écromeximab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 87 292819-64-8 HSC/31 (3002.10)
ecubectedin écubectédine 2939.80 NC2930Bc Ann. P/25 HSC/69 2022 124 2248127-53-7
eculizumab eculizumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 87 219685-50-4 HSC/31 (3002.10)
edaglitazone edaglitazone 2934.10 NC0938B2b Ann. O/3 (II) HSC/35 2005 91 213411-83-7
edaravone édaravone 2933.19 42.100 Ann. O (III) HSC/21 1998 74 89-25-8
edasalonexent édasalonexent 2924.29 NC2373B1b Ann. O/6 HSC/59 2017 114 1204317-86-1
edaxeterkib édaxeterkib 2933.59 NC2930Bc Ann. P/25 HSC/69 2022 124 1695534-88-3
edelfosine édelfosine 2923.90 38.100 Ann. Q (No. 278) HSC/11 1993 59 70641-51-9
edicotinib édicotinib 2934.99 NC2626B1b Ann. O/5 HSC/63 2019 118 1142363-52-7
edifolone édifolone 2932.99 NC2004B1b Ann. O/6 HSC/53 2014 56 90733-40-7 HSC/11 (2932.90)
edivoxetine édivoxétine 2934.99 NC1760B1b Ann. N/7 HSC/49 2012 104 1194508-25-2
edodekin alfa édodékine alfa 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 79 187348-17-0 HSC/23 (3002.10)
edonentan edonentan 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 86 210891-04-6 HSC/31 (2935.00)
edonerpic édonerpic 2934.99 NC2373B1b Ann. O/6 HSC/59 2017 114 519187-23-6
edotecarin édotécarine 2934.99 NC0730B2 Ann. M/7 HSC/31 2003 87 174402-32-5
edotreotide édotréotide 2934.99 NC0590B2 Ann. L/15 HSC/29 2002 84 204318-14-9
edoxaban édoxaban 2934.99 NC1443B1b Ann. P/6 HSC/43 2009 99 480449-70-5
edralbrutinib édralbrutinib 2933.99 NC2803Bc Ann. T/7 HSC/67 2021 123 1858206-58-2
edratide edratide 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 89 433922-67-9 HSC/47 (3002.10)
edrecolomab édrécolomab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 74 156586-89-9 HSC/21 (3002.10)
edronocaine édronocaïne 2922.19 NC0590B2 Ann. L/15 HSC/29 2002 84 190258-12-9
efalizumab éfalizumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 85 214745-43-4 HSC/29 (3002.10)
efanesoctocog alfa éfanésoctocog alfa 3002.12 NC2803Bc Ann. T/6 HSC/67 2021 122 2252477-42-0
efaprinermin alfa éfaprinermine alfa 3002.13 NC2803Bc Ann. T/2 HSC/67 2021 120 2102200-64-4
efaproxiral éfaproxiral 2924.29 NC0730B2 Ann. M/6 HSC/31 2003 86 131179-95-8
efavaleukin alfa éfavaleukine alfa 3002.13 NC2626B1b Ann. O/5 HSC/63 2019 118 2049067-94-7
efavirenz éfavirenz 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 78 154598-52-4 HSC/22 (2934.90)
efbemalenograstim alfa efbémalénograstim alfa 3002.13 NC2803Bc Ann. T/3 HSC/67 2021 121 2200269-79-8
efdamrofusp alfa efdamrofusp alfa 3002.13 NC2930Bc Ann. P/27 HSC/69 2022 125 2375661-82-6
efegatran éfégatran 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 71 105806-65-3 HSC/18 (2933.90)
efepoetin alfa éfépoétine alfa 3002.12 NC2501B1b Ann. M/6 HSC/61 2018 117 1905452-78-9
efepristin éfépristine 2941.90 42.100 Ann. O (IV) HSC/21 1998 75 57206-54-9
efgartigimod alfa efgartigimod alfa 3002.13 NC2501B1b Ann. M/5 HSC/61 2018 116 1821402-21-4
efgivanermin alfa efgivanermine alfa 3002.13 NC2803Bc Ann. T/2 HSC/67 2021 120 1807864-13-6

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
efinaconazole éfinaconazole 2933.39 NC1760B1b Ann. N/7 HSC/49 2012 104 164650-44-6
efineptakin alfa éfineptakine alfa 3002.13 NC2626B1b Ann. O/5 HSC/63 2019 118 2026634-47-7
efinopegdutide éfinopégdutide 2937.19 NC2626B1b Ann. O/5 HSC/63 2019 118 2055640-93-0
efipladib efipladib 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 92 381683-94-9 HSC/37 (2935.00)
efizonerimod alfa éfizonérimod alfa 3002.13 NC2501B1b Ann. M/6 HSC/61 2018 117 1635395-27-5
eflapegastrim éflapégastrim 3002.13 NC2373B1b Ann. O/8 HSC/59 2017 111 1384099-30-2 HSC/55 (3002.10)
eflenograstim alfa éflénograstim alfa 3002.13 NC2501B1b Ann. M/6 HSC/61 2018 117 1905459-83-7
eflepedocokin alfa eflépédocokine alfa 3002.13 NC2803Bc Ann. T/6 HSC/67 2021 122 2200269-84-5
efletirizine éflétirizine 2933.59 40.600 Ann. D, par. 6 HSC/18 1996 71 150756-35-7
eflimrufusp alfa éflimrufusp alfa 3002.13 NC2930Bc Ann. P/25 HSC/69 2022 124 2363779-14-8
eflucimibe éflucimibe 2930.90 NC0590B2 Ann. L/15 HSC/29 2002 84 202340-45-2
efmarodocokin alfa efmarodocokine alfa 3002.13 NC2803Bc Ann. T/6 HSC/67 2021 122 2247840-74-8
efmitermant alfa efmitermant alfa 3002.13 NC2803Bc Ann. T/3 HSC/67 2021 121 1644543-31-6
efmoroctocog alfa efmoroctocog alfa 3002.12 NC2237B1b Ann. T/13 HSC/57 2016 111 1270012-79-7 HSC/55 (3002.10)
efpeglenatide efpèglénatide 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 111 1296200-77-5 HSC/53 (3002.10)
efpegsomatropin efpegsomatropine 2937.11 NC2237B1b Ann. S/9 HSC/57 2016 113 1314472-89-3
efprezimod alfa efprézimod alfa 3002.13 NC2930Bc Ann. P/27 HSC/69 2022 125 2574508-57-7
efruxifermin éfruxifermine 3002.13 NC2930Bc Ann. P/25 HSC/69 2022 124 2375240-92-7
eftansomatropin alfa eftansomatropine alfa 2937.11 NC2626B1b Ann. O/5 HSC/63 2019 118 1905448-17-0
eftilagimod alfa eftilagimod alfa 3002.13 NC2501B1b Ann. M/5 HSC/61 2018 116 1800476-36-1
eftozanermin alfa eftozanermine alfa 3002.13 NC2626B1b Ann. O/6 HSC/63 2019 119 1820660-69-2
eftrenonacog alfa eftrénonacog alfa 3002.12 NC2116B1b Ann. S/2 HSC/55 2015 109 1270012-74-2 HSC/53 (3002.10)
efungumab éfungumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 95 762260-74-2 HSC/39 (3002.10)
efzofitimod efzofitimod 3002.13 NC2930Bc Ann. P/27 HSC/69 2022 125 2566615-11-8
eganelisib éganélisib 2933.79 NC2930Bc Ann. P/25 HSC/69 2022 124 1693758-51-8
eganoprost eganoprost 2937.50 NC0590B2 Ann. L/15 HSC/29 2002 84 63266-93-3
egaptivon pegol egaptivon pégol 3907.29 NC2803Bc Ann. T/4 HSC/67 2021 104 934868-74-3 HSC/49 (3907.20)
eglumetad églumétad 2922.49 NC0730B2 Ann. M/7 HSC/31 2003 90 176199-48-7
elacestrant élacestrant 2922.29 NC2373B1b Ann. O/7 HSC/59 2017 115 722533-56-4
elacridar élacridar 2933.49 NC2004B1b Ann. O/6 HSC/53 2014 76 143664-11-3 HSC/21 (2933.40)
elacytarabine élacytarabine 2934.99 NC1178B1c Ann. O/5 HSC/39 2007 95 188181-42-2
eladocagene exuparvovec éladocagène exuparvovec 3002.49 NC2930Bc Ann. P/33 HSC/69 2022 119 2098615-91-7 HSC/63 (3002.90)
elafibranor élafibranor 2930.90 NC2237B1b Ann. S/8 HSC/57 2016 112 824932-88-9
elagolix élagolix 2937.90 NC1443B1b Ann. P/6 HSC/43 2009 99 834153-87-6
elamipretide élamiprétide 2925.29 NC2237B1b Ann. S/9 HSC/57 2016 113 736992-21-5
elapegademase élapégadémase 3507.90 NC2373B1b Ann. O/7 HSC/59 2017 115 1709806-75-6
elarofiban elarofiban 2933.39 NC0430B2 Ann. Q/1 (II) HSC/27 2001 83 198958-88-2
elasomeran élasoméran 3002.41 NC2930Bc Ann. P/27 HSC/69 2022125-COVID2430046-03-8
elbasvir elbasvir 2934.99 NC2116B1b Ann. R/4 HSC/55 2015 110 1370468-36-2

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
elbimilast elbimilast 2933.39 NC1760B1b Ann. N/7 HSC/49 2012 107 418794-42-0
eldacimibe eldacimibe 2922.50 42.100 Ann. O (V) HSC/21 1998 76 141993-70-6
eldecalcitol eldécalcitol 2936.29 NC1443B1b Ann. P/3 HSC/43 2009 97 104121-92-8
eldelumab eldélumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 109 946414-98-8 HSC/53 (3002.10)
eleclazine éléclazine 2934.99 NC2237B1b Ann. S/8 HSC/57 2016 112 1443211-72-0
eledoisin élédoïsine 2933.79 40.260 Ann. L/2 (No. 25) HSC/17 1996 28 69-25-0
elenbecestat élenbécestat 2934.99 NC2501B1b Ann. M/6 HSC/61 2018 117 1388651-30-6
elesclomol élesclomol 2930.90 NC1443B1b Ann. P/6 HSC/43 2009 99 488832-69-5
eletriptan élétriptan 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 74 143322-58-1 HSC/21 (2933.90)
elexacaftor élexacaftor 2935.90 NC2803Bc Ann. T/3 HSC/67 2021 121 2216712-66-0
elezanumab élézanumab 3002.13 NC2373B1b Ann. O/7 HSC/59 2017 115 1791416-49-3
HSC/57 (3002.10)
elgemtumab elgemtumab 3002.13 NC2237B1b Ann. T/10 HSC/57 2016 112 1512559-37-3
(S/8)
eliapixant éliapixant 2934.10 NC2803Bc Ann. T/6 HSC/67 2021 122 1948229-21-7
eliglustat éliglustat 2934.99 NC1649B3b Ann. R/14 HSC/47 2011 103 491833-29-5
elimusertib élimusertib 2934.99 NC2803Bc Ann. T/7 HSC/67 2021 123 1876467-74-1
elinafide élinafide 2925.19 42.100 Ann. O (IV) HSC/21 1998 75 162706-37-8
elinogrel élinogrel 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 101 936500-94-6 HSC/46 (2935.00)
elinzanetant élinzanétant 2934.99 NC2803Bc Ann. T/6 HSC/67 2021 122 929046-33-3
elipovimab élipovimab 3002.13 NC2803Bc Ann. T/2 HSC/67 2021 120 2101210-43-7
elisartan élisartan 2933.29 40.600 Ann. D, par. 6 HSC/18 1996 72 158682-68-9
elisidepsin élisidepsine 2934.99 NC1649B3b Ann. R/12 HSC/47 2011 101 681272-30-0
elismetrep élismétrep 2935.90 NC2626B1b Ann. O/5 HSC/63 2019 118 1400699-64-0
elivaldogene autotemcel élivaldogène autotemcel 3002.51 NC2803Bc Ann. T/3 HSC/67 2021 121 no mention
elivaldogene tavalentivec élivaldogène tavalentivec 3002.49 NC2930Bc Ann. P/33 HSC/69 2022 115 1905397-73-0 HSC/59 (3002.90)
HSC/11 (2939.90)
elliptinium acetate acétate d'elliptinium 2939.79 NC2116B1b Ann. S/1 HSC/55 2015 43 58337-35-2
HSC/53 (2939.99)
elobixibat élobixibat 2934.99 NC1760B1b Ann. N/7 HSC/49 2012 104 439087-18-0
elocalcitol élocalcitol 2906.19 NC1178B1c Ann. O/5 HSC/39 2007 95 199798-84-0
elomotecan élomotécan 2934.99 NC2237B1b Ann. S/11 HSC/57 2016 92 220998-10-7 HSC/37 (2939.99)
elopiprazole élopiprazole 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 70 115464-77-2 HSC/18 (2934.90)
elopultide élopultide 2933.29 NC2626B1b Ann. O/6 HSC/63 2019 119 1018791-84-8
elosulfase alfa élosulfase alfa 3507.90 NC2004B1b Ann. O/4 HSC/53 2014 108 9025-60-9
elotuzumab elotuzumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 100 915296-00-3 HSC/44 (3002.10)
elpamotide elpamotide 3002.41 NC2803Bc Ann. T/4 HSC/67 2021 103 673478-49-4 HSC/47 (3002.20)
elpetrigine elpétrigine 2933.99 NC1604B1b Ann. N/5 HSC/46 2010 101 212778-82-0
elraglusib elraglusib 2934.99 NC2930Bc Ann. P/25 HSC/69 2022 124 1034895-42-5
elranatamab elranatamab 3002.13 NC2930Bc Ann. P/27 HSC/69 2022 125 2408850-14-4
elsamitrucin elsamitrucine 2941.90 38.100 Ann. Q (No. 281) HSC/11 1993 62 97068-30-9

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
elsibucol elsibucol 2930.90 NC1178B1c Ann. O/5 HSC/39 2007 95 216167-95-2
elsiglutide elsiglutide 2937.19 NC1760B1b Ann. N/7 HSC/49 2012 104 914009-84-0
elsubrutinib elsubrutinib 2933.39 NC2803Bc Ann. T/3 HSC/67 2021 121 1643570-24-4
elsulfavirine elsulfavirine 2935.90 NC2501B1b Ann. M/6 HSC/61 2018 117 868046-19-9
eltanexor eltanexor 2933.59 NC2501B1b Ann. M/5 HSC/61 2018 116 1642300-52-4
eltrapuldencel eltrapuldencel 3002.51 NC2803Bc Ann. T/4 HSC/67 2021 115 no mention HSC/61 (3002.90)
eltrombopag eltrombopag 2933.19 NC1178B1c Ann. O/3 HSC/39 2007 94 496775-61-2
elubrixin élubrixine 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 107 688763-64-6 HSC/51 (2935.00)
eluforsen éluforsen 2934.99 NC2626B1b Ann. O/6 HSC/63 2019 119 2101868-82-8
elunonavir élunonavir 2934.99 NC2930Bc Ann. P/27 HSC/69 2022 125 2242428-57-3
eluvixtamab éluvixtamab 3002.13 NC2803Bc Ann. T/7 HSC/67 2021 123 1679391-73-1
eluxadoline eluxadoline 2933.29 NC2004B1b Ann. O/5 HSC/53 2014 109 864821-90-9
elvitegravir elvitégravir 2933.49 NC1310B1b Ann. N/4 HSC/41 2008 97 697761-98-1
elzasonan elzasonan 2934.99 NC0730B2 Ann. M/7 HSC/31 2003 87 361343-19-3
emactuzumab emactuzumab 3002.13 NC2237B1b Ann. T/13 HSC/57 2016 111 1448221-67-7 HSC/55 (3002.10)
emapalumab émapalumab 3002.13 NC2373B1b Ann. O/7 HSC/59 2017 115 1709815-23-5
emapticap pegol émapticap pégol 3907.29 NC2803Bc Ann. T/4 HSC/67 2021 108 1390630-22-4 HSC/53 (3907.20)
emapunil émapunil 2933.59 NC0938B2b Ann. O/3 (I) HSC/35 2005 90 226954-04-7
emavusertib émavusertib 2934.99 NC2930Bc Ann. P/25 HSC/69 2022 124 1801344-14-8
embeconazole embéconazole 2934.99 NC1059B2b Ann. O/4 HSC/37 2006 92 329744-44-7
embusartan embusartan 2933.79 42.750 Ann. O HSC/22 1998 78 156001-18-2
emeramide éméramide 2930.90 NC2237B1b Ann. S/8 HSC/57 2016 112 351994-94-0
emerfetamab émerfétamab 3002.13 NC2803Bc Ann. T/7 HSC/67 2021 123 2250261-27-7
emfilermin emfilermine 2933.29 NC0430B2 Ann. Q/1 (I) HSC/27 2001 82 159075-60-2
emibetuzumab émibetuzumab 3002.13 NC2237B1b Ann. T/13 HSC/57 2016 111 1365287-97-3 HSC/55 (3002.10)
emicerfont emicerfont 2933.29 NC1649B3b Ann. R/13 HSC/47 2011 102 786701-13-1
HSC/57 (3002.10)
emicizumab émicizumab 3002.13 NC2237B1b Ann. T/11 HSC/57 2016 113 1610943-06-0
(S/9)
emideltide émideltide 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 70 62568-57-4 HSC/18 (2933.90)
emiplacel émiplacel 3002.51 NC2803Bc Ann. T/4 HSC/67 2021 117 no mention HSC/63 (3002.90)
emivirine émivirine 2933.59 NC0430B2 Ann. Q/1 (I) HSC/27 2001 82 149950-60-7
emixustat émixustat 2922.50 NC2004B1b Ann. O/4 HSC/53 2014 108 1141777-14-1
emlenoflast emlénoflast 2935.90 NC2930Bc Ann. P/27 HSC/69 2022 125 1995067-59-8
emoctakin émoctakine 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 74 142298-00-8 HSC/21 (3002.10)
emodepside emodepside 2934.99 NC0590B2 Ann. L/15 HSC/29 2002 84 155030-63-0
empagliflozin empagliflozin 2932.19 NC1760B1b Ann. N/7 HSC/49 2012 104 864070-44-0
empegfilgrastim empegfilgrastim 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 107 1192706-53-8 HSC/51 (3002.10)
empesertib empésertib 2933.99 NC2501B1b Ann. M/5 HSC/61 2018 116 1443763-60-7
emraclidine emraclidine 2933.39 NC2930Bc Ann. P/27 HSC/69 2022 125 2170722-84-4

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
emricasan emricasan 2924.29 NC1443B1b Ann. P/5 HSC/43 2009 98 254750-02-2
emtricitabine emtricitabine 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 80 143491-57-0 HSC/23 (2934.90)
emvododstat emvododstat 2933.99 NC2930Bc Ann. P/25 HSC/69 2022 124 1256565-36-2
enadenoticirev énadénoticirev 3002.49 NC2930Bc Ann. P/33 HSC/69 2022 111 1402042-02-7 HSC/55 (3002.90)
enapotamab énapotamab 3002.13 NC2626B1b Ann. O/5 HSC/63 2019 118 1912423-61-0
enapotamab vedotin énapotamab védotine 3002.13 NC2626B1b Ann. O/5 HSC/63 2019 118 1912424-97-5
enarodustat énarodustat 2933.99 NC2501B1b Ann. M/6 HSC/61 2018 117 1262132-81-9
enasidenib énasidénib 2933.69 NC2237B1b Ann. S/9 HSC/57 2016 113 1446502-11-9
enavatuzumab énavatuzumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 104 62149-33-0 HSC/49 (3002.10)
enavogliflozin énavogliflozine 2932.99 NC2803Bc Ann. T/3 HSC/67 2021 121 1415472-28-4
encaleret encaléret 2922.19 NC1874B1b Ann. O/4 HSC/51 2013 105 787583-71-5
encelimab encelimab 3002.13 NC2803Bc Ann. T/3 HSC/67 2021 121 2173096-82-5
encenicline encénicline 2934.99 NC2116B1b Ann. R/5 HSC/55 2015 111 550999-75-2
encequidar encéquidar 2934.99 NC2626B1b Ann. O/6 HSC/63 2019 119 849675-66-7
encoberminogene rezmadenoveencoberminogène rezmadénove 3002.49 NC2930Bc Ann. P/25 HSC/69 2022 124 2376853-01-7
encorafenib encorafénib 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 109 1269440-17-6 HSC/53 (2935.00)
endixaprine endixaprine 2933.39 38.100 Ann. Q (No. 282) HSC/11 1993 60 93181-85-2
enecadin énécadine 2933.59 NC0730B2 Ann. M/7 HSC/31 2003 87 259525-01-4
enerisant énérisant 2934.99 NC2237B1b Ann. S/9 HSC/57 2016 113 1152747-82-4
enestebol énestébol 2937.29 NC2004B1b Ann. O/6 HSC/53 2014 22 2320-86-7 HSC/11 (2937.99)
enexasogaol énexasogaol 2914.50 NC2626B1b Ann. O/5 HSC/63 2019 118 23513-13-5
enflicoxib enflicoxib 2935.90 NC2803Bc Ann. T/6 HSC/67 2021 122 251442-94-1
enfortumab vedotin enfortumab vedotin 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 109 1346452-25-2 HSC/53 (3002.10)
enfuvirtide enfuvirtide 2933.29 NC0730B2 Ann. M/4 (III) HSC/31 2003 85 159519-65-0
enibarcimab énibarcimab 3002.13 NC2803Bc Ann. T/7 HSC/67 2021 123 2305638-98-4
eniluracil eniluracil 2933.59 42.100 Ann. O (VI) HSC/21 1998 77 59989-18-3
eniporide éniporide 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 79 176644-21-6 HSC/23 (2933.90)
enisamium iodide iodure d'énisamium 2933.39 NC1604B1b Ann. N/5 HSC/46 2010 101 201349-37-3
enlimomab enlimomab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 70 142864-19-5 HSC/18 (3002.10)
enlimomab pegol enlimomab pégol 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 77 169802-84-0 HSC/21 (3002.10)
enmetazobactam enmétazobactam 2934.99 NC2803Bc Ann. T/3 HSC/67 2021 121 1001404-83-6
enoblituzumab énoblituzumab 3002.13 NC2373B1b Ann. O/6 HSC/59 2017 114 1353485-38-7
enobosarm enobosarm 2926.90 NC1874B1b Ann. O/2 HSC/51 2013 107 841205-47-8
enocitabine énocitabine 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 46 55726-47-1 HSC/11 (2934.90)
enokizumab énokizumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 104 909875-08-7 HSC/49 (3002.10)
enomimeran énomiméran 2934.99 NC2803Bc Ann. T/7 HSC/67 2021 123 2348560-99-4
enoticumab énoticumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 107 1192578-27-0 HSC/51 (3002.10)
enoxacin énoxacine 2933.59 38.100 Ann. Q (No. 285) HSC/11 1993 49 74011-58-8
enoxaparin sodium énoxaparine sodique 3001.90 NC1553B1b Ann. O/5 HSC/45 2010 65 9041-08-1

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
enoximone énoximone 2933.29 38.100 Ann. Q (No. 287) HSC/11 1993 52 77671-31-9
enpatoran enpatoran 2933.49 NC2803Bc Ann. T/11 HSC/67 2021
124 COVID-19
2101938-42-3
enprofylline enprofylline 2939.59 NC2004B1b Ann. O/6 HSC/53 2014 44 41078-02-8 HSC/11 (2939.50)
enrasentan enrasentan 2932.99 NC0090B2 Ann. M/5 HSC/23 1999 80 167256-08-8
ensartinib ensartinib 2933.59 NC2373B1b Ann. O/7 HSC/59 2017 115 1370651-20-9
ensereptide enséreptide 2934.99 NC1874B1b Ann. O/2 HSC/51 2013 107 254433-51-7
ensifentrine ensifentrine 2933.59 NC2626B1b Ann. O/6 HSC/63 2019 119 1884461-72-6
ensituximab ensituximab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 103 1092658-06-4 HSC/47 (3002.10)
ensomafusp alfa ensomafusp alfa 3002.13 NC2930Bc Ann. P/27 HSC/69 2022 125 2417199-08-5
ensovibep ensovibep 2933.29 NC2930Bc Ann. P/25 HSC/69 2022 124 2451126-06-8
ensulizole ensulizole 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 83 27503-81-7 HSC/27 (2933.90)
entacingene turiparvovec entacingène turiparvovec 3002.49 NC2930Bc Ann. P/33 HSC/69 2022 123 2247971-01-1 HSC/67 (3002.90)
entasobulin entasobuline 2933.49 NC2116B1b Ann. R/4 HSC/55 2015 110 501921-61-5
entecavir entécavir 2933.59 NC0430B2 Ann. Q/1 (I) HSC/27 2001 82 142217-69-4
entinostat entinostat 2933.39 NC1443B1b Ann. P/6 HSC/43 2009 99 209783-80-2
entolimod entolimod 3002.13 NC2237B1b Ann. T/13 HSC/57 2016 108 951628-22-1 HSC/53 (3002.10)
entospletinib entosplétinib 2934.99 NC2116B1b Ann. R/4 HSC/55 2015 110 1229208-44-9
entrectinib entrectinib 2934.99 NC2237B1b Ann. S/9 HSC/57 2016 113 1108743-60-7
enuvaptan énuvaptan 2933.39 NC2930Bc Ann. P/25 HSC/69 2022 124 2145062-48-0
enuzovimab énuzovimab 3002.13 NC2930Bc Ann. P/27 HSC/69 2022 125 2531098-91-4
envafolimab envafolimab 3002.13 NC2803Bc Ann. T/2 HSC/67 2021 120 2102192-68-5
enzacamene enzacamène 2914.39 NC0430B2 Ann. Q/1 (II) HSC/27 2001 83 36861-47-9
enzalutamide enzalutamide 2933.29 NC1874B1b Ann. O/2 HSC/51 2013 107 915087-33-1
enzaplatovir enzaplatovir 2934.99 NC2373B1b Ann. O/7 HSC/59 2017 115 1323077-89-9
enzastaurin enzastaurine 2933.39 NC0938B2b Ann. O/3 (I) HSC/35 2005 90 170364-57-5
epacadostat épacadostat 2934.99 NC2373B1b Ann. O/6 HSC/59 2017 114 1204669-58-8
epafipase epafipase 3507.90 NC0730B2 Ann. M/4 (III) HSC/31 2003 85 208576-22-1
epaminurad épaminurad 2934.99 NC2626B1b Ann. O/5 HSC/63 2019 118 1198153-15-9
epcoritamab épcoritamab 3002.13 NC2803Bc Ann. T/3 HSC/67 2021 121 2134641-34-0
epeleuton épéleuton 2918.19 NC2626B1b Ann. O/5 HSC/63 2019 118 1667760-39-5
epelsiban épelsiban 2934.99 NC1760B1b Ann. N/8 HSC/49 2012 105 872599-83-2
eperezolid épérézolide 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 76 165800-04-4 HSC/21 (2934.90)
epertinib épertinib 2934.99 NC2373B1b Ann. O/7 HSC/59 2017 115 908305-13-5
epervudine épervudine 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 61 60136-25-6 HSC/11 (2934.90)
epetirimod épétirimod 2933.99 NC1310B1b Ann. N/4 HSC/41 2008 97 227318-71-0
epetraborole épétraborole 2934.99 NC2237B1b Ann. S/8 HSC/57 2016 112 1093643-37-8
epicriptine épicriptine 2939.69 NC2004B1b Ann. O/6 HSC/53 2014 58 88660-47-3 HSC/11 (2939.60)
epiestriol épiestriol 2937.23 NC2004B1b Ann. O/6 HSC/53 2014 12 547-81-9 HSC/11 (2937.92)
epimestrol épimestrol 2937.23 NC2004B1b Ann. O/6 HSC/53 2014 22 7004-98-0 HSC/11 (2937.92)

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
epipropidine épipropidine 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 12 5696-17-3 HSC/11 (2934.90)
epirubicin épirubicine 2941.90 38.100 Ann. Q (No. 294) HSC/11 1993 48 56420-45-2
epitizide épitizide 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 91 1764-85-8 HSC/11 (2935.00)
epitumomab epitumomab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 82 263547-71-3 HSC/27 (3002.10)
eplerenone éplérénone 2937.29 NC2004B1b Ann. O/6 HSC/53 2014 77 107724-20-9 HSC/21 (2932.29)
eplivanserin éplivansérine 2928.00 NC0090B2 Ann. M/5 HSC/23 1999 80 130579-75-8
eplontersen éplontersen 2934.99 NC2803Bc Ann. T/7 HSC/67 2021 123 1637600-16-8
epoetin alfa époétine alfa 3002.12 NC2373B1b Ann. O/8 HSC/59 2017 66 113427-24-0 HSC/41 (3002.10)
epoetin beta époétine bêta 3002.12 NC2373B1b Ann. O/8 HSC/59 2017 62 122312-54-3 HSC/41 (3002.10)
epoetin delta epoétine delta 3002.12 NC2373B1b Ann. O/8 HSC/59 2017 85 261356-80-3 HSC/31 (3002.10)
epoetin epsilon époétine epsilon 3002.12 NC2373B1b Ann. O/8 HSC/59 2017 72 154725-65-2 HSC/23 (3002.10)
epoetin gamma époétine gamma 3002.12 NC2373B1b Ann. O/8 HSC/59 2017 67 130455-76-4 HSC/41 (3002.10)
epoetin kappa époétine kappa 3002.12 NC2373B1b Ann. O/8 HSC/59 2017 97 879555-13-2 HSC/41 (3002.10)
epoetin omega époétine oméga 3002.12 NC2373B1b Ann. O/8 HSC/59 2017 73 148363-16-0 HSC/18 (3002.10)
epoetin theta époétine thêta 3002.12 NC2373B1b Ann. O/8 HSC/59 2017 95 762263-14-9 HSC/39 (3002.10)
epoetin zeta epoétine zéta 3002.12 NC2373B1b Ann. O/8 HSC/59 2017 92 604802-70-2 HSC/39 (3002.10)
epratuzumab épratuzumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 82 205923-57-5 HSC/27 (3002.10)
eprenetapopt éprénétapopt 2933.39 NC2803Bc Ann. T/7 HSC/67 2021 123 5291-32-7
eprinomectin éprinomectine 2941.90 40.600 Ann. D, par. 6 HSC/18 1996 73 123997-26-2
eprociclovir éprociclovir 2933.59 NC2237B1b Ann. S/8 HSC/57 2016 112 145512-85-2
eprodisate éprodisate 2904.10 NC1178B1c Ann. O/3 HSC/39 2007 94 21668-77-9
eprosartan éprosartan 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 71 133040-01-4 HSC/18 (2934.90)
eprotirome éprotirome 2924.29 NC1443B1b Ann. P/6 HSC/43 2009 99 355129-15-6
epsiprantel epsiprantel 2933.59 38.100 Ann. Q (No. 296) HSC/11 1993 57 98123-83-2
eptacog alfa (activated) eptacog alfa (activé) 3002.12 NC2116B1b Ann. S/2 HSC/55 2015 72 102786-61-8 HSC/18 (3002.10)
eptacog alfa pegol (activated) eptacog alfa pégol (activé) 3002.12 NC2116B1b Ann. S/2 HSC/55 2015 101 944130-77-2 HSC/47 (3002.10)
HSC/57 (3002.10)
eptacog beta (activated) eptacog bêta (activé) 3002.12 NC2237B1b Ann. T/10 HSC/57 2016 112 1228539-24-9
(S/8)
eptapirone eptapirone 2933.69 NC0430B2 Ann. Q/1 (I) HSC/27 2001 82 179756-85-5
eptaplatin eptaplatine 2843.90 NC0430B2 Ann. Q/1 (II) HSC/27 2001 83 146665-77-2
eptifibatide eptifibatide 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 78 148031-34-9 HSC/22 (2934.90)
eptinezumab eptinezumab 3002.13 NC2373B1b Ann. O/7 HSC/59 2017 115 1644539-04-7
eptotermin alfa eptotermine alfa 2933.29 NC0938B2b Ann. O/2 HSC/35 2005 89 129805-33-0
eragidomide éragidomide 2933.79 NC2930Bc Ann. P/27 HSC/69 2022 125 1860875-51-9
eramkafusp alfa éramkafusp alfa 3002.13 NC2930Bc Ann. P/25 HSC/69 2022 124 2388499-82-7
eravacycline éravacycline 2941.30 NC2004B1b Ann. O/4 HSC/53 2014 108 1207283-85-9
erdafitinib erdafitinib 2933.19 NC2237B1b Ann. S/9 HSC/57 2016 113 1346242-81-6
erenumab érénumab 3002.13 NC2373B1b Ann. O/7 HSC/59 2017 115 1582205-90-0
eretidigene velentivec érétidigène vélentivec 3002.49 NC2930Bc Ann. P/33 HSC/69 2022 115 1800541-90-5 HSC/59 (3002.90)
erfonrilimab erfonrilimab 3002.13 NC2930Bc Ann. P/25 HSC/69 2022 124 2367013-69-0

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
ergometrine ergométrine 2939.61 E.N. Chap. 29 - List I-III (Prec HSC/21 1998 4 60-79-7
ergotamine ergotamine 2939.62 E.N. Chap. 29 - List I-III (Prec HSC/21 1998 4 113-15-5
eribaxaban éribaxaban 2933.79 NC1443B1b Ann. P/5 HSC/43 2009 98 536748-46-6
eribulin éribuline 2932.19 NC1310B1b Ann. N/4 HSC/41 2008 97 253128-41-5
ericolol éricolol 2922.19 40.260 Ann. L/2 (No. 66) HSC/17 1996 50 85320-67-8
eritoran eritoran 2932.99 NC1178B1c Ann. O/2 HSC/39 2007 92 185955-34-4
eritrityl tetranitrate tétranitrate d'éritrityle 2920.90 38.100 Ann. Q (No. 298) HSC/11 1993 13 7297-25-8
erlizumab erlizumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 84 211323-03-4 HSC/29 (3002.10)
erlotinib erlotinib 2933.59 NC0590B2 Ann. L/15 HSC/29 2002 85 183321-74-6
ersemadromcel ersémadromcel 3002.51 NC2930Bc Ann. P/27 HSC/69 2022 125 no mention
ersentilide ersentilide 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 72 125279-79-0 HSC/18 (2935.00)
ertapenem ertapénem 2941.90 NC0590B2 Ann. L/15 HSC/29 2002 84 153832-46-3
erteberel ertébérel 2932.99 NC1760B1b Ann. N/7 HSC/49 2012 104 533884-09-2
ertiprotafib ertiprotafib 2934.99 NC0730B2 Ann. M/7 HSC/31 2003 87 251303-04-5
ertugliflozin ertugliflozine 2932.99 NC1874B1b Ann. O/2 HSC/51 2013 107 1210344-57-2
ertumaxomab ertumaxomab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 93 509077-99-0 HSC/37 (3002.10)
ervogastat ervogastat 2934.99 NC2930Bc Ann. P/25 HSC/69 2022 124 2186700-33-2
esafoxolaner ésafoxolaner 2934.99 NC2803Bc Ann. T/2 HSC/67 2021 120 1096103-99-9
esamisulpride ésamisulpride 2933.99 NC2803Bc Ann. T/6 HSC/67 2021 122 71675-92-8
esatenolol ésaténolol 2924.29 42.100 Ann. O (V) HSC/21 1998 76 93379-54-5
esaxerenone ésaxérénone 2933.99 NC2373B1b Ann. O/6 HSC/59 2017 114 1632006-28-0
escibenzoline escibenzoline 2933.29 NC2930Bc Ann. P/27 HSC/69 2022 125 103419-18-7
escitalopram escitalopram 2932.99 NC0430B2 Ann. Q/1 (I) HSC/27 2001 82 128196-01-0
esketamine eskétamine 2922.39 NC2004B1b Ann. O/6 HSC/53 2014 81 33643-46-8 HSC/25 (2922.30)
eslicarbazepine eslicarbazépine 2933.99 NC0938B2b Ann. O/3 (I) HSC/35 2005 90 104746-04-5
esmirtazapine esmirtazapine 2933.59 NC1059B2b Ann. O/5 HSC/37 2006 93 61337-87-9
esmolol esmolol 2922.19 40.260 Ann. L/2 (No. 67) HSC/17 1996 50 103598-03-4
esomeprazole ésoméprazole 2933.39 NC0090B2 Ann. M/1 (II) HSC/23 1999 79 119141-88-7
esonarimod ésonarimod 2930.90 NC0090B2 Ann. M/1 (II) HSC/23 1999 79 101973-77-7
esorubicin ésorubicine 2941.90 38.100 Ann. Q (No. 299) HSC/11 1993 47 63521-85-7
esoxybutynin ésoxybutynine 2922.19 NC0938B2b Ann. O/3 (I) HSC/35 2005 90 119618-22-3
esreboxetine esréboxétine 2934.99 NC1443B1b Ann. P/6 HSC/43 2009 99 98819-76-2
estazolam estazolam 2933.91 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 31 29975-16-4
estetrol estétrol 2937.23 NC2501B1b Ann. M/5 HSC/61 2018 116 15183-37-6
esuberaprost ésubéraprost 2932.99 NC2237Bib Ann. S/10 HSC/57 2016 111 94132-88-4
eszopiclone eszopiclone 2933.79 NC0845B2 Ann. M/1 (II) HSC/33 2004 87 138729-47-2
HSC/53 (2939.49)
etafedrine étafédrine 2939.49 NC2803Bc Ann. T/4 HSC/67 2021 14 7681-79-0
HSC/63 (2939.79)
etafenone étafénone 2922.19 40.260 Ann. L/2 (No. 68) HSC/17 1996 19 90-54-0

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
etalocib étalocib 2918.99 NC2373B1b Ann. O/12 HSC/59 2017 92 161172-51-6 HSC/37 (2918.90)
etamicastat étamicastat 2934.99 NC1604B1b Ann. N/5 HSC/46 2010 101 760173-05-5
etanercept étanercept 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 81 185243-69-0 HSC/25 (3002.10)
etaracizumab étaracizumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 99 892553-42-3 HSC/43 (3002.10)
etavopivat étavopivat 2935.90 NC2930Bc Ann. P/25 HSC/69 2022 124 2245053-57-8
etelcalcetide ételcalcétide 2928.00 NC2116B1b Ann. R/4 HSC/55 2015 110 1093130-72-3
eteplirsen étéplirsen 2934.99 NC1649B3b Ann. R/14 HSC/47 2011 103 1173755-55-9
etesevimab étésévimab 3002.13 NC2803Bc Ann. T/11 HSC/67 2021
124 COVID-19
2423948-94-9
etevritamab étévritamab 3002.13 NC2803Bc Ann. T/7 HSC/67 2021 123 2329692-74-0
ethchlorvynol éthchlorvynol 2905.51 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 38 113-18-8
ethinamate éthinamate 2924.24 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 6 126-52-3
ethyl loflazepate loflazépate d'éthyle 2933.91 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 43 29177-84-2
ethylcellulose éthylcellulose 3912.39 NC0090B2 Ann. M/5 HSC/23 1999 80 9004-57-3
ethylestrenol éthylestrénol 2937.23 NC2004B1b Ann. O/6 HSC/53 2014 13 965-90-2 HSC/21 (2937.99)
ethylmethylthiambutene éthylméthylthiambutène 2934.99 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 3 441-61-2
ethynerone éthynérone 2937.23 NC2004B1b Ann. O/6 HSC/53 2014 17 3124-93-4 HSC/11 (2937.92)
ethypicone éthypicone 2933.79 38.100 Ann. Q (No. 302) HSC/11 1993 6 467-90-3
eticyclidine éticyclidine 2921.49 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 44 2201-15-2
etidaligide étidaligide 2934.99 NC2626B1b Ann. O/5 HSC/63 2019 118 1974402-87-3
etigilimab étigilimab 3002.13 NC2626B1b Ann. O/5 HSC/63 2019 118 2044984-83-8
etiguanfacine étiguanfacine 2925.29 NC2116B1b Ann. R/4 HSC/55 2015 110 1346686-31-4
etilamfetamine étilamfétamine 2921.46 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 40 457-87-4
etilevodopa étilévodopa 2922.50 NC0090B2 Ann. M/5 HSC/23 1999 80 37178-37-3
etiprednol dicloacetate dicloacétate d'étiprednol 2937.22 NC0845B2 Ann. M/2 HSC/33 2004 88 199331-40-3
etirinotecan pegol étirinotecan pégol 2939.79 NC2116B1b Ann. S/1 HSC/55 2015 107 848779-32-8 HSC/51 (2933.99)
etisomicin étisomicine 2941.90 42.100 Ann. O (II) HSC/21 1998 47 70639-48-4
etisulergine étisulergine 2939.69 42.100 Ann. O (I) HSC/21 1998 47 64795-23-9
etofenamate étofénamate 2922.49 40.260 Ann. L/2 (No. 69) HSC/17 1996 29 30544-47-9
etofylline étofylline 2939.59 NC2004B1b Ann. O/6 HSC/53 2014 14 519-37-9 HSC/11 (2939.50)
etofylline clofibrate clofibrate d'étofylline 2939.59 NC2004B1b Ann. O/6 HSC/53 2014 38 54504-70-0 HSC/11 (2939.50)
etokimab étokimab 3002.13 NC2803Bc Ann. T/2 HSC/67 2021 120 2022981-44-6
etonitazene étonitazène 2933.99 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 11 911-65-9
etoposide étoposide 2938.90 38.100 Ann. Q (No. 305) HSC/11 1993 34 33419-42-0
etoposide toniribate toniribate d'étoposide 2938.90 NC2626B1b Ann. O/3 HSC/63 2019 116 433304-61-1
etoricoxib étoricoxib 2933.39 NC0590B2 Ann. L/15 HSC/29 2002 84 202409-33-4
etorphine étorphine 2939.11 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 17 14521-96-1
etoxeridine étoxéridine 2933.39 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 6 469-82-9
etoxybamide étoxybamide 2924.19 NC1760B1b Ann. N/8 HSC/49 2012 105 66857-17-8
etrabamine étrabamine 2934.20 38.100 Ann. Q (No. 306) HSC/11 1993 59 70590-58-8

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
etranacogene dezaparvovec étranacogène dezaparvovec 3002.49 NC2930Bc Ann. P/33 HSC/69 2022 120 2156583-26-3 HSC/67 (3002.90)
etrasimod étrasimod 2933.99 NC2501B1b Ann. M/5 HSC/61 2018 116 1206123-37-6
etravirine etravirine 2933.59 NC0845B2 Ann. M/2 HSC/33 2004 88 269055-15-4
etriciguat etriciguat 2933.59 NC0845B2 Ann. M/2 HSC/33 2004 88 402595-29-3
etripamil étripamil 2926.90 NC2237B1b Ann. S/9 HSC/57 2016 113 1593673-23-4
etrolizumab étrolizumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 104 1044758-60-2 HSC/49 (3002.10)
etrumadenant étrumadénant 2933.59 NC2930Bc Ann. P/25 HSC/69 2022 124 2239273-34-6
etuvetidigene autotemcel étuvétidigène autotemcel 3002.51 NC2930Bc Ann. P/27 HSC/69 2022 125 no mention
eufauserase eufausérase 3507.90 NC0590B2 Ann. L/15 HSC/29 2002 84 no mention
evacetrapib évacétrapib 2933.99 NC1760B1b Ann. N/8 HSC/49 2012 105 1186486-62-3
evagenretcel évagenretcel 3002.51 NC2803Bc Ann. T/4 HSC/67 2021 116 no mention HSC/63 (3002.90)
evandamine évandamine 2934.20 38.100 Ann. Q (No. 307) HSC/11 1993 56 100035-75-4
evatanepag évatanépag 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 101 223488-57-1 HSC/46 (2935.00)
evenamide événamide 2924.29 NC2237B1b Ann. S/9 HSC/57 2016 113 1092977-61-1
evernimicin evernimicine 2941.90 NC0590B2 Ann. L/10 HSC/29 2002 82 109545-84-8
everolimus évérolimus 2934.99 NC1874B1b Ann. O/5 HSC/51 2013 82 159351-69-6
evexomostat évexomostat 3906.90 NC2930Bc Ann. P/27 HSC/69 2022 125 2416263-67-5
evifacotrep évifacotrep 2933.59 NC2930Bc Ann. P/27 HSC/69 2022 125 2413739-88-3
HSC/57 (3002.10)
evinacumab évinacumab 3002.13 NC2237B1b Ann. T/10 HSC/57 2016 112 1446419-85-7
(S/8)
evixapodlin évixapodline 2933.79 NC2930Bc Ann. P/27 HSC/69 2022 125 2374856-75-2
evobrutinib évobrutinib 2933.59 NC2373B1b Ann. O/7 HSC/59 2017 115 1415823-73-2
evocalcet évocalcet 2933.99 NC2237B1b Ann. S/9 HSC/57 2016 113 870964-67-3
evodenoson évodénoson 2934.99 NC2004B1b Ann. O/4 HSC/53 2014 108 844873-47-8
evofosfamide évofosfamide 2933.29 NC2116B1b Ann. R/5 HSC/55 2015 111 918633-87-1
evogliptin évogliptin 2933.59 NC1874B1b Ann. O/2 HSC/51 2013 107 1222102-29-5
evolocumab évolocumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 108 1256937-27-5 HSC/53 (3002.10)
evoncabtagene pazurgedleucel évoncabtagène pazurgedleucel 3002.51 NC2930Bc Ann. P/27 HSC/69 2022 125 no mention
exagamglogene autotemcel exagamglogène autotemcel 3002.51 NC2930Bc Ann. P/25 HSC/69 2022 124 no mention
exaluren exalurène 2932.19 NC2803Bc Ann. T/6 HSC/67 2021 122 1375073-93-0
exametazime examétazime 2928.00 38.100 Ann. Q (No. 308) HSC/11 1993 57 105613-48-7
HSC/53 (2937.19)
examorelin examoréline 2937.19 NC2004B1b Ann. O/6 HSC/53 2014 72 140703-51-1
HSC/18 (2937.99)
exaprolol exaprolol 2922.19 40.260 Ann. L/2 (No. 70) HSC/17 1996 32 55837-19-9
HSC/27 (2939.90)
exatecan exatécan 2939.79 NC2116B1b Ann. S/1 HSC/55 2015 81 171335-80-1
HSC/53 (2939.99)
exatecan alideximer exatécan alideximer 2939.79 NC2237B1b Ann. T/12 HSC/57 2016 89 no mention HSC/37 (2939.99)
exbivirumab exbivirumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 91 569658-80-6 HSC/35 (3002.10)
exebacase exébacase 3507.90 NC2501B1b Ann. M/6 HSC/61 2018 117 1404122-92-4

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
exenatide exenatide 2937.19 NC1760B1b Ann. N/3 HSC/49 2012 89 141758-74-9
exeporfinium chloride chlorure d'exéporfinium 2933.99 NC1760B1b Ann. N/8 HSC/49 2012 105 718638-68-7
exicorilant exicorilant 2935.90 NC2626B1b Ann. O/6 HSC/63 2019 119 1781244-77-6
exidavnemab exidavnémab 3002.13 NC2930Bc Ann. P/27 HSC/69 2022 125 2438229-02-6
exisulind exisulind 2930.90 NC0090B2 Ann. M/5 HSC/23 1999 80 59973-80-7
ezabenlimab ézabenlimab 3002.13 NC2803Bc Ann. T/6 HSC/67 2021 122 2249882-54-8
ezaladcigene resoparvovec ézaladcigène résoparvovec 3002.49 NC2930Bc Ann. P/33 HSC/69 2022 121 2226647-27-2 HSC/67 (3002.90)
ezatiostat ézatiostat 2930.90 NC1443B1b Ann. P/5 HSC/43 2009 98 168682-53-9
ezeprogind ézéprogind 2933.59 NC2803Bc Ann. T/6 HSC/67 2021 122 615539-20-3
ezetimibe ézétimibe 2933.79 NC0430B2 Ann. Q/1 (II) HSC/27 2001 83 163222-33-1
ezlopitant ezlopitant 2933.39 NC0430B2 Ann. Q/1 (I) HSC/27 2001 82 147116-64-1
ezurpimtrostat ézurpimtrostat 2933.49 NC2930Bc Ann. P/27 HSC/69 2022 125 1914148-72-3
ezutromid ézutromid 2934.99 NC2237B1b Ann. S/9 HSC/57 2016 113 945531-77-1
fabesetron fabésétron 2933.79 42.100 Ann. O (III) HSC/21 1998 74 129300-27-2
facinicline facinicline 2933.39 NC1760B1b Ann. N/8 HSC/49 2012 105 677306-35-3
fadaltran fadaltran 2934.99 NC2803Bc Ann. T/2 HSC/67 2021 120 1799809-36-1
fadolmidine fadolmidine 2933.29 NC0430B2 Ann. Q/1 (I) HSC/27 2001 86 189353-31-9
fadraciclib fadraciclib 2933.59 NC2803Bc Ann. T/3 HSC/67 2021 121 1070790-89-4
faldaprevir faldaprévir 2934.10 NC1874B1b Ann. O/1 HSC/51 2013 106 801283-95-4
falnidamol falnidamol 2933.59 NC0250B2 Ann. P/1 (II) HSC/25 2000 81 196612-93-8
famciclovir famciclovir 2933.59 38.100 Ann. Q (No. 309) HSC/11 1993 61 104227-87-4
famiraprinium chloride chlorure de famiraprinium 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 58 108894-41-3 HSC/11 (2933.90)
famitinib famitinib 2933.79 NC2930Bc Ann. P/27 HSC/69 2022 125 1044040-56-3
fampridine fampridine 2933.39 40.600 Ann. D, par. 6 HSC/18 1996 72 504-24-5
fampronil fampronil 2933.29 NC0938B2b Ann. O/3 (II) HSC/35 2005 91 134183-95-2
fanapanel fanapanel 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 80 161605-73-8 HSC/23 (2934.90)
fandofloxacin fandofloxacine 2933.59 42.750 Ann. O HSC/22 1998 78 164150-99-6
fandosentan fandosentan 2934.99 NC0730B2 Ann. M/7 HSC/31 2003 87 221241-63-0
fanotaprim fanotaprim 2933.59 NC2803Bc Ann. T/7 HSC/67 2021 123 2120282-75-7
faralimomab faralimomab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 76 167816-91-3 HSC/21 (3002.10)
farampator farampator 2934.99 NC1059B2b Ann. O/4 HSC/37 2006 92 211735-76-1
farglitazar farglitazar 2934.99 NC0590B2 Ann. L/15 HSC/29 2002 84 196808-45-4
faricimab faricimab 3002.13 NC2626B1b Ann. O/5 HSC/63 2019 118 1607793-29-2
farletuzumab farletuzumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 100 896723-44-7 HSC/44 (3002.10)
farletuzumab ecteribulin farlétuzumab ectéribuline 3002.13 NC2930Bc Ann. P/27 HSC/69 2022 125 2407465-18-1
farudodstat farudodstat 2933.39 NC2930Bc Ann. P/27 HSC/69 2022 125 1035688-66-4
fasidotril fasidotril 2932.99 42.100 Ann. O (III) HSC/21 1998 74 135038-57-2
fasiglifam fasiglifam 2932.99 NC1874B1b Ann. O/2 HSC/51 2013 107 1000413-72-8
fasinumab fasinumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 107 1190239-42-9 HSC/51 (3002.10)

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
fasitibant chloride chlorure de fasitibant 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 103 1157852-02-2 HSC/47 (2935.00)
fasobegron fasobégron 2922.50 NC1443B1b Ann. P/5 HSC/43 2009 98 643094-49-9
fasoracetam fasoracétam 2933.79 42.750 Ann. O HSC/22 1998 78 110958-19-5
favipiravir favipiravir 2933.99 NC1443B1b Ann. P/5 HSC/43 2009 98 259793-96-9
faxeladol faxéladol 2922.29 NC1310B1b Ann. N/4 HSC/41 2008 97 433265-65-7
fazarabine fazarabine 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 56 65886-71-7 HSC/11 (2934.90)
fazulemeran fazuléméran 2934.99 NC2930Bc Ann. P/27 HSC/69 2022 125 2417174-26-4
febuxostat febuxostat 2934.10 NC0590B2 Ann. L/15 HSC/29 2002 85 144060-53-7
fedotozine fédotozine 2922.19 40.260 Ann. L/2 (No. 71) HSC/17 1996 62 123618-00-8
fedovapagon fédovapagon 2933.99 NC1649B3b Ann. R/14 HSC/47 2011 103 347887-36-9
fedratinib fédratinib 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 108 936091-26-8 HSC/53 (2935.00)
feladilimab féladilimab 3002.13 NC2803Bc Ann. T/6 HSC/67 2021 122 2252518-85-5
felbinac felbinac 2916.39 38.100 Ann. Q (No. 312) HSC/11 1993 54 5728-52-9
felcisetrag felcisétrag 2933.39 NC2803Bc Ann. T/3 HSC/67 2021 121 916075-84-8
felezonexor félézonexor 2933.39 NC2803Bc Ann. T/3 HSC/67 2021 121 1076235-04-5
feloprentan féloprentan 2933.59 NC0590B2 Ann. L/15 HSC/29 2002 85 204267-33-4
felvizumab felvizumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 77 167747-20-8 HSC/21 (3002.10)
felzartamab felzartamab 3002.13 NC2803Bc Ann. T/6 HSC/67 2021 122 2197112-39-1
fenalcomine fénalcomine 2922.19 40.260 Ann. L/2 (No. 72) HSC/17 1996 29 34616-39-2
fencamfamin fencamfamine 2921.46 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 12 1209-98-9
fenebrutinib fénébrutinib 2934.99 NC2501B1b Ann. M/6 HSC/61 2018 117 1434048-34-6
fenetylline fénétylline 2939.51 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 16 3736-08-1
fenfluthrin fenfluthrine 2916.20 38.100 Ann. Q (No. 314) HSC/11 1993 54 75867-00-4
fenleuton fenleuton 2928.00 40.600 Ann. D, par. 6 HSC/18 1996 72 141579-54-6
fenproporex fenproporex 2926.30 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 17 15686-61-0
fentanyl fentanyl 2933.33 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 14 437-38-7
HSC/11 (2939.90)
fentonium bromide bromure de fentonium 2939.79 NC2116B1b Ann. S/1 HSC/55 2015 29 5868-06-4
HSC/53 (2939.99)
fermagate fermagate 2842.90 NC1443B1b Ann. P/5 HSC/43 2009 98 119175-48-3
soluté injec.de citrate ferrique
ferric (59Fe) citrate injection 2844.43 NC2803Bc Ann. T/4 HSC/67 2021 24 54063-42-2 HSC/11 (2844.40)
(59Fe)
ferric bepectate bépectate ferrique 3505.10 NC2803Bc Ann. T/3 HSC/67 2021 121 2087952-70-1
ferric carboxymaltose carboxymaltose ferrique 2940.00 NC1553B1b Ann. O/2 HSC/45 2010 97 9007-72-1
ferric derisomaltose dérisomaltose ferrique 2940.00 NC2116B1b Ann. R/4 HSC/55 2015 110 1345510-43-1
ferric maltol maltol ferrique 2932.99 NC2116B1b Ann. R/5 HSC/55 2015 111 33725-54-1
ferroquine ferroquine 2933.49 NC1178B1c Ann. O/5 HSC/39 2007 95 185055-67-8
ferrotrenine ferrotrénine 2925.29 NC2004B1b Ann. O/6 HSC/53 2014 15 15339-50-1 HSC/21 (2925.20)
fesomersen fésomersen 2934.99 NC2930Bc Ann. P/25 HSC/69 2022 124 2380135-03-3
fesoterodine fésotérodine 2922.50 NC0730B2 Ann. M/4 HSC/31 2003 84 286930-03-8

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
fevipiprant févipiprant 2933.99 NC2004B1b Ann. O/5 HSC/53 2014 109 872365-14-5
fexapotide fexapotide 2930.90 NC2373B1b Ann. O/6 HSC/59 2017 114 492447-54-8
fexofenadine fexofénadine 2933.39 42.100 Ann. O (III) HSC/21 1998 74 83799-24-0
fexuprazan fexuprazan 2935.90 NC2626B1b Ann. O/5 HSC/63 2019 120 1902954-60-2 (List 118 abeprazan)
fezakinumab fézakinumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 101 1007106-86-6 HSC/46 (3002.10)
fezolinetant fézolinétant 2934.99 NC2373B1b Ann. O/7 HSC/59 2017 115 1629229-37-3
fiacitabine fiacitabine 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 59 69123-90-6 HSC/11 (2934.90)
fianlimab fianlimab 3002.13 NC2803Bc Ann. T/3 HSC/67 2021 121 2126132-98-5
fiboflapon fiboflapon 2933.39 NC1760B1b Ann. N/8 HSC/49 2012 105 936350-00-4
ficlatuzumab ficlatuzumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 105 1174900-84-5 HSC/49 (3002.10)
fidanacogene elaparvovec fidanacogène élaparvovec 3002.49 NC2930Bc Ann. P/33 HSC/69 2022 118 1954659-47-2 HSC/63 (3002.90)
fidarestat fidarestat 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 78 136087-85-9 HSC/22 (2934.90)
fidasimtamab fidasimtamab 3002.13 NC2930Bc Ann. P/27 HSC/69 2022 125 2377419-89-9
fidaxomicin fidaxomicine 2941.90 NC1553B1b Ann. O/7 HSC/45 2010 100 873857-62-6
fidexaban fidexaban 2933.39 NC0938B2b Ann. O/3 (II) HSC/35 2005 91 183305-24-0
fiduxosin fiduxosine 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 82 208993-54-8 HSC/27 (2934.90)
figitumumab figitumumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 100 943453-46-1 HSC/44 (3002.10)
figopitant figopitant 2933.59 NC0430B2 Ann. Q/1 (I) HSC/27 2001 82 502422-74-4
filaminast filaminast 2928.00 42.100 Ann. O (IV) HSC/21 1998 75 141184-34-1
filanesib filanésib 2934.99 NC2004B1b Ann. O/5 HSC/53 2014 109 885060-09-3
filapixant filapixant 2934.10 NC2803Bc Ann. T/6 HSC/67 2021 122 1948232-63-0
filgotinib filgotinib 2934.99 NC2004B1b Ann. O/4 HSC/53 2014 108 1206161-97-8
filibuvir filibuvir 2934.99 NC1604B1b Ann. N/5 HSC/46 2010 101 877130-28-4
filociclovir filociclovir 2933.59 NC2116B1b Ann. R/5 HSC/55 2015 111 632325-71-4
filorexant filorexant 2933.59 NC2004B1b Ann. O/4 HSC/53 2014 108 1088991-73-4
fimaporfin fimaporfine 2933.99 NC2116B1b Ann. R/4 HSC/55 2015 110 1443547-43-0
fimasartan fimasartan 2933.59 NC1178B1c Ann. O/3 HSC/39 2007 94 247257-48-3
fimepinostat fimépinostat 2934.99 NC2626B1b Ann. O/5 HSC/63 2019 118 1339928-25-4
finafloxacin finafloxacine 2934.99 NC0590B2 Ann. L/15 HSC/29 2002 85 209342-40-5
finerenone finérénone 2933.99 NC2004B1b Ann. O/4 HSC/53 2014 108 1050477-31-0
fingolimod fingolimod 2922.19 NC0938B2b Ann. O/3 (II) HSC/35 2005 91 162359-55-9
finotonlimab finotonlimab 3002.13 NC2930Bc Ann. P/25 HSC/69 2022 124 2350298-85-8
finrozole finrozole 2933.99 NC2373B1b Ann. O/12 HSC/59 2017 81 160146-17-8 HSC/25 (2933.90)
finrozole finrozole 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 81 160146-17-8
fipamezole fipamézole 2933.29 NC0845B2 Ann. M/2 HSC/33 2004 88 150586-58-6
firategrast firatégrast 2924.29 NC1310B1b Ann. N/10 HSC/41 2008 96 402567-16-2
firazorexton firazorexton 2935.90 NC2803Bc Ann. T/7 HSC/67 2021 123 2274802-95-6
firibastat firibastat 2930.90 NC2501B1b Ann. M/6 HSC/61 2018 117 648927-86-0
firivumab firivumab 3002.13 NC2237B1b Ann. T/13 HSC/57 2016 111 1443004-15-6 HSC/55 (3002.10)

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
firolimogene autotemcel firolimogène autotemcel 3002.51 NC2930Bc Ann. P/27 HSC/69 2022 125 no mention
firsocostat firsocostat 2934.99 NC2626B1b Ann. O/5 HSC/63 2019 118 1434635-54-7
HSC/53 (2933.99)
firtecan peglumer firtécan péglumère 2939.79 NC2373B1b Ann. O/12 HSC/59 2017 108 1204768-03-5
HSC/57 (2939.99)
firtecan pegol firtécan pégol 2939.79 NC2116B1b Ann. S/1 HSC/55 2015 107 946062-05-1 HSC/51 (2939.99)
firuglipel firuglipel 2934.99 NC2501B1b Ann. M/5 HSC/61 2018 116 1371591-51-3
firzacorvir firzacorvir 2934.10 NC2930Bc Ann. P/25 HSC/69 2022 124 2243747-96-6
firzotemcel firzotemcel 3002.51 NC2803Bc Ann. T/3 HSC/67 2021 121 no mention
fisogatinib fisogatinib 2934.99 NC2803Bc Ann. T/2 HSC/67 2021 120 1707289-21-1
fispemifene fispémifène 2909.49 NC0938B2b Ann. O/2 HSC/35 2005 89 341524-89-8
fitusiran fitusiran 2934.99 NC2237B1b Ann. S/9 HSC/57 2016 113 1499251-18-1
flanvotumab flanvotumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 106 1188277-05-5 HSC/51 (3002.10)
flestolol flestolol 2924.21 38.100 Ann. Q (No. 317) HSC/11 1993 53 87721-62-8
fletikumab flétikumab 3002.13 NC2237B1b Ann. T/13 HSC/57 2016 110 1357158-22-5 HSC/55 (3002.10)
flibanserin flibansérine 2933.59 42.100 Ann. O (IV) HSC/21 1998 75 167933-07-5
flindokalner flindokalner 2933.79 NC0730B2 Ann. M/6 HSC/31 2003 86 187523-35-9
flomoxef flomoxef 2941.90 38.100 Ann. Q (No. 318) HSC/11 1993 55 99665-00-6
flopristin flopristine 2941.90 NC1553B1b Ann. O/3 HSC/45 2010 98 318498-76-9
florbenazine (18F) florbénazine (18F) 2844.43 NC2803Bc Ann. T/4 HSC/67 2021 104 956903-29-0 HSC/49 (2844.40)
florbetaben (18F) florbétabène (18F) 2844.43 NC2803Bc Ann. T/4 HSC/67 2021 102 902143-01-5 HSC/46 (2844.40)
florbetapir (18F) florbétapir (18F) 2844.43 NC2803Bc Ann. T/4 HSC/67 2021 103 956103-76-7 HSC/47 (2844.40)
florfenicol florfénicol 2941.40 40.260 Ann. L/2 (No. 1) HSC/17 1996 54 76639-94-6
florilglutamic acid (18F) acide florilglutamique (18F) 2844.43 NC2803Bc Ann. T/4 HSC/67 2021 106 1196963-74-2 HSC/51 (2844.40)
flortanidazole (18F) flortanidazole (18F) 2844.43 NC2803Bc Ann. T/4 HSC/67 2021 108 70878-86-2 HSC/53 (2844.40)
flortaucipir (18F) flortaucipir (18F) 2844.43 NC2803Bc Ann. T/4 HSC/67 2021 114 1522051-90-6 HSC/59 (2844.40)
flotegatide (18F) flotégatide (18F) 2844.43 NC2803Bc Ann. T/4 HSC/67 2021 108 1010702-75-6 HSC/53 (2844.40)
flotetuzumab flotétuzumab 3002.13 NC2626B1b Ann. O/5 HSC/63 2019 118 1664355-28-5
flotufolastat (18F) flotufolastat (18F) 2844.43 NC2803Bc Ann. T/7 HSC/67 2021 123 2305060-41-5
flovagatran flovagatran 2933.99 NC1310B1b Ann. N/4 HSC/41 2008 97 871576-03-3
flubentylosin flubentylosine 2941.90 NC2803Bc Ann. T/7 HSC/67 2021 123 1809266-03-2
flubrobenguane (18F) flubrobenguane (18F) 2844.43 NC2803Bc Ann. T/3 HSC/67 2021 121 1037359-47-9
fluciclatide (18F) fluciclatide (18F) 2844.43 NC2803Bc Ann. T/4 HSC/67 2021 103 879894-01-6 HSC/47 (2844.40)
fluciclovine (18F) fluciclovine (18F) 2844.43 NC2803Bc Ann. T/4 HSC/67 2021 103 222727-39-1 HSC/47 (2844.40)
fludalanine fludalanine 2845.90 38.100 Ann. Q (No. 319) HSC/11 1993 38 35523-45-6
fludeoxyglucose (18F) fludésoxyglucose (18F) 2844.43 NC2803Bc Ann. T/4 HSC/67 2021 61 105851-17-0 HSC/11 (2844.40)
fludiazepam fludiazépam 2933.91 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 36 3900-31-0
flugestone flugestone 2937.23 NC2004B1b Ann. O/6 HSC/53 2014 16 337-03-1 HSC/11 (2937.92)
fluindarol fluindarol 2914.79 NC2116B1b Ann. S/1 HSC/55 2015 16 6723-40-6 HSC/21 (2914.70)
fluindione fluindione 2914.79 NC2116B1b Ann. S/1 HSC/55 2015 40 957-56-2 HSC/11 (2914.70)

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
flumazenil flumazénil 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 55 78755-81-4 HSC/11 (2933.90)
flumbatinib flumbatinib 2933.59 NC2930Bc Ann. P/27 HSC/69 2022 125 895519-90-1
flumoxonide flumoxonide 2937.22 40.260 Ann. L/2 (No. 29) HSC/17 1996 38 60135-22-0
flunitrazepam flunitrazépam 2933.91 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 24 1622-62-4
fluocortin fluocortine 2937.22 42.100 Ann. O (I) HSC/21 1998 31 33124-50-4
fluorfenidine (18F) fluorfénidine (18F) 2844.43 NC2803Bc Ann. T/4 HSC/67 2021 108 917894-12-3 HSC/53 (2844.40)
fluralaner fluralaner 2934.99 NC1874B1b Ann. O/2 HSC/51 2013 107 864731-61-3
flurazepam flurazépam 2933.91 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 20 17617-23-1
flurdihydroergotamine flurdihydroergotamine 2939.69 NC2373B1b Ann. O/7 HSC/59 2017 115 1416417-27-0
flurpiridaz (18F) flurpiridaz (18F) 2844.43 NC2803Bc Ann. T/4 HSC/67 2021 103 863887-89-2 HSC/47 (2844.40)
flusoxolol flusoxolol 2922.19 40.260 Ann. L/2 (No. 73) HSC/17 1996 50 84057-96-5
fluspirilene fluspirilène 2933.39 40.260 Ann. L/2 (No. 26) HSC/17 1996 15 1841-19-6
flutafuranol (18F) flutafuranol (18F) 2844.43 NC2803Bc Ann. T/4 HSC/67 2021 112 1211333-21-9 HSC/57 (2844.40)
flutemetamol (18F) flutémétamol (18F) 2844.43 NC2803Bc Ann. T/4 HSC/67 2021 101 765922-62-1 HSC/46 (2844.40)
fluticasone furoate furoate de fluticasone 2937.22 NC1178B1c Ann. O/5 HSC/39 2007 95 397864-44-7
flutriciclamide (18F) flutriciclamide (18F) 2844.43 NC2803Bc Ann. T/4 HSC/67 2021 108 1274863-98-7 HSC/53 (2844.40)
fluvastatin fluvastatine 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 62 93957-54-1 HSC/11 (2933.90)
fobrépodacine fobrépodacine 2934.99 NC2930Bc Ann. P/27 HSC/69 2022 125 1384984-31-9
fodipir fodipir 2933.39 40.600 Ann. D, par. 6 HSC/18 1996 72 118248-91-2
foliglurax foliglurax 2934.99 NC2501B1b Ann. M/6 HSC/61 2018 117 1883329-51-8
folitixorin folitixorine 2933.59 NC1443B1b Ann. P/5 HSC/43 2009 98 3432-99-3
follitropin alfa follitropine alfa 2937.19 NC2004B1b Ann. O/6 HSC/53 2014 71 9002-68-0 HSC/18 (2937.10)
follitropin beta follitropine bêta 2937.19 NC2004B1b Ann. O/6 HSC/53 2014 75 150490-84-9 HSC/21 (2937.10)
follitropin delta fillitropine delta 2937.19 NC2237B1b Ann. S/8 HSC/57 2016 112 146479-72-3
follitropin epsilon follitropine epsilon 2937.19 NC2373B1b Ann. O/7 HSC/59 2017 115 1359819-75-2
follitropin gamma follitropine gamma 2937.19 NC1874B1b Ann. O/1 HSC/51 2013 106 1219693-73-8
fomidacillin fomidacilline 2941.10 38.100 Ann. Q (No. 325) HSC/11 1993 55 98048-07-8
fomivirsen fomivirsen 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 75 144245-52-3 HSC/21 (2934.90)
fonadelpar fonadelpar 2934.10 NC2373B1b Ann. O/6 HSC/59 2017 114 515138-06-4
fondaparinux sodium fondaparinux sodique 2932.99 NC0590B2 Ann. L/10 HSC/29 2002 83 114870-03-0
fontolizumab fontolizumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 87 326859-36-3 HSC/31 (3002.10)
fonturacetam fonturacétam 2933.79 NC1604B1b Ann. N/5 HSC/46 2010 101 77472-70-9
foralumab foralumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 103 946415-64-1 HSC/47 (3002.10)
forasartan forasartan 2933.39 42.100 Ann. O (III) HSC/21 1998 74 145216-43-9
foravirumab foravirumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 99 944548-38-3 HSC/43 (3002.10)
fordadistrogene movaparvovec fordadistrogène movaparvovec 3002.49 NC2930Bc Ann. P/33 HSC/69 2022 123 2248111-37-5 HSC/67 (3002.90)
foretinib forétinib 2934.99 NC1604B1b Ann. N/6 HSC/46 2010 102 849217-64-7
forigerimod forigérimod 2933.29 NC1760B1b Ann. N/7 HSC/49 2012 104 497156-60-2
formebolone formébolone 2937.29 NC2004B1b Ann. O/6 HSC/53 2014 31 2454-11-7 HSC/11 (2937.99)

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
forodesine forodesine 2933.59 NC1059B2b Ann. O/4 HSC/37 2006 92 209799-67-7
foropafant foropafant 2934.10 42.100 Ann. O (IV) HSC/21 1998 75 136468-36-5
fosalvudine tidoxil fosalvudine tidoxil 2934.99 NC1178B1c Ann. O/5 HSC/39 2007 95 763903-67-9
fosamprenavir fosamprénavir 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 83 226700-79-4 HSC/27 (2935.00)
fosaprepitant fosaprépitant 2934.99 NC1123B1b Ann. N/1 HSC/38 2006 94 172673-20-0
fosbretabulin fosbrétabuline 2919.90 NC1500B1b Ann. K/6 HSC/44 2009 100 222030-63-9
foscarbidopa foscarbidopa 2928.00 NC2803Bc Ann. T/2 HSC/67 2021 120 1907685-81-7
foscenvivint foscenvivint 2933.79 NC2930Bc Ann. P/25 HSC/69 2022 124 1422253-38-0
fosciclopirox fosciclopirox 2933.79 NC2803Bc Ann. T/6 HSC/67 2021 122 1380539-06-9
fosdagrocorat fosdagrocorat 2933.39 NC2116B1b Ann. R/5 HSC/55 2015 111 1044535-58-1
fosdenopterin fosdénoptérine 2934.99 NC2803Bc Ann. T/3 HSC/67 2021 121 150829-29-1
fosdevirine fosdévirine 2933.99 NC1649B3b Ann. R/14 HSC/47 2011 103 1018450-26-4
fosfluconazole fosfluconazole 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 83 194798-83-9 HSC/27 (2933.90)
fosfluridine tidoxil fosfluridine tidoxil 2934.99 NC1059B2b Ann. O/5 HSC/37 2006 93 174638-15-4
fosfructose fosfructose 2940.00 NC0250B2 Ann. P/1 (II) HSC/25 2000 81 488-69-7
fosgemcitabine palabenamide fosgemcitabine palabénamide 2934.99 NC2626B1b Ann. O/6 HSC/63 2019 119 1562406-27-2
fosgonimeton fosgoniméton 2924.29 NC2930Bc Ann. P/27 HSC/69 2022 125 2093305-05-4
fosifidancitinib fosifidancitinib 2934.99 NC2803Bc Ann. T/6 HSC/67 2021 122 1237168-58-9
fosifloxuridine nafalbenamide fosifloxuridine nafalbénamide 2934.99 NC2626B1b Ann. O/6 HSC/63 2019 119 1332837-31-6
foslevodopa foslévodopa 2922.50 NC2803Bc Ann. T/2 HSC/67 2021 120 97321-87-4
foslinanib foslinanib 2933.49 NC2626B1b Ann. O/6 HSC/63 2019 119 1256037-60-1
fosmanogepix fosmanogépix 2934.99 NC2626B1b Ann. O/6 HSC/63 2019 119 2091769-17-2
fosmetpantotenate fosmetpantoténate 2929.90 NC2501B1b Ann. M/5 HSC/61 2018 116 1858268-66-2
fosnetupitant fosnétupitant 2933.59 NC2237B1b Ann. S/9 HSC/57 2016 113 1703748-89-3
fosopamine fosopamine 2922.29 40.260 Ann. L/2 (No. 74) HSC/17 1996 69 103878-96-2
fospropofol fospropofol 2919.90 NC1123B1b Ann. N/1 HSC/38 2006 94 258516-89-1
fosquidone fosquidone 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 64 114517-02-1 HSC/11 (2933.90)
fosravuconazole fosravuconazole 2934.10 NC2116B1b Ann. R/4 HSC/55 2015 110 351227-64-0
fostamatinib fostamatinib 2934.99 NC1500B1b Ann. K/6 HSC/44 2009 100 901119-35-5
fostemsavir fostemsavir 2933.59 NC2373B1b Ann. O/7 HSC/59 2017 115 864953-29-7
fostriecin fostriécine 2932.20 NC2004B1b Ann. O/6 HSC/53 2014 55 87810-56-8 HSC/11 (2932.29)
fostroxacitabine bralpamide fostroxacitabine bralpamide 2934.99 NC2930Bc Ann. P/27 HSC/69 2022 125 2129993-56-0
fosveset fosvéset 2922.50 NC0430B2 Ann. Q/1 (II) HSC/27 2001 83 193901-91-6
fozivudine tidoxil fozivudine tidoxil 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 73 141790-23-0 HSC/18 (2934.90)
fradafiban fradafiban 2933.79 40.600 Ann. D, par. 6 HSC/18 1996 72 148396-36-5
frakefamide frakéfamide 2924.29 NC0250B2 Ann. P/1 (II) HSC/25 2000 81 188196-22-7
fremanezumab frémanezumab 3002.13 NC2373B1b Ann. O/7 HSC/59 2017 115 1655501-53-3
frenlosirsen frenlosirsen 2934.99 NC2930Bc Ann. P/27 HSC/69 2022 125 2304711-81-5
fresolimumab frésolimumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 101 948564-73-6 HSC/46 (3002.10)

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
frovatriptan frovatriptan 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 78 158747-02-5 HSC/22 (2933.90)
frovocimab frovocimab 3002.13 NC2626B1b Ann. O/6 HSC/63 2019 119 1643672-70-1
frunevetmab frunévetmab 3002.13 NC2501B1b Ann. M/5 HSC/61 2018 116 1708936-80-4
fruquintinib fruquintinib 2934.99 NC2501B1b Ann. M/5 HSC/61 2018 116 1194506-26-7
fudosteine fudostéine 2930.90 42.100 Ann. O (VI) HSC/21 1998 77 13189-98-5
fulacimstat fulacimstat 2934.99 NC2501B1b Ann. M/6 HSC/61 2018 117 1488354-15-9
Component A4 :
150702-32-2 /
fuladectin fuladectine 3003.90 40.600 Ann. D, par. 6 HSC/18 1996 71
Component A3 :
150702-33-3
fulranumab fulranumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 104 902141-80-4 HSC/49 (3002.10)
fulvestrant fulvestrant 2937.23 NC2116B1b Ann. R/7 HSC/55 2015 78 129453-61-8 HSC/22 (2930.90)
funapide funapide 2934.99 NC2116B1b Ann. R/5 HSC/55 2015 111 1259933-16-8
furaprevir furaprévir 2935.90 NC2237B1b Ann. T/12 HSC/57 2016 111 1435923-88-8 HSC/55 (2935.00)
furethidine furéthidine 2934.99 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 9 2385-81-1
furomine furomine 2932.19 42.100 Ann. O (III) HSC/21 1998 74 142996-66-5
futibatinib futibatinib 2933.59 NC2626B1b Ann. O/6 HSC/63 2019 119 1448169-71-8
futuximab futuximab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 107 1310460-85-5 HSC/51 (3002.10)
fuzapladib fuzapladib 2935.90 NC2803Bc Ann. T/2 HSC/67 2021 120 141283-87-6
fuzuloparib fuzuloparib 2933.59 NC2930Bc Ann. P/27 HSC/69 2022 125 1358715-18-0
gabapentin enacarbil gabapentine énacarbil 2924.29 NC1178B1c Ann. O/3 HSC/39 2007 94 478296-72-9
gacyclidine gacyclidine 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 76 68134-81-6 HSC/21 (2934.90)
gadocoletic acid acide gadocolétique 2846.90 NC0590B2 Ann. L/15 HSC/29 2002 85 280776-87-6
gadodenterate gadodentérate 2846.90 NC0938B2b Ann. O/3 (II) HSC/35 2005 91 544697-52-1
gadodiamide gadodiamide 2846.90 38.100 Ann. Q (No. 329) HSC/11 1993 70 131410-48-5
gadofosveset gadofosvéset 2846.90 NC0430B2 Ann. Q/1 (II) HSC/27 2001 83 193901-90-5
gadomelitol gadomélitol 2846.90 NC0590B2 Ann. L/15 HSC/29 2002 85 227622-74-4
gadopenamide gadopénamide 2846.90 38.100 Ann. Q (No. 330) HSC/11 1993 60 117827-80-2
gadopentetic acid acide gadopentétique 2846.90 38.100 Ann. Q (No. 331) HSC/11 1993 50 80529-93-7
gadopiclenol gadopiclénol 2846.90 NC2626B1b Ann. O/5 HSC/63 2019 118 933983-75-6
gadoquatrane gadoquatrane 2846.90 NC2930Bc Ann. P/27 HSC/69 2022 125 2048221-65-2
gadoteric acid acide gadotérique 2846.90 38.100 Ann. Q (No. 332) HSC/11 1993 59 72573-82-1
gadoversetamide gadoversétamide 2846.90 40.600 Ann. D, par. 6 HSC/18 1996 71 131069-91-5
gadoxetic acid acide gadoxétique 2846.90 40.600 Ann. D, par. 6 HSC/18 1996 71 135326-11-3
HSC/11 (2939.90)
galantamine galantamine 2939.79 NC2116B1b Ann. S/1 HSC/55 2015 79 357-70-0
HSC/53 (2939.99)
galarubicin galarubicine 2941.90 NC0090B2 Ann. M/5 HSC/23 1999 80 140637-86-1
galcanezumab galcanézumab 3002.13 NC2373B1b Ann. O/6 HSC/59 2017 114 1578199-75-3
galdansetron galdansétron 2933.29 40.600 Ann. D, par. 6 HSC/18 1996 72 116684-92-5

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
galegenimab galégénimab 3002.13 NC2930Bc Ann. P/27 HSC/69 2022 125 2403683-24-7
galeterone galétérone 2937.29 NC1760B1b Ann. N/8 HSC/49 2012 105 851983-85-2
galicaftor galicaftor 2932.99 NC2626B1b Ann. O/6 HSC/63 2019 119 1918143-53-9
galidesivir galidésivir 2933.59 NC2373B1b Ann. O/6 HSC/59 2017 114 249503-25-1
gallium (68Ga) gozetotide gallium (68Ga) gozétotide 2844.43 NC2803Bc Ann. T/7 HSC/67 2021 123 1906894-20-9
galsulfase galsulfase 3507.90 NC1004B1b Ann. L/11 HSC/36 2005 92 552858-79-4
galunisertib galunisertib 2933.49 NC2004B1b Ann. O/5 HSC/53 2014 109 700874-72-2
gamithromycin gamithromycine 2941.90 NC1178B1c Ann. O/5 HSC/39 2007 95 145435-72-9
ganaplacide ganaplacide 2933.59 NC2626B1b Ann. O/5 HSC/63 2019 118 1261113-96-5
ganaxolone ganaxolone 2914.40 42.100 Ann. O (V) HSC/21 1998 76 38398-32-2
ganciclovir ganciclovir 2933.59 38.100 Ann. Q (No. 334) HSC/11 1993 56 82410-32-0
gancotamab gancotamab 3002.13 NC2626B1b Ann. O/6 HSC/63 2019 119 1509928-00-0
gandotinib gandotinib 2934.99 NC2004B1b Ann. O/4 HSC/53 2014 108 1229236-86-5
ganetespib ganétespib 2933.99 NC1760B1b Ann. N/8 HSC/49 2012 105 888216-25-9
ganglefene ganglefène 2922.19 40.260 Ann. L/2 (No. 75) HSC/17 1996 12 299-61-6
ganitumab ganitumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 103 905703-97-1 HSC/47 (3002.10)
ganstigmine ganstigmine 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 81 457075-21-7 HSC/25 (2934.90)
gantacurium chloride chlorure de gantacurium 2933.49 NC0938B2b Ann. O/3 (II) HSC/35 2005 91 213998-46-0
gantenerumab ganténérumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 108 1043556-46-2 HSC/41 (3002.10)
gantofiban gantofiban 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 80 183547-57-1 HSC/23 (2934.90)
ganulameran ganulaméran 3002.41 NC2803Bc Ann. T/11 HSC/67 2021
124 COVID-19
2433844-55-2
garadacimab garadacimab 3002.13 NC2803Bc Ann. T/2 HSC/67 2021 120 2162134-62-3
garenoxacin garénoxacine 2933.49 NC0730B2 Ann. M/7 HSC/31 2003 87 194804-75-6
garetosmab garétosmab 3002.13 NC2803Bc Ann. T/2 HSC/67 2021 120 2097125-54-5
garivulimab garivulimab 3002.13 NC2803Bc Ann. T/7 HSC/67 2021 123 2342597-81-1
garnocestim garnocestim 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 85 246861-96-1 HSC/31 (3002.10)
gartisertib gartisertib 2934.99 NC2930Bc Ann. P/27 HSC/69 2022 125 1613191-99-3
garvagliptin garvagliptine 2935.90 NC2501B1b Ann. M/6 HSC/61 2018 117 1601479-87-1
garveleucel garvéleucel 3002.51 NC2803Bc Ann. T/7 HSC/67 2021 123 no mention
gataparsen gataparsen 2934.99 NC1649B3b Ann. R/14 HSC/47 2011 103 1065019-70-6
gatifloxacin gatifloxacine 2933.59 42.100 Ann. O (III) HSC/21 1998 74 160738-57-8
gatipotuzumab gatipotuzumab 3002.13 NC2501B1b Ann. M/5 HSC/61 2018 116 1264737-26-9
gatralimab gatralimab 3002.13 NC2803Bc Ann. T/3 HSC/67 2021 121 1826020-80-7
gavestinel gavestinel 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 77 153436-22-7 HSC/21 (2933.90)
gavilimomab gavilimomab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 84 244096-20-6 HSC/29 (3002.10)
gavocabtagene autoleucel gavocabtagène autoleucel 3002.51 NC2803Bc Ann. T/7 HSC/67 2021 123 no mention
gaxilose gaxilose 2940.00 NC1760B1b Ann. N/7 HSC/49 2012 104 14087-31-1
geclosporin géclosporine 2933.79 40.600 Ann. D, par. 6 HSC/18 1996 70 74436-00-3
gedatolisib gedatolisib 2934.99 NC2116B1b Ann. R/5 HSC/55 2015 111 1197160-78-3

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
gedivumab gédivumab 3002.13 NC2501B1b Ann. M/5 HSC/61 2018 116 1807954-17-1
gefapixant géfapixant 2935.90 NC2626B1b Ann. O/5 HSC/63 2019 118 1015787-98-0
gefitinib gefitinib 2934.99 NC0590B2 Ann. L/15 HSC/29 2002 85 184475-35-2
gemcabene gemcabène 2918.99 NC2373B1b Ann. O/12 HSC/59 2017 88 183293-82-5 HSC/33 (2918.90)
gemcitabine gemcitabine 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 62 95058-81-4 HSC/11 (2934.90)
gemcitabine elaidate élaïdate de gemcitabine 2934.99 NC1874B1b Ann. O/1 HSC/51 2013 106 210829-30-4
gemifloxacin gémifloxacine 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 81 204519-64-2 HSC/25 (2933.90)
gemigliptin gémigliptine 2933.79 NC1649B3b Ann. R/14 HSC/47 2011 103 911637-19-9
gemilukast gémilukast 2933.99 NC2116B1b Ann. R/4 HSC/55 2015 110 1232861-58-3
gemnelatinib gemnélatinib 2933.79 NC2930Bc Ann. P/27 HSC/69 2022 125 2225123-30-6
gemopatrilat gémopatrilate 2933.79 NC0590B2 Ann. L/15 HSC/29 2002 84 160135-92-2
gemtuzumab gemtuzumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 83 220578-59-6 HSC/27 (3002.10)
gemtuzumab ozogamicin gemtuzumab ozogamicine 3002.13 NC2373B1b Ann. O/7 HSC/59 2017 115 220578-59-6
genistein génistéine 2932.99 NC2803Bc Ann. T/6 HSC/67 2021 122 446-72-0
gepotidacin gépotidacine 2934.99 NC2237B1b Ann. S/8 HSC/57 2016 112 1075236-89-3
geptanolimab geptanolimab 3002.13 NC2803Bc Ann. T/7 HSC/67 2021 123 2348469-43-0
gevokizumab gévokizumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 104 1129435-60-4 HSC/49 (3002.10)
giloralimab giloralimab 3002.13 NC2803Bc Ann. T/6 HSC/67 2021 122 2226292-20-0
gilteritinib giltéritinib 2934.99 NC2237B1b Ann. S/8 HSC/57 2016 112 1254053-43-4
gilvetmab gilvetmab 3002.13 NC2501B1b Ann. M/5 HSC/61 2018 116 1808081-43-7
gimatecan gimatécan 2939.79 NC2116B1b Ann. S/1 HSC/55 2015 86 292618-32-7 HSC/31 (2939.99)
gimeracil giméracil 2933.39 NC0090B2 Ann. M/5 HSC/23 1999 80 103766-25-2
giminabant giminabant 2933.59 NC1874B1b Ann. O/2 HSC/51 2013 107 890033-57-5
gimsilumab gimsilumab 3002.13 NC2501B1b Ann. M/6 HSC/61 2018 117 1648796-29-5
gindameran gindaméran 2934.99 NC2803Bc Ann. T/7 HSC/67 2021 123 2348560-89-2
ginisortamab ginisortamab 3002.13 NC2930Bc Ann. P/27 HSC/69 2022 125 2390147-17-6
giractide giractide 2937.19 NC2004B1b Ann. O/6 HSC/53 2014 29 24870-04-0 HSC/21 (2937.10)
giredestrant girédestrant 2933.99 NC2803Bc Ann. T/6 HSC/67 2021 122 1953133-47-5
girentuximab girentuximab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 101 916138-87-9 HSC/46 (3002.10)
giripladib giripladib 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 96 865200-20-0 HSC/41 (2935.00)
giroctocogene fitelparvovec giroctocogène fitelparvovec 3002.49 NC2930Bc Ann. P/33 HSC/69 2022 121 2166101-71-7 HSC/67 (3002.90)
gisadenafil gisadénafil 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 101 334826-98-1 HSC/46 (2935.00)
givinostat givinostat 2928.00 NC1649B3b Ann. R/12 HSC/47 2011 101 497833-27-9
givosiran givosiran 2934.99 NC2373B1b Ann. O/6 HSC/59 2017 114 1639325-43-1
glasdegib glasdégib 2933.39 NC2116B1b Ann. R/5 HSC/55 2015 111 1095173-27-5
glaspimod glaspimod 2933.79 42.100 Ann. O (III) HSC/21 1998 74 134143-28-5
HSC/21 (2939.90)
glaziovine glaziovine 2939.79 NC2116B1b Ann. S/1 HSC/55 2015 34 17127-48-9
HSC/53 (2939.99)
glecaprevir glécaprévir 2935.90 NC2373B1b Ann. O/6 HSC/59 2017 114 1365970-03-1

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
glembatumumab glembatumumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 102 1020264-78-1 HSC/46 (3002.10)
HSC/57 (3002.10)
glembatumumab vedotin glembatumumab védotine 3002.13 NC2237B1b Ann. T/11 HSC/57 2016 113 1182215-65-1
(S/9)
glenvastatin glenvastatine 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 70 122254-45-9 HSC/18 (2934.90)
glenzocimab glenzocimab 3002.13 NC2803Bc Ann. T/2 HSC/67 2021 120 2101829-58-5
glepaglutide glépaglutide 2937.19 NC2501B1b Ann. M/5 HSC/61 2018 116 914009-86-2
gleptoferron gleptoferron 3913.90 38.100 Ann. Q (No. 336) HSC/11 1993 36 57680-55-4
glesatinib glésatinib 2934.99 NC2373B1b Ann. O/6 HSC/59 2017 114 936694-12-1
glofitamab glofitamab 3002.13 NC2803Bc Ann. T/3 HSC/67 2021 121 2229047-91-8
gloximonam gloximonam 2941.90 38.100 Ann. Q (No. 337) HSC/11 1993 54 90850-05-8
glucalox glucalox 3003.90 42.100 Ann. O (II) HSC/21 1998 13 12182-48-8
glucarpidase glucarpidase 3507.90 NC1004B1b Ann. L/11 HSC/36 2005 92 9074-87-7
glufosfamide glufosfamide 2940.00 42.100 Ann. O (VI) HSC/21 1998 77 132682-98-5
glusoferron glusoferron 3911.90 38.100 Ann. Q (No. 338) HSC/11 1993 37 56959-18-3
glutethimide glutéthimide 2925.12 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 6 77-21-4
glycerol phenylbutyrate phénylbutyrate de glycérol 2916.39 NC1874B1b Ann. O/1 HSC/51 2013 106 611168-24-2
goflikicept goflikicept 3002.13 NC2803Bc Ann. T/11 HSC/67 2021
124 COVID-19
2416984-26-2
golexanolone golexanolone 2928.00 NC2626B1b Ann. O/6 HSC/63 2019 119 2089238-18-4
golidocitinib golidocitinib 2933.59 NC2930Bc Ann. P/27 HSC/69 2022 125 2091134-68-6
golimumab golimumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 91 476181-74-5 HSC/35 (3002.10)
golnerminogene pradenovec golnerminogène pradénovec 3002.49 NC2930Bc Ann. P/33 HSC/69 2022 101 957472-14-9 HSC/47 (3002.90)
golodirsen golodirsen 2934.99 NC2447B1b Ann. N/2 HSC/60 2017 115 1422959-91-8
golotimod golotimod 2933.99 NC1310B1b Ann. N/4 HSC/41 2008 97 229305-39-9
golvatinib golvatinib 2933.59 NC1874B1b Ann. O/2 HSC/51 2013 107 928037-13-2
gontivimab gontivimab 3002.13 NC2803Bc Ann. T/3 HSC/67 2021 121 1257358-38-5
goralatide goralatide 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 72 120081-14-3 HSC/18 (2933.90)
goserelin goséréline 2937.19 NC2004B1b Ann. O/6 HSC/53 2014 55 65807-02-5 HSC/11 (2937.99)
gosogliptin gosogliptin 2933.59 NC1649B3b Ann. R/12 HSC/47 2011 101 869490-23-3
gosuranemab gosuranémab 3002.13 NC2626B1b Ann. O/6 HSC/63 2019 119 1788032-39-2
govorestat govorestat 2934.20 NC2930Bc Ann. P/25 HSC/69 2022 124 2170729-29-8
goxalapladib goxalapladib 2933.39 NC1178B1c Ann. O/3 HSC/39 2007 94 412950-27-7
granotapide granotapide 2924.29 NC1760B1b Ann. N/7 HSC/49 2012 104 594842-13-4
grapiprant grapiprant 2935.90 NC2237B1b Ann. T/12 HSC/57 2016 110 415903-37-6 HSC/55 (2935.00)
HSC/57 (3002.13)
graunimotide graunimotide 3002.41 NC2803Bc Ann. T/4 HSC/67 2021 113 851666-89-2
HSC/59 (3002.20)
grazoprevir grazoprévir 2935.90 NC2237B1b Ann. T/12 HSC/57 2016 110 1350514-68-9 HSC/55 (2935.00)
gremubamab grémubamab 3002.13 NC2803Bc Ann. T/3 HSC/67 2021 121 1800381-36-5
gresonitamab grésonitamab 3002.13 NC2930Bc Ann. P/27 HSC/69 2022 125 2413817-97-5
grisnilimab grisnilimab 3002.13 NC2803Bc Ann. T/7 HSC/67 2021 123 2367001-70-3

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
grisnilimab setaritox grisnilimab sétaritox 3002.13 NC2803Bc Ann. T/7 HSC/67 2021 123 2361013-29-6
guadecitabine guadécitabine 2934.99 NC2237B1b Ann. S/9 HSC/57 2016 113 929901-49-5
guafecainol guafécaïnol 2922.19 40.260 Ann. L/2 (No. 76) HSC/17 1996 38 36199-78-7
guaiactamine guaïactamine 2922.19 40.260 Ann. L/2 (No. 77) HSC/17 1996 16 15687-23-7
guaraprolose guaraprolose 1302.32 NC1649B3b Ann. R/13 HSC/47 2011 102 39421-75-5
gumokimab gumokimab 3002.13 NC2930Bc Ann. P/27 HSC/69 2022 125 2428381-52-4
gunagratinib gunagratinib 2933.19 NC2930Bc Ann. P/27 HSC/69 2022 125 2211082-53-8
guretolimod gurétolimod 2933.59 NC2930Bc Ann. P/25 HSC/69 2022 124 1488364-57-3
gusacitinib gusacitinib 2933.59 NC2803Bc Ann. T/2 HSC/67 2021 120 1425381-60-7
guselkumab guselkumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 109 1350289-85-8 HSC/53 (3002.10)
halazepam halazépam 2933.91 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 29 23092-17-3
halopredone haloprédone 2937.22 38.100 Ann. Q (No. 341) HSC/11 1993 36 57781-15-4
haloxazolam haloxazolam 2934.91 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 38 59128-97-1
hemoglobin betafumaril hémoglobine bêtafumaril
3002.12 NC2373B1b Ann. O/7 HSC/59 2017 115 1797415-38-3
(bovine) (bovine)
hemoglobin crosfumaril hémoglobine crosfumaril 3002.12 NC2116B1b Ann. S/2 HSC/55 2015 76 142261-03-8 HSC/21 (3002.10)
hemoglobin crosfumaril hémoglobine crosfumaril
3002.12 NC2116B1b Ann. S/2 HSC/55 2015 108 1360741-07-6 HSC/53 (3002.10)
(bovine) (bovine)
hemoglobin glutamer hémoglobine glutamère 3002.12 NC2116B1b Ann. S/2 HSC/55 2015 80 no mention HSC/25 (3002.10)
hemoglobin raffimer raffimère d'hémoglobine 3002.12 NC2116B1b Ann. S/2 HSC/55 2015 89 197462-97-8 HSC/37 (3002.10)
hepcidin hepcidine 2937.19 NC2803Bc Ann. T/7 HSC/67 2021 123 1356390-47-0
hexasodium fytate fytate d'hexasodium 2919.90 NC2930Bc Ann. P/27 HSC/69 2022 125 34367-89-0
hexobendine hexobendine 2922.19 40.260 Ann. L/2 (No. 78) HSC/17 1996 15 54-03-5
histrelin histréline 2937.19 NC2004B1b Ann. O/6 HSC/53 2014 53 76712-82-8 HSC/11 (2937.99)
homidium bromide bromure d'homidium 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 36 1239-45-8 HSC/11 (2933.90)
hydrocodone hydrocodone 2939.11 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 1 125-29-1
hydroflumethiazide hydrofluméthiazide 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 10 135-09-1 HSC/11 (2935.00)
hydromethylthionine hydrométhylthionine 2934.30 NC2626B1b Ann. O/6 HSC/63 2019 119 613-11-6
hydromorphinol hydromorphinol 2939.19 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 11 2183-56-4
hydromorphone hydromorphone 2939.11 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 1 466-99-9
hydroxycarbamide hydroxycarbamide 2928.00 38.100 Ann. Q (No. 342) HSC/11 1993 16 127-07-1
hydroxypethidine hydroxypéthidine 2933.39 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 5 468-56-4
hyetellose hyétellose 3912.39 NC0090B2 Ann. M/5 HSC/23 1999 80 9004-62-0
hymetellose hymétellose 3912.39 NC0090B2 Ann. M/5 HSC/23 1999 80 9032-42-2
hyprolose hyprolose 3912.39 NC0090B2 Ann. M/5 HSC/23 1999 80 9004-64-2
hypromellose hypromellose 3912.39 38.100 Ann. Q (No. 343) HSC/11 1993 80 9004-65-3
iadademstat iadademstat 2921.59 NC2626B1b Ann. O/6 HSC/63 2019 119 1431304-21-0
ianalumab ianalumab 3002.13 NC2501B1b Ann. M/6 HSC/61 2018 117 1929549-92-7
ibacitabine ibacitabine 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 57 611-53-0 HSC/11 (2934.90)

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
ibafloxacin ibafloxacine 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 60 91618-36-9 HSC/11 (2933.90)
ibalizumab ibalizumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 97 680188-33-4 HSC/41 (3002.10)
HSC/18 (2931.00)
ibandronic acid acide ibandronique 2931.49 NC2803Bc Ann. T/4 HSC/67 2021 71 114084-78-5
HSC/59 (2931.39)
ibazocine ibazocine 2933.39 40.260 Ann. L/2 (No. 16) HSC/17 1996 36 57653-28-8
iberdomide iberdomide 2934.99 NC2501B1b Ann. M/6 HSC/61 2018 117 1323403-33-3
ibezapolstat ibézapolstat 2934.99 NC2803Bc Ann. T/7 HSC/67 2021 123 1275582-97-2
ibipinabant ibipinabant 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 99 464213-10-3 HSC/43 (2935.00)
iboctadekin iboctadékine 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 92 479198-61-3 HSC/39 (3002.10)
ibodutant ibodutant 2934.99 NC1443B1b Ann. P/5 HSC/43 2009 98 522664-63-7
ibrexafungerp ibrexafungerp 2934.99 NC2626B1b Ann. O/5 HSC/63 2019 118 1207753-03-4
ibrigampar ibrigampar 2935.90 NC2930Bc Ann. P/25 HSC/69 2022 124 315224-26-1
ibritumomab tiuxetan ibritumomab tiuxétan 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 81 206181-63-7 HSC/25 (3002.10)
HSC/33 (2931.00)
ibrolipim ibrolipim 2931.59 NC2803Bc Ann. T/4 HSC/67 2021 88 133208-93-2
HSC/56 (2931.39)
ibrutinib ibrutinib 2933.59 NC1874B1b Ann. O/2 HSC/51 2013 107 936563-96-1
ibudilast ibudilast 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 58 50847-11-5 HSC/11 (2933.90)
ibutamoren ibutamoren 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 78 159634-47-6 HSC/22 (2935.00)
icapamespib icapamespib 2934.99 NC2803Bc Ann. T/7 HSC/67 2021 123 1000999-96-1
icaridin icaridine 2933.39 NC0730B2 Ann. M/6 HSC/31 2003 86 119515-38-7
icatolimab icatolimab 3002.13 NC2803Bc Ann. T/6 HSC/67 2021 122 2236068-83-8
icenticaftor icenticaftor 2933.39 NC2803Bc Ann. T/6 HSC/67 2021 122 1334546-77-8
icerguastat icerguastat 2928.00 NC2803Bc Ann. T/6 HSC/67 2021 122 951441-04-6
iclaprim iclaprim 2934.99 NC0845B2 Ann. M/2 HSC/33 2004 88 192314-93-5
iclepertin iclépertine 2934.99 NC2930Bc Ann. P/27 HSC/69 2022 125 1421936-85-7
icometasone enbutate icométasone enbutate 2937.22 40.600 Ann. D, par. 6 HSC/18 1996 70 103466-73-5
icomucret icomucret 2918.19 NC1059B2b Ann. O/4 HSC/37 2006 92 54845-95-3
icopezil icopézil 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 75 145508-78-7 HSC/21 (2934.90)
icosabutate icosabutate 2918.99 NC2116B1b Ann. R/4 HSC/55 2015 110 1253909-57-7
icospiramide icospiramide 2933.39 40.260 Ann. L/2 (No. 27) HSC/17 1996 68 79449-99-3
icrucumab icrucumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 104 1024603-92-6 HSC/49 (3002.10)
idactamab idactamab 3002.13 NC2803Bc Ann. T/7 HSC/67 2021 123 2245205-37-0
idalopirdine idalopirdine 2933.99 NC2116B1b Ann. R/4 HSC/55 2015 110 467459-31-0
idarubicin idarubicine 2941.90 38.100 Ann. Q (No. 347) HSC/11 1993 47 58957-92-9
idarucizumab idarucizumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 109 1362509-93-0 HSC/53 (3002.10)
idasanutlin idasanutline 2933.99 NC2116B1b Ann. R/5 HSC/55 2015 111 1229705-06-9
idecabtagene vicleucel idécabtagène vicleucel 3002.51 NC2803Bc Ann. T/4 HSC/67 2021 119 no mention HSC/63 (3002.90)
idelalisib idélalisib 2933.59 NC1874B1b Ann. O/2 HSC/51 2013 107 870281-82-6
idestopoetin alfa idestopoétine alfa 3002.12 NC2930Bc Ann. P/27 HSC/69 2022 125 2370888-96-1

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
idetrexed idétrexed 2933.59 NC2803Bc Ann. T/6 HSC/67 2021 122 501332-69-0
idrabiotaparinux sodium idrabiotaparinux sodique 2934.99 NC1310B1b Ann. N/4 HSC/41 2008 97 405159-59-3
idramantone idramantone 2914.40 40.600 Ann. D, par. 6 HSC/18 1996 71 20098-14-0
idraparinux sodium idraparinux sodique 2932.99 NC0430B2 Ann. Q/1 (II) HSC/27 2001 83 149920-56-9
idremcinal idremcinal 2941.50 NC0250B2 Ann. P/1 (II) HSC/25 2000 81 110480-13-2
idrevloride idrévloride 2933.99 NC2930Bc Ann. P/27 HSC/69 2022 125 1416973-63-1
idronoxil idronoxil 2932.99 NC0938B2b Ann. O/3 (II) HSC/35 2005 91 81267-65-4
idropranolol idropranolol 2922.19 40.260 Ann. L/2 (No. 79) HSC/17 1996 31 27581-02-8
idroxioleic acid acide idroxioléique 2918.19 NC2930Bc Ann. P/25 HSC/69 2022 124 56472-29-8
idursulfase idursulfase 3507.90 NC0730B2 Ann. M/7 HSC/31 2003 90 50936-59-9
idursulfase beta idursulfase bêta 3507.90 NC1874B1b Ann. O/1 HSC/51 2013 106 1271734-34-9
ieramilimab iéramilimab 3002.13 NC2803Bc Ann. T/2 HSC/67 2021 120 2137049-37-5
ifabotuzumab ifabotuzumab 3002.13 NC2237B1b Ann. T/11 HSC/57 2016 115 1234137-51-9 (List 114 fibatuzumab)
iferanserin iféransérine 2933.39 NC0938B2b Ann. O/2 HSC/35 2005 89 58754-46-4
ifetroban ifétroban 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 71 143443-90-7 HSC/18 (2934.90)
ifezuntirgene inilparvovec ifezuntirgène inilparvovec 3002.49 NC2930Bc Ann. P/27 HSC/69 2022 125 2407582-19-6
ifidancitinib ifidancitinib 2934.99 NC2803Bc Ann. T/6 HSC/67 2021 122 1236667-40-5
iganidipine iganidipine 2933.59 40.600 Ann. D, par. 6 HSC/18 1996 70 119687-33-1
igovomab igovomab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 74 171656-50-1 HSC/21 (3002.10)
iguratimod iguratimod 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 86 123663-49-0 HSC/31 (2935.00)
ilacirnon ilacirnon 2935.90 NC2803Bc Ann. T/7 HSC/67 2021 123 1100318-47-5
iladatuzumab iladatuzumab 3002.13 NC2501B1b Ann. M/6 HSC/61 2018 117 1906205-76-2
iladatuzumab vedotin iladatuzumab védotine 3002.13 NC2501B1b Ann. M/6 HSC/61 2018 117 1906205-77-3
ilaprazole ilaprazole 2933.39 NC0730B2 Ann. M/6 HSC/31 2003 86 172152-36-2
ilepatril ilépatril 2933.79 NC1178B1c Ann. O/5 HSC/39 2007 95 473289-62-2
HSC/18 (2934.90)
ilepcimide ilepcimide 2939.79 NC2803Bc Ann. T/10 HSC/67 2021 70 82857-82-7
HSC/53 (2934.99)
ilginatinib ilginatinib 2933.39 NC2626B1b Ann. O/6 HSC/63 2019 119 1239358-86-1
ilixadencel ilixadencel 3002.51 NC2803Bc Ann. T/4 HSC/67 2021 116 no mention HSC/61 (3002.90)
ilmetropium iodide iodure d'ilmétropium 2939.79 NC2373B1b Ann. O/7 HSC/59 2017 115 129109-88-2
ilodecakin ilodécakine 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 81 149824-15-7 HSC/25 (3002.10)
ilofotase alfa ilofotase alfa 3507.90 NC2930Bc Ann. P/25 HSC/69 2022 124 2387636-92-0
ilomastat ilomastat 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 73 142880-36-2 HSC/18 (2933.90)
ilonidap ilonidap 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 70 135202-79-8 HSC/18 (2934.90)
iloprost iloprost 2918.19 38.100 Ann. Q (No. 351) HSC/11 1993 48 73873-87-7
ilorasertib ilorasertib 2934.99 NC2004B1b Ann. O/4 HSC/53 2014 108 1227939-82-3
iltamiocel iltamiocel 3002.51 NC2930Bc Ann. P/25 HSC/69 2022 124 no mention
ilunocitinib ilunocitinib 2935.90 NC2930Bc Ann. P/27 HSC/69 2022 125 1187594-14-4
imagabalin imagabaline 2922.49 NC1604B1b Ann. N/5 HSC/46 2010 101 610300-07-7

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
imalumab imalumab 3002.13 NC2237B1b Ann. T/13 HSC/57 2016 111 1430205-07-4 HSC/55 (3002.10)
imaprelimab imaprélimab 3002.13 NC2626B1b Ann. O/5 HSC/63 2019 118 2014343-04-3
imaradenant imaradénant 2933.69 NC2803Bc Ann. T/6 HSC/67 2021 122 1321514-06-0
imarikiren imarikirène 2934.99 NC2501B1b Ann. M/5 HSC/61 2018 116 1202265-63-1
imatinib imatinib 2933.59 NC0590B2 Ann. L/15 HSC/29 2002 84 152459-95-5
imazodan imazodan 2933.29 38.100 Ann. Q (No. 352) HSC/11 1993 55 84243-58-3
imdevimab imdévimab 3002.13 NC2803Bc Ann. T/11 HSC/67 2021
124 COVID-19
2415933-40-1
imeglimin iméglimine 2933.69 NC1443B1b Ann. P/5 HSC/43 2009 98 775351-65-0
imepitoin imépitoïne 2934.99 NC1310B1b Ann. N/10 HSC/41 2008 96 188116-07-6
imetelstat imételstat 2934.99 NC1604B1b Ann. N/5 HSC/46 2010 101 868169-64-6
imgatuzumab imgatuzumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 107 959963-46-3 HSC/51 (3002.10)
imidafenacin imidafénacine 2933.29 NC0938B2b Ann. O/3 (I) HSC/35 2005 90 170105-16-5
imidaprilat imidaprilate 2933.29 40.600 Ann. D, par. 6 HSC/18 1996 71 89371-44-8
imifoplatin imifoplatine 2843.90 NC2803Bc Ann. T/3 HSC/67 2021 121 1339960-28-9
imiglitazar imiglitazar 2934.99 NC0938B2b Ann. O/3 (II) HSC/35 2005 91 250601-04-8
imiglucerase imiglucérase 3507.90 40.600 Ann. D, par. 6 HSC/18 1996 72 154248-97-2
imirestat imirestat 2933.21 38.100 Ann. Q (No. 353) HSC/11 1993 59 89391-50-4
imisopasem manganese imisopasem manganèse 2933.39 NC1310B1b Ann. N/3 HSC/41 2008 95 218791-21-0
imitrodast imitrodast 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 70 114686-12-3 HSC/18 (2934.90)
imlatoclax imlatoclax 2935.90 NC2373B1b Ann. O/7 HSC/59 2017 115 1257050-45-5
imlifidase imlifidase 3507.90 NC2501B1b Ann. M/6 HSC/61 2018 117 1947415-68-0
imnopitant imnopitant 2933.59 NC2803Bc Ann. T/3 HSC/67 2021 121 290297-57-3
implitapide implitapide 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 82 177469-96-4 HSC/27 (2933.90)
imsidolimab imsidolimab 3002.13 NC2930Bc Ann. P/25 HSC/69 2022 124 2102543-86-0
inakalant inakalant 2934.99 NC1178B1c Ann. O/5 HSC/39 2007 95 335619-18-6
inarigivir soproxil inarigivir soproxil 2934.99 NC2501B1b Ann. M/5 HSC/61 2018 116 942123-43-5
inavolisib inavolisib 2934.99 NC2803Bc Ann. T/6 HSC/67 2021 122 2060571-02-8
inaxaplin inaxapline 2933.79 NC2930Bc Ann. P/27 HSC/69 2022 125 2446816-88-0
inbakicept inbakicept 3002.13 NC2803Bc Ann. T/2 HSC/67 2021 120 2135939-52-3
HSC/18 (2931.00)
incadronic acid acide incadronique 2931.49 NC2803Bc Ann. T/4 HSC/67 2021 70 124351-85-5
HSC/59 (2931.39)
inclacumab inclacumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 106 1256258-86-2 HSC/51 (3002.10)
inclisiran inclisiran 2934.99 NC2373B1b Ann. O/6 HSC/59 2017 115 1639324-58-5 (List 114)
incyclinide incyclinide 2924.29 NC1178B1c Ann. O/3 HSC/39 2007 94 15866-90-7
indacaterol indacaterol 2933.79 NC0938B2b Ann. O/3 (II) HSC/35 2005 91 312753-06-3
indalpine indalpine 2933.39 38.100 Ann. Q (No. 354) HSC/11 1993 41 63758-79-2
indanidine indanidine 2933.29 38.100 Ann. Q (No. 355) HSC/11 1993 50 85392-79-6
indantadol indantadol 2924.29 NC1178B1c Ann. O/3 HSC/39 2007 94 202844-10-8
indatuximab ravtansine indatuximab ravtansine 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 105 1238517-16-2 HSC/49 (3002.10)

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
indeglitazar indéglitazar 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 100 835619-41-5 HSC/44 (2935.00)
indenolol indénolol 2922.19 40.260 Ann. L/2 (No. 80) HSC/17 1996 37 60607-68-3
indibulin indibuline 2933.39 NC0938B2b Ann. O/3 (II) HSC/35 2005 91 204205-90-3
indimilast indimilast 2934.10 NC2237B1b Ann. S/8 HSC/57 2016 112 1038825-85-2
indinavir indinavir 2933.59 42.100 Ann. O (III) HSC/21 1998 74 150378-17-9
indiplon indiplon 2934.99 NC0730B2 Ann. M/7 HSC/31 2003 87 325715-02-4
indisetron indisétron 2933.59 42.100 Ann. O (V) HSC/21 1998 76 141549-75-9
indisulam indisulam 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 86 165668-41-7 HSC/31 (2935.00)
indolidan indolidan 2933.79 38.100 Ann. Q (No. 356) HSC/11 1993 57 100643-96-7
indoprofen indoprofène 2933.79 38.100 Ann. Q (No. 357) HSC/11 1993 32 31842-01-0
indoramin indoramine 2933.39 38.100 Ann. Q (No. 358) HSC/11 1993 25 26844-12-2
indoximod indoximod 2933.99 NC2116B1b Ann. R/5 HSC/55 2015 111 110117-83-4
HSC/57 (3002.10)
indusatumab indusatumab 3002.13 NC2237B1b Ann. T/10 HSC/57 2016 112 1497400-26-6
(S/8)
HSC/57 (3002.10)
indusatumab vedotin indusatumab védotine 3002.13 NC2237B1b Ann. T/10 HSC/57 2013 112 1514889-12-3
(S/8)
HSC/57 (3002.10)
inebilizumab inébilizumab 3002.13 NC2237B1b Ann. T/11 HSC/57 2013 113 1299440-37-1
(S/9)
inecalcitol inécalcitol 2906.19 NC0938B2b Ann. O/1 HSC/35 2005 87 163217-09-2
inetagugene geperpavec inétagugène géperpavec 3002.49 NC2930Bc Ann. P/25 HSC/69 2022 124 2374924-65-7
infigratinib infigratinib 2933.59 NC2237B1b Ann. S/8 HSC/57 2016 112 872511-34-7
infliximab infliximab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 77 170277-31-3 HSC/21 (3002.10)
ingenol disoxate disoxate d'ingénol 2934.99 NC2237B1b Ann. S/9 HSC/57 2016 113 1383547-60-1
ingenol mebutate mébutate d'ingénol 2916.19 NC1553B1b Ann. O/7 HSC/45 2010 100 75567-37-2
ingliforib ingliforib 2933.99 NC0590B2 Ann. L/15 HSC/29 2002 85 186392-65-4
iniparib iniparib 2924.29 NC1649B3b Ann. R/14 HSC/47 2011 103 160003-66-7
inlezifigene civaparvovec inlezifigène civaparvovec 3002.49 NC2930Bc Ann. P/33 HSC/69 2022 120 2143578-31-6 HSC/67 (3002.90)
inobrodib inobrodib 2934.99 NC2930Bc Ann. P/27 HSC/69 2022 125 2222941-37-7
inocoterone inocotérone 2937.90 NC2004B1b Ann. O/6 HSC/53 2014 54 83646-97-3 HSC/11 (2937.99)
inodiftagene vixteplasmid inodiftagène vixteplasmide 2934.99 NC2803Bc Ann. T/2 HSC/67 2021 120 2166100-08-7
inogatran inogatran 2933.39 40.600 Ann. D, par. 6 HSC/18 1996 72 155415-08-0
inolimomab inolimomab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 71 152981-31-2 HSC/18 (3002.10)
inolitazone inolitazone 2934.10 NC1443B1b Ann. P/6 HSC/43 2009 99 223132-37-4
inositol inositol 2906.13 NC2501B1b Ann. M/5 HSC/61 2018 116 87-89-8
inotersen inotersen 2934.99 NC2373B1b Ann. O/7 HSC/59 2017 115 1492984-65-2
inotuzumab ozogamicin inotuzumab ozogamicine 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 92 635715-01-4 HSC/37 (3002.10)
insulin argine insuline argine 2937.19 NC2004B1b Ann. O/6 HSC/53 2014 58 68859-20-1 HSC/11 (2937.99)
insulin aspart insuline asparte 2937.19 NC2004B1b Ann. O/6 HSC/53 2014 76 116094-23-6 HSC/21 (2937.99)
insulin degludec insuline dégludec 2937.19 NC1649B3b Ann. R/12 HSC/47 2011 101 844439-96-9

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
HSC/25 (2934.90)
insulin detemir insuline detemir 2937.19 NC2116B1b Ann. R/7 HSC/55 2015 80 169148-63-4
HSC/53 (2934.99)
insulin glargine insuline glargine 2937.19 NC2004B1b Ann. O/6 HSC/53 2014 76 160337-95-1 HSC/21 (2937.99)
insulin glulisine insuline glulisine 2937.19 NC0730B2 Ann. M/4 HSC/31 2003 84 207748-29-6
insulin icodec insuline icodec 2937.19 NC2803Bc Ann. T/7 HSC/67 2021 123 1188379-43-2
HSC/21 (2934.90)
insulin lispro insuline lispro 2937.19 NC2116B1b Ann. R/7 HSC/55 2015 72 133107-64-9
HSC/53 (2934.99)
insulin peglispro insulin péglispro 2937.19 NC1874B1b Ann. O/2 HSC/51 2013 107 1200440-65-8
insulin sudelidec insuline sudélidec 2937.19 NC2930Bc Ann. P/27 HSC/69 2022 125 2415174-82-0
insulin tregopil insuline trégopil 2937.19 NC1649B3b Ann. R/14 HSC/47 2011 103 874442-57-6
insuline efsitora alfa insuline efsitora alfa 2937.19 NC2803Bc Ann. T/6 HSC/67 2021 122 2131038-11-2
intedanib intédanib 2933.79 NC1649B3b Ann. R/13 HSC/47 2011 102 656247-17-5
intepirdine intépirdine 2933.59 NC2373B1b Ann. O/6 HSC/59 2017 114 607742-69-8
interferon alfacon-1 interféron alfacon-1 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 77 118390-30-0 HSC/21 (3002.10)
intetumumab intétumumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 101 725735-28-4 HSC/46 (3002.10)
intiquinatine intiquinatine 2933.49 NC1310B1b Ann. N/4 HSC/41 2008 99 445041-75-8
inupadenant inupadénant 2934.99 NC2803Bc Ann. T/7 HSC/67 2021 123 2246607-08-7
invimestrocel invimestrocel 3002.51 NC2803Bc Ann. T/7 HSC/67 2021 123 no mention
iocanlidic acid acide iocanlidique (123I) 2844.43 NC2803Bc Ann. T/4 HSC/67 2021 77 74855-17-7 HSC/21 (2844.40)
iodine (124I) evuzamitide iodine (124I) évuzamitide 2844.43 NC2930Bc Ann. P/27 HSC/69 2022 125 2420475-06-3
iodine (124I) girentuximab girentuximab iodé (124I) 2844.43 NC2803Bc Ann. T/4 HSC/67 2021 101 1011710-99-8 HSC/46 (2844.40)
iodine (131I) apamistamab iodine (131I) apamistamab 2844.43 NC2803Bc Ann. T/4 HSC/67 2021 119 2097132-02-8 HSC/63 (2844.40)
iodine (131I) derlotuximab
iodine ( I) derlotuximab biotin
131
2844.43 NC2803Bc Ann. T/4 HSC/67 2021 113 340013-96-9 HSC/57 (2844.40)
biotine
iodofiltic acid (123I) acide iodofiltique (123 I) 2844.43 NC2803Bc Ann. T/4 HSC/67 2021 95 123748-56-1 HSC/39 (2844.40)
iodophthalein sodium iodophtaléine sodique 2918.99 NC2373B1b Ann. O/12 HSC/59 2017 1 2217-44-9 HSC/11 (2918.90)
ioflubenzamide (131I) ioflubenzamide (131I) 2844.43 NC2803Bc Ann. T/4 HSC/67 2021 103 1214283-52-9 HSC/47 (2844.40)
ioflupane (123I) ioflupane (123I) 2844.43 NC2803Bc Ann. T/4 HSC/67 2021 75 155798-07-5 HSC/24 (2844.40)
iofolastat (123I) iofolastat (123I) 2844.43 NC2803Bc Ann. T/4 HSC/67 2021 105 949575-24-0 HSC/49 (2844.40)
ioforminol ioforminol 2924.29 NC1649B3b Ann. R/14 HSC/47 2011 103 1095110-48-7
iolopride (123I) iolopride (123I) 2844.43 NC2803Bc Ann. T/4 HSC/67 2021 73 113716-48-6 HSC/18 (2844.40)
iometopane (123I) iométopane (123I) 2844.43 NC2803Bc Ann. T/4 HSC/67 2021 76 136794-86-0 HSC/21 (2844.40)
iosimenol iosiménol 2924.29 NC0845B2 Ann. M/2 HSC/33 2004 88 181872-90-2
ipafricept ipafricept 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 109 1391727-24-4 HSC/53 (3002.10)
ipamorelin ipamoréline 2937.19 NC1649B3b Ann. R/10 HSC/47 2011 78 170851-70-4
iparomlimab iparomlimab 3002.13 NC2930Bc Ann. P/27 HSC/69 2022 125 2417649-33-1
ipatasertib ipatasertib 2933.59 NC2004B1b Ann. O/4 HSC/53 2014 108 1001264-89-6
ipazilide ipazilide 2933.19 38.100 Ann. Q (No. 362) HSC/11 1993 62 115436-73-2
ipenoxazone ipénoxazone 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 71 104454-71-9 HSC/18 (2934.90)
ipidacrine ipidacrine 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 73 62732-44-9 HSC/18 (2933.90)

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
ipilimumab ipilimumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 94 477202-00-9 HSC/38 (3002.10)
ipivivint ipivivint 2933.39 NC2803Bc Ann. T/7 HSC/67 2021 123 1481617-15-5
ipragliflozin ipragliflozine 2934.99 NC1649B3b Ann. R/14 HSC/47 2011 103 761423-87-4
ipragratine ipragratine 2933.39 38.100 Ann. Q (No. 363) HSC/11 1993 35 22150-28-3
HSC/11 (2939.90)
ipratropium bromide bromure d'ipratropium 2939.79 NC2237B1b Ann. T/12 HSC/57 2016 31 22254-24-6
HSC/53 (2939.99)
ipravacaine ipravacaïne 2933.39 NC0590B2 Ann. L/15 HSC/29 2002 85 166181-63-1
iproxamine iproxamine 2922.19 40.260 Ann. L/2 (No. 81) HSC/17 1996 34 52403-19-7
ipsapirone ipsapirone 2934.20 38.760 Ann. D, par. 34 HSC/13 1994 54 95847-70-4
iptacopan iptacopan 2933.39 NC2803Bc Ann. T/6 HSC/67 2021 122 1644670-37-0
iralukast iralukast 2932.99 40.600 Ann. D, par. 6 HSC/18 1996 70 151581-24-7
irampanel irampanel 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 82 206260-33-5 HSC/27 (2934.90)
iratumumab iratumumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 94 640735-09-7 HSC/38 (3002.10)
irbesartan irbésartan 2933.29 40.600 Ann. D, par. 6 HSC/18 1996 71 138402-11-6
irbinitinib irbinitinib 2934.99 NC2116B1b Ann. R/5 HSC/55 2015 111 937263-43-9
irdabisant irdabisant 2933.99 NC1760B1b Ann. N/8 HSC/49 2012 105 1005402-19-6
HSC/16 (2939.90)
irinotecan irinotécan 2939.79 NC2116B1b Ann. S/1 HSC/55 2015 64 97682-44-5
HSC/53 (2939.99)
irofulven irofulvène 2914.40 NC0430B2 Ann. Q/1 (I) HSC/27 2001 82 158440-71-2
iroplact iroplact 3002.12 NC2116B1b Ann. S/2 HSC/55 2015 74 154248-96-1 HSC/21 (3002.10)
irosustat irosustat 2932.20 NC1760B1b Ann. N/7 HSC/49 2012 104 288628-05-7
iroxanadine iroxanadine 2934.99 NC0730B2 Ann. M/7 HSC/31 2003 87 276690-58-5
irsenontrine irsénontrine 2934.99 NC2930Bc Ann. P/27 HSC/69 2022 125 1429509-82-9
irtemazole irtémazole 2933.29 38.100 Ann. Q (No. 366) HSC/11 1993 60 115574-30-6
isalmadol isalmadol 2922.50 NC1059B2b Ann. O/4 HSC/37 2006 92 269079-62-1
isamoltan isamoltan 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 58 116861-00-8 HSC/11 (2933.90)
isaralgagene civaparvovec isaralgagène civaparvovec 3002.49 NC2930Bc Ann. P/25 HSC/69 2022 124 2378601-29-5
isatoribine isatoribine 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 83 122970-40-5 HSC/27 (2934.90)
HSC/57 (3002.10)
isatuximab isatuximab 3002.13 NC2237B1b Ann. T/10 HSC/57 2016 112 1461640-62-9
(S/8)
isavuconazole isavuconazole 2934.10 NC1310B1b Ann. N/10 HSC/41 2008 96 241479-67-4
isavuconazonium chloride chlorure d'isavuconazonium 2934.10 NC1310B1b Ann. N/10 HSC/41 2008 96 338990-84-4
isbufylline isbufylline 2939.59 NC2004B1b Ann. O/6 HSC/53 2014 62 90162-60-0 HSC/11 (2939.50)
iscalimab iscalimab 3002.13 NC2626B1b Ann. O/5 HSC/63 2019 118 2031153-61-2
isecarosmab isécarosmab 3002.13 NC2803Bc Ann. T/6 HSC/67 2021 122 2254082-79-4
iseganan iséganan 2934.99 NC0590B2 Ann. L/15 HSC/29 2002 85 257277-05-7
isepamicin isépamicine 2941.90 38.100 Ann. Q (No. 369) HSC/11 1993 54 58152-03-7
islatravir islatravir 2934.99 NC2803Bc Ann. T/2 HSC/67 2021 120 865363-93-5
ismomultin alfa ismomultine alfa 2934.99 NC0938B2b Ann. O/3 (II) HSC/35 2005 91 457913-93-8

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
isoetarine isoétarine 2922.50 38.100 Ann. Q (No. 370) HSC/11 1993 13 530-08-5
isoflupredone isofluprédone 2937.22 38.100 Ann. Q (No. 371) HSC/11 1993 36 338-95-4
isometamidium chloride chlorure d'isométamidium 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 18 34301-55-8 HSC/11 (2933.90)
isomethadone isométhadone 2922.39 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 1 466-40-0
isophane insulin isophane insuline 3003.31 38.100 Ann. Q (No. 373) HSC/11 1993 4 8052-74-2
isoprednidene isoprednidène 2937.29 42.100 Ann. O (I) HSC/21 1998 24 17332-61-5
isoprenaline isoprénaline 2922.50 38.100 Ann. Q (No. 374) HSC/11 1993 1 7683-59-2
isosorbide isosorbide 2932.99 NC2004B1b Ann. O/6 HSC/53 2014 61 652-67-5 HSC/11 (2932.90)
isosulpride isosulpride 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 36 42792-26-7 HSC/11 (2935.00)
ispinesib ispinesib 2933.59 NC1059B2b Ann. O/4 HSC/37 2006 92 336113-53-2
ispronicline ispronicline 2933.39 NC1059B2b Ann. O/5 HSC/37 2006 93 252870-53-4
israpafant israpafant 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 76 117279-73-9 HSC/21 (2934.90)
istaroxime istaroxime 2928.00 NC1059B2b Ann. O/5 HSC/37 2006 93 203737-93-3
istiratumab istiratumab 3002.13 NC2501B1b Ann. M/6 HSC/61 2018 117 1509928-04-4
HSC/57 (3002.10)
isunakinra isunakinra 3002.13 NC2237B1b Ann.T/11 HSC/57 2016 113 1357527-05-9
(S/9)
isuzinaxib isuzinaxib 2933.39 NC2930Bc Ann. P/25 HSC/69 2022 124 1270084-92-8
itacitinib itacitinib 2933.59 NC2373B1b Ann. O/7 HSC/59 2017 115 1334298-90-6
itacnosertib itacnosertib 2933.59 NC2803Bc Ann. T/6 HSC/67 2021 122 1628870-27-8
itameline itaméline 2933.39 40.600 Ann. D, par. 6 HSC/18 1996 71 121750-57-0
itanapraced itanapraced 2916.39 NC2501B1b Ann. M/5 HSC/61 2018 116 749269-83-8
itepekimab itépékimab 3002.13 NC2803Bc Ann. T/6 HSC/67 2021 122 2226742-52-3
itezocabtagene autoleucel itézocabtagène autoleucel 3002.51 NC2930Bc Ann. P/27 HSC/69 2022 125 no mention
itolizumab itolizumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 103 1116433-11-4 HSC/47 (3002.10)
itriglumide itriglumide 2933.39 NC0430B2 Ann. Q/1 (I) HSC/27 2001 82 201605-51-8
itrocainide itrocaïnide 2933.49 NC2004B1b Ann. O/6 HSC/53 2014 54 90828-99-2 HSC/11 (2933.40)
iturelix iturélix 2933.39 NC0090B2 Ann. M/1 (II) HSC/23 1999 79 112568-12-4
ivabradine ivabradine 2933.79 42.100 Ann. O (IV) HSC/21 1998 75 155974-00-8
ivacaftor ivacaftor 2933.49 NC1760B1b Ann. N/7 HSC/49 2012 104 873054-44-5
ivaltinostat ivaltinostat 2928.00 NC2803Bc Ann. T/3 HSC/67 2021 121 936221-33-9
ivermectin ivermectine 2932.20 NC2004B1b Ann. O/6 HSC/53 2014 43 70288-86-7 HSC/41 (2932.29)
ivicentamab ivicentamab 3002.13 NC2930Bc Ann. P/27 HSC/69 2022 125 2364496-42-2
ivonescimab ivonescimab 3002.13 NC2930Bc Ann. P/27 HSC/69 2022 125 2428381-53-5
ivoqualine ivoqualine 2933.49 NC2004B1b Ann. O/6 HSC/53 2014 52 72714-75-1 HSC/11 (2933.40)
ivosidenib ivosidénib 2933.79 NC2373B1b Ann. O/6 HSC/59 2017 114 1448347-49-6
ivospemin ivospémine 2922.19 NC2930Bc Ann. P/27 HSC/69 2022 125 748119-79-1
ivuxolimab ivuxolimab 3002.13 NC2803Bc Ann. T/3 HSC/67 2021 121 2128729-41-7
ixabepilone ixabépilone 2941.90 NC1059B2b Ann. O/3 HSC/37 2006 89 219989-84-1
ixazomib ixazomib 2931.90 NC2373B1b Ann. O/12 HSC/59 2017 104 1072833-77-2 HSC/49 (2931.00)

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
ixekizumab ixékizumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 105 1143503-69-8 HSC/49 (3002.10)
izaflortaucipir (18F) izaflortaucipir (18F) 2844.43 NC2803Bc Ann. T/6 HSC/67 2021 122 2173353-61-0
izencitinib izencitinib 2933.39 NC2803Bc Ann. T/3 HSC/67 2021 121 2051918-33-1
izokibep izokibep 2933.99 NC2803Bc Ann. T/6 HSC/67 2021 122 2226130-02-3
izonsteride izonstéride 2934.20 NC0250B2 Ann. P/1 (II) HSC/25 2000 81 176975-26-1
izuralimab izuralimab 3002.13 NC2803Bc Ann. T/7 HSC/67 2021 123 2329669-80-7
josamycin josamycine 2941.90 38.100 Ann. Q (No. 380) HSC/11 1993 23 16846-24-5
kalafungin kalafungine 2941.90 38.100 Ann. Q (No. 381) HSC/11 1993 20 11048-15-0
kallidinogenase kallidinogénase 3507.90 38.100 Ann. Q (No. 382) HSC/11 1993 22 9001-01-8
kanamycin kanamycine 2941.90 38.100 Ann. Q (No. 383) HSC/11 1993 10 59-01-8
keliximab kéliximab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 76 174722-30-6 HSC/21 (3002.10)
keracyanin kéracyanine 2938.90 38.100 Ann. Q (No. 384) HSC/11 1993 31 18719-76-1
ketanserin kétansérine 2933.59 38.100 Ann. Q (No. 385) HSC/11 1993 46 74050-98-9
ketazocine kétazocine 2933.39 38.100 Ann. Q (No. 386) HSC/11 1993 34 36292-69-0
ketazolam kétazolam 2934.91 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 26 27223-35-4
ketobemidone cétobémidone 2933.33 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 1 469-79-4
ketocaine kétocaïne 2922.19 40.260 Ann. L/2 (No. 82) HSC/17 1996 15 1092-46-2
ketocainol kétocaïnol 2922.19 40.260 Ann. L/2 (No. 83) HSC/17 1996 32 7488-92-8
ketorfanol kétorfanol 2933.49 NC2004B1b Ann. O/6 HSC/53 2014 49 79798-39-3 HSC/11 (2933.40)
ketotrexate kétotrexate 2933.59 38.100 Ann. Q (No. 388) HSC/11 1993 50 52196-22-2
khelloside khelloside 2938.90 38.100 Ann. Q (No. 389) HSC/11 1993 8 17226-75-4
kitasamycin kitasamycine 2941.90 38.100 Ann. Q (No. 390) HSC/11 1993 13 1392-21-8
labetuzumab labetuzumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 85 219649-07-7 HSC/29 (3002.10)
HSC/57 (3002.10)
labetuzumab govitecan labétuzumab govitécan 3002.13 NC2237B1b Ann. T/11 HSC/57 2016 113 1469876-18-3
(S/9)
labradimil labradimil 2937.19 NC0730B2 Ann. M/4 HSC/31 2003 83 159768-75-9
labuvirtide labuvirtide 2933.29 NC2930Bc Ann. P/25 HSC/69 2022 124 2395796-76-4
lacnotuzumab lacnotuzumab 3002.13 NC2501B1b Ann. M/5 HSC/61 2018 116 1831128-32-5
lacosamide lacosamide 2924.29 NC0590B2 Ann. L/15 HSC/29 2002 90 175481-36-4
lactalfate lactalfate 2940.00 38.100 Ann. Q (No. 391) HSC/11 1993 53 96427-12-2
lacutamab lacutamab 3002.13 NC2803Bc Ann. T/2 HSC/67 2021 120 2187368-16-5 List 121 change
ladarixin ladarixine 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 105 849776-05-2 HSC/49 (2935.00)
lademirsen lademirsen 2934.99 NC2803Bc Ann. T/2 HSC/67 2021 120 1404019-95-9
ladiratuzumab ladiratuzumab 3002.13 NC2501B1b Ann. M/6 HSC/61 2018 117 1629760-28-6
ladiratuzumab vedotin ladiratuzumab védotine 3002.13 NC2501B1b Ann. M/6 HSC/61 2018 117 1629760-29-7
ladirubicin ladirubicine 2941.90 NC0430B2 Ann. Q/1 (II) HSC/27 2001 83 171047-47-5
laduviglusib laduviglusib 2933.59 NC2803Bc Ann. T/7 HSC/67 2021 123 252917-06-9
laflunimus laflunimus 2926.90 40.600 Ann. D, par. 6 HSC/18 1996 70 147076-36-6
lafutidine lafutidine 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 70 118288-08-7 HSC/18 (2934.90)

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
lagatide lagatide 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 75 157476-77-2 HSC/21 (2933.90)
lagociclovir lagociclovir 2934.99 NC1649B3b Ann. R/12 HSC/47 2011 101 92562-88-4
laidlomycin laidlomycine 2941.90 38.100 Ann. Q (No. 392) HSC/11 1993 61 56283-74-0
lalikinogene sifuplasmid lalikinogène sifuplasmide 2934.99 NC2930Bc Ann. P/27 HSC/69 2022 125 2418030-84-7
lamifiban lamifiban 2933.39 40.600 Ann. D, par. 6 HSC/18 1996 72 144412-49-7
lampalizumab lampalizumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 107 1278466-20-8 HSC/51 (3002.10)
lamtidine lamtidine 2933.39 38.100 Ann. Q (No. 393) HSC/11 1993 48 73278-54-3
lanabecestat lanabécestat 2933.39 NC2501B1b Ann. M/5 HSC/61 2018 116 1383982-64-6
lanacogene vosiparvovec lanacogène vosiparvovec 3002.49 NC2930Bc Ann. P/33 HSC/69 2022 117 1939139-26-0 HSC/61 (3002.90)
lanadelumab lanadélumab 3002.13 NC2373B1b Ann. O/6 HSC/59 2017 114 1426055-14-2
lancovutide lancovutide 2934.99 NC1443B1b Ann. P/6 HSC/43 2009 99 1391-36-2
landiolol landiolol 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 75 133242-30-5 HSC/21 (2934.90)
landipirdine landipirdine 2930.90 NC2501B1b Ann. M/5 HSC/61 2018 116 1000308-25-7
HSC/57 (3002.10)
landogrozumab landogrozumab 3002.13 NC2237B1b Ann. T/11 HSC/57 2016 113 1391726-30-9
(S/9)
lanepitant lanépitant 2933.39 42.100 Ann. O (VI) HSC/21 1998 77 170566-84-4
lanicemine lanicémine 2933.39 NC0430B2 Ann. Q/1 (I) HSC/27 2001 82 153322-05-5
lanifibranor lanifibranor 2935.90 NC2501B1b Ann. M/5 HSC/61 2018 116 927961-18-0
lanimostim lanimostim 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 91 117276-75-2 HSC/47 (3002.10)
laninamivir laninamivir 2932.99 NC1500B1b Ann. K/6 HSC/44 2009 100 203120-17-6
laniquidar laniquidar 2933.49 NC0590B2 Ann. L/15 HSC/29 2002 85 197509-46-9
lanopepden lanopepdène 2934.99 NC2237B1b Ann. S/8 HSC/57 2016 112 1152107-25-9
lanoteplase lanotéplase 3507.90 NC0090B2 Ann. M/1 (III) HSC/23 1999 76 171870-23-8
lanperisone lanpérisone 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 72 116287-14-0 HSC/18 (2933.90)
lanproston lanprostone 2932.99 40.600 Ann. D, par. 6 HSC/18 1996 72 105674-77-9
lanraplenib lanraplénib 2934.99 NC2626B1b Ann. O/5 HSC/63 2019 118 1800046-95-0
lapaquistat lapaquistat 2934.99 NC1178B1c Ann. O/5 HSC/39 2007 95 189059-71-0
lapisteride lapistéride 2933.79 NC0730B2 Ann. M/4 (III) HSC/31 2003 85 142139-60-4
laprafylline laprafylline 2939.59 NC2004B1b Ann. O/6 HSC/53 2014 60 90749-32-9 HSC/11 (2939.50)
lapretolimod laprétolimod 2932.99 NC2803Bc Ann. T/2 HSC/67 2021 120 960324-04-3
laprituximab laprituximab 3002.13 NC2373B1b Ann. O/6 HSC/59 2017 114 1622327-38-1
laprituximab emtansine laprituximab emtansine 3002.13 NC2373B1b Ann. O/6 HSC/59 2017 114 1622327-37-0
laquinimod laquinimod 2933.79 NC0590B2 Ann. L/15 HSC/29 2002 85 248281-84-7
larazotide larazotide 2933.99 NC1553B1b Ann. O/4 HSC/45 2010 99 258818-34-7
larcaviximab larcaviximab 3002.13 NC2501B1b Ann. M/5 HSC/61 2018 116 1792982-56-9
laromustine laromustine 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 98 173424-77-6 HSC/43 (2935.00)
laronidase laronidase 3507.90 NC0590B2 Ann. L/15 HSC/29 2002 85 210589-09-6
laropiprant laropiprant 2933.99 NC1310B1b Ann. N/4 HSC/41 2008 97 571170-77-9
larotaxel larotaxel 2932.99 NC1178B1c Ann. O/3 HSC/39 2007 94 156294-36-9

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
larotrectinib larotrectinib 2933.59 NC2373B1b Ann. O/7 HSC/59 2017 115 1223403-58-4
lasalocid lasalocide 2941.90 38.100 Ann. Q (No. 395) HSC/11 1993 30 25999-31-9
lascufloxacin lascufloxacine 2933.49 NC2237B1b Ann. S/8 HSC/57 2016 112 848416-07-9
lasinavir lasinavir 2924.29 42.100 Ann. O (V) HSC/21 1998 76 175385-62-3
lasmiditan lasmiditan 2933.39 NC1604B1b Ann. N/6 HSC/46 2010 102 439239-90-4
lasofoxifene lasofoxifène 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 81 180916-16-9 HSC/25 (2933.90)
latamoxef latamoxef 2941.90 38.100 Ann. Q (No. 396) HSC/11 1993 46 64952-97-2
latanoprostene bunod latanoprostène bunod 2937.50 NC1874B1b Ann. O/2 HSC/51 2013 107 860005-21-6
latidectin latidectine 2941.90 NC0845B2 Ann. M/2 HSC/33 2004 88 371918-51-3
latozinemab latozinémab 3002.13 NC2930Bc Ann. P/25 HSC/69 2022 124 2376132-27-1
latrepirdine latrépirdine 2933.39 NC1604B1b Ann. N/6 HSC/46 2010 102 3613-73-8
latromotide latromotide 3002.41 NC2803Bc Ann. T/4 HSC/67 2021 107 1049674-65-8 HSC/51 (3002.20)
laurcetium bromide bromure de laurcétium 2923.90 40.600 Ann. D, par. 6 HSC/18 1996 70 1794-75-8
lauroguadine lauroguadine 2925.29 NC2004B1b Ann. O/6 HSC/53 2014 29 135-43-3 HSC/11 (2925.20)
lauromacrogol 400 lauromacrogol 400 3402.42 NC2803Bc Ann. T/4 HSC/67 2021 90 9002-92-0 HSC/11 (3402.13)
lavamilast lavamilast 2934.99 NC2237B1b Ann. S/8 HSC/57 2016 112 1218778-89-2
lavoltidine lavoltidine 2933.39 38.100 Ann. Q (No. 399) HSC/11 1993 61 76956-02-0
lazertinib lazertinib 2934.99 NC2501B1b Ann. M/6 HSC/61 2018 117 1903008-80-9
lazucirnon lazucirnon 2933.79 NC2803Bc Ann. T/7 HSC/67 2021 123 1251528-23-0
lazuvapagon lazuvapagon 2933.19 NC2803Bc Ann. T/6 HSC/67 2021 122 2379889-71-9
lebrikizumab lébrikizumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 101 953400-68-5 HSC/46 (3002.10)
lecanemab lécanémab 3002.13 NC2803Bc Ann. T/6 HSC/67 2021 122 1260393-98-3
lecimibide lécimibide 2933.29 40.600 Ann. D, par. 6 HSC/18 1996 70 130804-35-2
leconotide léconotide 2934.99 NC0730B2 Ann. M/6 HSC/31 2003 86 247207-64-3
lecozotan lecozotan 2934.99 NC1059B2b Ann. O/5 HSC/37 2006 93 434283-16-6
ledaborbactam lédaborbactam 2934.99 NC2930Bc Ann. P/27 HSC/69 2022 125 1842397-36-7
ledaborbactam etzadroxil lédaborbactam étzadroxil 2934.99 NC2930Bc Ann. P/27 HSC/69 2022 125 1842399-68-1
ledelabricin alfa lédélabricine alfa 3504.00 NC2930Bc Ann. P/28 HSC/69 2022 122/1242252176-75-1
ledipasvir ledipasvir 2933.39 NC2004B1b Ann. O/5 HSC/53 2014 109 1256388-51-8
ledismase lédismase 3507.90 40.600 Ann. D, par. 6 HSC/18 1996 70 149394-67-2
ledoxantrone ledoxantrone 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 76 113457-05-9 HSC/21 (2934.90)
lefamulin léfamuline 2941.90 NC2116B1b Ann. R/4 HSC/55 2015 110 1061337-51-6
lefetamine léfétamine 2921.46 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 30 7262-75-1
lefitolimod léfitolimod 2934.99 NC2237B1b Ann. S/9 HSC/57 2016 113 1548439-51-5
leflutrozole leflutrozole 2933.99 NC2501B1b Ann. M/6 HSC/61 2018 117 143030-47-1
lefradafiban léfradafiban 2933.79 42.100 Ann. O (IV) HSC/21 1998 75 149503-79-7
lemalesomab lémalésomab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 84 250242-54-7 HSC/29 (3002.10)
lemborexant lemborexant 2933.59 NC2116B1b Ann. R/5 HSC/55 2015 111 1369764-02-2
lemidosul lémidosul 2930.90 38.100 Ann. Q (No. 400) HSC/11 1993 52 88041-40-1

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
lemoxinol lémoxinol 3824.99 NC2116B1b Ann. S/1 HSC/55 2015 70 no mention HSC/18 (3824.90)
lemuteporfin lémutéporfine 2933.99 NC0938B2b Ann. O/3 (II) HSC/35 2005 91 215808-49-4
lemzoparlimab lemzoparlimab 3002.13 NC2930Bc Ann. P/25 HSC/69 2022 124 2377483-71-9
lenabasum lénabasum 2932.99 NC2626B1b Ann. O/5 HSC/63 2019 118 137945-48-3
lenacapavir lénacapavir 2935.90 NC2803Bc Ann. T/3 HSC/67 2021 121 2189684-44-2
lenadogene nolparvovec lénadogène nolparvovec 3002.49 NC2930Bc Ann. P/33 HSC/69 2022 114 1640969-63-6 HSC/59 (3002.90)
lenalidomide lénalidomide 2933.79 NC0938B2b Ann. O/3 (II) HSC/35 2005 91 191732-72-6
lenampicillin lénampicilline 2941.10 38.100 Ann. Q (No. 401) HSC/11 1993 50 86273-18-9
lenapenem lénapénem 2941.90 40.600 Ann. D, par. 6 HSC/18 1996 73 149951-16-6
lenercept lénercept 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 72 156679-34-4 HSC/18 (3002.10)
leniolisib léniolisib 2933.59 NC2373B1b Ann. O/6 HSC/59 2017 114 1354690-24-6
lenomorelin lénomoréline 2937.19 NC1760B1b Ann. N/8 HSC/49 2012 105 258279-04-8
lenrispodun lenrispodun 2933.59 NC2930Bc Ann. P/25 HSC/69 2022 124 1160521-50-5
lensiprazine lensiprazine 2934.99 NC1443B1b Ann. P/6 HSC/43 2009 99 327026-93-7
lenvatinib lenvatinib 2933.49 NC1760B1b Ann. N/7 HSC/49 2012 104 417716-92-8
lenvervimab lenvervimab 3002.13 NC2626B1b Ann. O/5 HSC/63 2019 118 2055006-79-4
lenzilumab lenzilumab 3002.13 NC2237B1b Ann. T/13 HSC/57 2016 111 1229575-09-0 HSC/55 (3002.10)
lenzumestrocel lenzumestrocel 3002.51 NC2803Bc Ann. T/4 HSC/67 2021 119 no mention HSC/63 (3002.90)
lepirudin lépirudine 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 73 138068-37-8 HSC/18 (2934.90)
lepunafusp alfa lépunafusp alfa 3002.13 NC2930Bc Ann. P/27 HSC/69 2022 125 2396411-71-3
lerapolturev lérapolturev 3002.49 NC2930Bc Ann. P/27 HSC/69 2022 125 2430048-02-3
lerdelimumab lerdelimumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 83 285985-06-0 HSC/27 (3002.10)
leridistim leridistim 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 80 193700-51-5 HSC/47 (3002.10)
leriglitazone lériglitazone 2934.10 NC2626B1b Ann. O/6 HSC/63 2019 119 146062-44-4
lerimazoline lérimazoline 2933.29 NC2116B1b Ann. R/4 HSC/55 2015 110 54765-26-3
lerociclib lérociclib 2933.59 NC2803Bc Ann. T/2 HSC/67 2021 120 1628256-23-4
lerodalcibep lérodalcibep 2934.99 NC2803Bc Ann. T/7 HSC/67 2021 123 2250073-78-8
leronlimab léronlimab 3002.13 NC2626B1b Ann. O/5 HSC/63 2019 118 674782-26-4
lersivirine lersivirine 2933.19 NC1604B1b Ann. N/5 HSC/46 2010 101 473921-12-9
lesinidase alfa lésinidase alfa 3507.90 NC2501B1b Ann. M/5 HSC/61 2018 116 1522433-40-4
lesinurad lésinurad 2933.99 NC1760B1b Ann. N/8 HSC/49 2012 105 878672-00-5
lesofavumab lésofavumab 3002.13 NC2501B1b Ann. M/5 HSC/61 2018 116 1807960-57-1
HSC/44 (2931.00)
lesogaberan lésogabéran 2931.59 NC2803Bc Ann. T/4 HSC/67 2021 100 344413-67-8
HSC/59 (2931.39)
lestaurtinib lestaurtinib 2934.99 NC0938B2b Ann. O/3 (II) HSC/35 2005 91 111358-88-4
letaplimab létaplimab 3002.13 NC2803Bc Ann. T/7 HSC/67 2021 123 2283356-07-8
letaxaban létaxaban 2933.59 NC1760B1b Ann. N/7 HSC/49 2012 104 870262-90-1
leteprinim létéprinim 2933.59 NC0090B2 Ann. M/5 HSC/23 1999 80 138117-50-7
letermovir létermovir 2933.59 NC1760B1b Ann. N/7 HSC/49 2012 104 917389-32-3

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
letetresgene autoleucel letetresgéne autoleucel 3002.51 NC2803Bc Ann. T/3 HSC/67 2021 121 no mention
letolizumab létolizumab 3002.13 NC2501B1b Ann. M/5 HSC/61 2018 116 1450981-87-9
letrozole létrozole 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 70 112809-51-5 HSC/18 (2933.90)
leuprorelin leuproréline 2937.19 NC2004B1b Ann. O/6 HSC/53 2014 47 53714-56-0 HSC/11 (2937.99)
levacetylmethadol lévacétylméthadol 2922.19 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 27 34433-66-4
levallorphan lévallorphane 2933.49 NC2004B1b Ann. O/6 HSC/53 2014 2 152-02-3 HSC/11 (2933.40)
levamfetamine lévamfétamine 2921.46 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 12 156-34-3
levamlodipine lévamlodipine 2933.39 NC1310B1b Ann. N/4 HSC/41 2008 97 103129-82-4
levilimab lévilimab 3002.13 NC2803Bc Ann. T/2 HSC/67 2021 120 2035008-70-7
levisoprenaline lévisoprénaline 2922.50 38.100 Ann. Q (No. 404) HSC/11 1993 10 51-31-0
HSC/27 (2921.49)
levmetamfetamine levmétamfétamine 2939.45 NC2803Bc Ann. T/4 HSC/67 2021 83 33817-09-3
HSC/63 (2939.71)
levobetaxolol lévobétaxolol 2922.19 40.260 Ann. L/2 (No. 84) HSC/17 1996 61 93221-48-8
levobunolol lévobunolol 2922.19 40.260 Ann. L/2 (No. 85) HSC/17 1996 42 47141-42-4
levobupivacaine lévobupivacaïne 2933.39 42.100 Ann. O (III) HSC/21 1998 74 27262-47-1
levocetirizine lévocétirizine 2933.59 42.750 Ann. O HSC/22 1998 78 130018-77-8
levodopa lévodopa 2922.50 38.100 Ann. Q (No. 405) HSC/11 1993 21 59-92-7
levoglucose lévoglucose 1702.30 NC1760B1b Ann. N/7 HSC/49 2012 104 921-60-8
levoketoconazole lévokétoconazole 2934.99 NC2373B1b Ann. O/6 HSC/59 2017 114 142128-57-2
levolansoprazole lévolansoprazole 2933.39 NC1059B2b Ann. O/5 HSC/37 2006 93 138530-95-7
levomefolic acid acide lévoméfolique 2936.29 NC1443B1b Ann. P/6 HSC/43 2009 99 31690-09-2
levomequitazine lévoméquitazine 2934.30 NC1649B3b Ann. R/12 HSC/47 2011 101 88598-74-7
levomethorphan lévométhorphane 2933.49 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 1 125-70-2
levomilnacipran lévomilnaciprane 2924.29 NC1443B1b Ann. P/6 HSC/43 2009 99 96847-55-1
levomoprolol lévomoprolol 2922.19 40.260 Ann. L/2 (No. 86) HSC/17 1996 58 77164-20-6
levomoramide lévomoramide 2934.99 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 6 5666-11-5
levonadifloxacin lévonadifloxacine 2933.39 NC1178B1c Ann. O/5 HSC/39 2007 95 154357-42-3
levonebivolol lévonébivolol 2932.99 NC1443B1b Ann. P/5 HSC/43 2009 98 118457-16-2
levonorgestrel lévonorgestrel 2937.23 NC2004B1b Ann. O/6 HSC/53 2014 33 797-63-7 HSC/11 (2937.92)
levophenacylmorphan lévophénacylmorphane 2933.49 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 9 10061-32-2
levopropoxyphene lévopropoxyphène 2922.19 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 7 2338-37-6
levopropylhexedrine lévopropylhexédrine 2921.30 38.100 Ann. Q (No. 409) HSC/11 1993 37 6192-97-8
levormeloxifene lévorméloxifène 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 73 78994-23-7 HSC/18 (2934.90)
levorphanol lévorphanol 2933.41 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 4 77-07-6
levosalbutamol lévosalbutamol 2922.50 42.750 Ann. O HSC/22 1998 78 34391-04-3
levosemotiadil lévosémotiadil 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 72 116476-16-5 HSC/18 (2934.90)
levosulpiride lévosulpiride 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 63 23672-07-3 HSC/11 (2935.00)
levotofisopam levotofisopam 2933.99 NC1004B1b Ann. L/11 HSC/36 2005 92 82059-51-6
lexacalcitol lexacalcitol 2909.49 42.100 Ann. O (VII) HSC/21 1998 71 131875-08-6

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
lexanersen lexanersen 2934.99 NC2930Bc Ann. P/27 HSC/69 2022 125 2073015-40-2
lexanopadol lexanopadol 2934.99 NC2004B1b Ann. O/5 HSC/53 2014 109 1357348-09-4
lexaptepid pegol lexaptépid pégol 3907.29 NC2803Bc Ann. T/4 HSC/67 2021 108 1390631-57-8 HSC/53 (3907.20)
lexatumumab lexatumumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 95 845816-02-6 HSC/39 (3002.10)
lexibulin lexibuline 2933.59 NC1760B1b Ann. N/8 HSC/49 2012 105 917111-44-5
lexipafant lexipafant 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 70 139133-26-9 HSC/18 (2935.00)
liafensine liafensine 2933.49 NC2004B1b Ann. O/5 HSC/53 2014 109 1198790-53-2
liatermin liatermine 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 81 188630-14-0 HSC/25 (2934.90)
libenzapril libenzapril 2933.79 38.100 Ann. Q (No. 412) HSC/11 1993 58 97878-35-8
libivirumab libivirumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 91 569658-79-3 HSC/35 (3002.10)
libvatrep libvatrep 2933.59 NC2930Bc Ann. P/25 HSC/69 2022 124 871814-52-7
licaminlimab licaminlimab 3002.13 NC2930Bc Ann. P/25 HSC/69 2022 124 1688648-13-6
licarbazepine licarbazépine 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 81 29331-92-8 HSC/25 (2933.90)
licofelone licofélone 2933.99 NC0730B2 Ann. M/6 HSC/31 2003 86 156897-06-2
licogliflozin licogliflozine 2932.99 NC2626B1b Ann. O/5 HSC/63 2019 118 1291094-73-9
licostinel licostinel 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 77 153504-81-5 HSC/21 (2933.90)
HSC/29 (2931.00)
lidadronic acid acide lidadronique 2931.49 NC2803Bc Ann. T/4 HSC/67 2021 84 63132-38-7
HSC/59 (2931.39)
lidamidine lidamidine 2925.29 NC2004B1b Ann. O/6 HSC/53 2014 41 66871-56-5 HSC/11 (2925.20)
lidorestat lidorestat 2934.20 NC0730B2 Ann. M/7 HSC/31 2003 87 245116-90-9
lifastuzumab vedotin lifastuzumab védotine 3002.13 NC2237B1b Ann. T/13 HSC/57 2016 110 1401812-88-1 HSC/55 (3002.10)
lifibrol lifibrol 2918.99 NC2373B1b Ann. O/12 HSC/59 2017 62 96609-16-4 HSC/11 (2918.90)
lificiguat lificiguat 2934.99 NC1178B1c Ann. O/5 HSC/39 2007 95 170632-47-0
lifileucel lifileucel 3002.51 NC2803Bc Ann. T/4 HSC/67 2021 118 no mention HSC/63 (3002.90)
lifirafenib lifirafénib 2934.99 NC2501B1b Ann. M/6 HSC/61 2018 117 1446090-79-4
lifitegrast lifitegrast 2934.99 NC1874B1b Ann. O/2 HSC/51 2013 107 1025967-78-5
ligelizumab ligelizumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 107 1322627-61-1 HSC/51 (3002.10)
ligufalimab ligufalimab 3002.13 NC2930Bc Ann. P/27 HSC/69 2022 125 2428381-55-7
lilopristone lilopristone 2922.50 38.100 Ann. Q (No. 415) HSC/11 1993 54 97747-88-1
HSC/57 (3002.10)
lilotomab lilotomab 3002.13 NC2237B1b Ann. T/10 HSC/57 2016 112 1453362-55-4
(S/8)
limiglidole limiglidole 2933.99 NC1500B1b Ann. K/6 HSC/44 2009 100 64644-54-8
linaclotide linaclotide 3002.49 NC2803Bc Ann. T/9 HSC/67 2021 96 851199-59-2 HSC/43 (3002.90)
linagliptin linagliptine 2933.59 NC1443B1b Ann. P/6 HSC/43 2009 99 668270-12-0
linaprazan linaprazan 2933.99 NC1004B1b Ann. L/11 HSC/36 2005 92 248919-64-4
linerixibat linérixibat 2934.99 NC2626B1b Ann. O/5 HSC/63 2019 118 1345982-69-5
linetastine linétastine 2933.39 42.100 Ann. O (III) HSC/21 1998 74 159776-68-8
linezolid linézolide 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 76 165800-03-3 HSC/21 (2934.90)
linifanib linifanib 2933.99 NC1604B1b Ann. N/6 HSC/46 2010 102 796967-16-3

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
linopristin linopristine 2941.90 NC1553B1b Ann. O/3 HSC/45 2010 98 325965-23-9
linperlisib linperlisib 2935.90 NC2803Bc Ann. T/3 HSC/67 2021 121 1702816-75-8
linrodostat linrodostat 2933.49 NC2626B1b Ann. O/6 HSC/63 2019 119 1923833-60-6
linsitinib linsitinib 2933.49 NC1760B1b Ann. N/7 HSC/49 2012 104 867160-71-2
lintitript lintitript 2934.10 42.100 Ann. O (III) HSC/21 1998 74 136381-85-6
lintuzumab lintuzumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 76 166089-32-3 HSC/21 (3002.10)
linzagolix linzagolix 2934.99 NC2626B1b Ann. O/5 HSC/63 2019 118 935283-04-8
liothyronine liothyronine 2937.90 NC2004B1b Ann. O/6 HSC/53 2014 6 1823692 HSC/11 (2937.99)
lipegfilgrastim lipegfilgrastim 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 105 1117844-87-7 HSC/49 (3002.10)
liraglutide liraglutide 2937.19 NC0845B2 Ann. M/1 (II) HSC/33 2004 87 204656-20-2
lirametostat liramétostat 2933.79 NC2803Bc Ann. T/7 HSC/67 2021 123 1621862-70-1
lirentelimab lirentélimab 3002.13 NC2930Bc Ann. P/25 HSC/69 2022 124 2283348-97-8
lirequinil liréquinil 2933.79 40.600 Ann. D, par. 6 HSC/18 1996 72 143943-73-1
lirexapride lirexapride 2933.39 42.100 Ann. O (III) HSC/21 1998 74 145414-12-6
lirilumab lirilumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 107 1000676-41-4 HSC/51 (3002.10)
lirimilast lirimilast 2932.99 NC0590B2 Ann. L/15 HSC/29 2002 85 329306-27-6
lisadimate lisadimate 2922.49 40.260 Ann. L/2 (No. 87) HSC/17 1996 63 136-44-7
lisaftoclax lisaftoclax 2935.90 NC2930Bc Ann. P/27 HSC/69 2022 125 2180923-05-9
lisavanbulin lisavanbuline 2934.99 NC2373B1b Ann. O/7 HSC/59 2017 115 1263384-43-5
lisdexamfetamine lisdexamphétamine 2924.29 NC1178B1c Ann. O/3 HSC/39 2007 94 608137-32-2
lisocabtagene maraleucel lisocabtagène maraleucel 3002.51 NC2803Bc Ann. T/4 HSC/67 2021 119 no mention HSC/63 (3002.90)
lisofylline lisofylline 2939.59 NC2004B1b Ann. O/6 HSC/53 2014 72 100324-81-0 HSC/18 (2939.50)
lisuride lisuride 2939.69 NC2004B1b Ann. O/6 HSC/53 2014 25 18016-80-3 HSC/11 (2939.60)
litenimod liténimod 2934.99 NC1310B1b Ann. N/10 HSC/41 2008 96 852313-25-8
litomeglovir litoméglovir 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 84 321915-31-5 HSC/29 (2935.00)
litronesib litronésib 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 101 910634-41-2 HSC/46 (2935.00)
livaraparin calcium livaraparin calcium 3001.90 NC1553B1b Ann. O/5 HSC/45 2010 85 no mention
lividomycin lividomycine 2941.90 38.100 Ann. Q (No. 419) HSC/11 1993 32 36441-41-5
livmoniplimab livmoniplimab 3002.13 NC2930Bc Ann. P/27 HSC/69 2022 125 2412004-88-5
livoletide livolétide 2937.19 NC2626B1b Ann. O/5 HSC/63 2019 118 1088543-62-7
lixadesiran lixadésiran 2934.99 NC2930Bc Ann. P/27 HSC/69 2022 125 1152798-49-6
lixazinone lixazinone 2933.59 38.100 Ann. Q (No. 420) HSC/11 1993 57 94192-59-3
lixisenatide lixisénatide 2937.19 NC1760B1b Ann. N/3 HSC/49 2012 99 320367-13-3
lixivaptan lixivaptan 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 83 168079-32-1 HSC/27 (2933.90)
lobeglitazone lobéglitazone 2934.10 NC1178B1c Ann. O/5 HSC/39 2007 95 607723-33-1
HSC/11 (2939.90)
lobeline lobéline 2939.79 NC2116B1b Ann. S/1 HSC/55 2015 4 90-69-7
HSC/53 (2939.99)
lobucavir lobucavir 2933.59 40.600 Ann. D, par. 6 HSC/18 1996 72 127759-89-1
locnartecan locnartécan 2939.79 NC2930Bc Ann. P/25 HSC/69 2022 124 1472614-83-7

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
lodapolimab lodapolimab 3002.13 NC2803Bc Ann. T/3 HSC/67 2021 121 2118349-31-6
lodelcizumab lodelcizumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 108 1355338-54-3 HSC/53 (3002.10)
lodenafil carbonate carbonate de lodenafil 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 94 398507-55-6 HSC/39 (2935.00)
lodenosine lodénosine 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 78 110143-10-7 HSC/22 (2934.90)
lodoxamide lodoxamide 2926.90 38.100 Ann. Q (No. 422) HSC/11 1993 38 53882-12-5
HSC/57 (3002.10)
lokivetmab lokivetmab 3002.13 NC2237B1b Ann. T/10 HSC/57 2016 112 1533403-95-0
(S/8)
lomardexamfetamine lomardexamfétamine 2925.29 NC2803Bc Ann. T/3 HSC/67 2021 121 1032291-80-7
lometraline lométraline 2922.29 38.100 Ann. Q (No. 423) HSC/11 1993 28 39951-65-0
lometrexol lométrexol 2933.59 38.100 Ann. Q (No. 424) HSC/11 1993 63 106400-81-1
lomevactone lomévactone 2932.20 NC2004B1b Ann. O/6 HSC/53 2014 48 81478-25-3 HSC/11 (2932.29)
lomibuvir lomibuvir 2934.99 NC1874B1b Ann. O/2 HSC/51 2013 107 1026785-55-6
lomifylline lomifylline 2939.59 NC2004B1b Ann. O/6 HSC/53 2014 37 10226-54-7 HSC/11 (2939.50)
lomitapide lomitapide 2933.39 NC1604B1b Ann. N/5 HSC/46 2010 101 182431-12-5
lomtegovimab lomtégovimab 3002.13 NC2930Bc Ann. P/27 HSC/69 2022 125 2550869-33-3
lonafarnib lonafarnib 2933.39 NC0730B2 Ann. M/6 HSC/31 2003 86 193275-84-2
lonapalene lonapalène 2915.39 38.100 Ann. Q (No. 427) HSC/11 1993 55 91431-42-4
lonapegsomatropin lonapegsomatropine 2937.11 NC2501B1b Ann. M/6 HSC/61 2018 117 1934255-39-6
lonaprisan lonaprisan 2937.29 NC1377E1b Ann. G/17 HSC/42 2008 97 211254-73-8
loncastuximab loncastuximab 3002.13 NC2501B1b Ann. M/6 HSC/61 2018 117 1875032-68-0
loncastuximab tesirine loncastuximab tésirine 3002.13 NC2501B1b Ann. M/6 HSC/61 2018 117 1879918-31-6
lonigutamab lonigutamab 3002.13 NC2930Bc Ann. P/25 HSC/69 2022 124 2362015-67-4
lonigutamab ugodotin lonigutamab ugodotine 3002.13 NC2930Bc Ann. P/25 HSC/69 2022 124 2363754-30-5
lonoctocog alfa lonoctocog alfa 3002.12 NC2237B1b Ann. T/13 HSC/57 2016 111 1388129-63-2 HSC/55 (3002.10)
lonodelestat lonodélestat 2933.79 NC2803Bc Ann. T/3 HSC/67 2021 121 906547-89-5
lopinavir lopinavir 2933.59 NC0090B2 Ann. M/5 HSC/23 1999 80 192725-17-0
lopobutan lopobutan 2922.50 40.600 Ann. D, par. 6 HSC/18 1996 70 6582-30-5
loprazolam loprazolam 2933.55 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 44 61197-73-7
loprodiol loprodiol 2905.59 NC2004B1b Ann. O/6 HSC/53 2014 43 2209-86-1 HSC/11 (2905.50)
loracarbef loracarbef 2941.90 38.100 Ann. Q (No. 429) HSC/11 1993 60 76470-66-1
HSC/11 (2939.90)
lorajmine lorajmine 2939.79 NC2116B1b Ann. S/1 HSC/55 2015 34 47562-08-3
HSC/53 (2939.99)
lorazepam lorazépam 2933.91 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 23 846-49-1
lorcaserin lorcasérine 2933.99 NC1178B1c Ann. O/5 HSC/39 2007 95 616202-92-7
loreclezole loréclézole 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 60 117857-45-1 HSC/11 (2933.90)
lorediplon lorédiplon 2934.99 NC1760B1b Ann. N/8 HSC/49 2012 105 917393-39-6
lorigerlimab lorigerlimab 3002.13 NC2930Bc Ann. P/27 HSC/69 2022 125 2416595-46-3
lorlatinib lorlatinib 2934.99 NC2373B1b Ann. O/6 HSC/59 2017 114 1454846-35-5
lormetazepam lormétazépam 2933.91 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 38 848-75-9

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
lorpiprazole lorpiprazole 2933.59 38.100 Ann. Q (No. 432) HSC/11 1993 60 108785-69-9
lorpucitinib lorpucitinib 2933.99 NC2803Bc Ann. T/6 HSC/67 2021 122 2230282-02-5
lorukafusp alfa lorukafusp alfa 3002.13 NC2803Bc Ann. T/2 HSC/67 2021 120 2131168-99-3
lorvotuzumab mertansine lorvotuzumab mertansine 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 103 1008106-64-6 HSC/47 (3002.10)
losatuxizumab losatuxizumab 3002.13 NC2501B1b Ann. M/5 HSC/61 2018 116 1801544-27-3
losatuxizumab vedotin losatuxizumab védotine 3002.13 NC2501B1b Ann. M/5 HSC/61 2018 116 1685249-67-5
losigamone losigamone 2932.20 NC2004B1b Ann. O/6 HSC/53 2014 61 112856-44-7 HSC/11 (2932.29)
losmapimod losmapimod 2933.39 NC1604B1b Ann. N/5 HSC/46 2010 101 585543-15-3
losmiprofen losmiprofène 2918.99 NC2373B1b Ann. O/12 HSC/59 2017 61 74168-08-4 HSC/11 (2918.90)
lotamilast lotamilast 2933.59 NC2626B1b Ann. O/5 HSC/63 2019 118 947620-48-6
lotazadromcel lotazadromcel 3002.51 NC2930Bc Ann. P/27 HSC/69 2022 125 no mention
lotilaner lotilaner 2934.99 NC2116B1b Ann. R/4 HSC/55 2015 110 1369852-71-0
lotilibcin lotilibcine 2941.90 NC1553B1b Ann. O/7 HSC/45 2010 100 169148-84-9
lotrafiban lotrafiban 2933.39 42.750 Ann. O HSC/22 1998 78 171049-14-2
loviride loviride 2924.29 40.600 Ann. D, par. 6 HSC/18 1996 70 147362-57-0
lovotibeglogene autotemcel lovotibéglogène autotemcel 3002.51 NC2930Bc Ann. P/27 HSC/69 2022 125 no mention
loxicodegol loxicodégol 2939.19 NC2501B1b Ann. M/6 HSC/61 2018 117 1211231-76-3
loxoprofen loxoprofène 2918.30 38.100 Ann. Q (No. 435) HSC/11 1993 50 68767-14-6
lozilurea lozilurée 2924.21 38.100 Ann. Q (No. 436) HSC/11 1993 44 71475-35-9
lubabegron lubabégron 2934.99 NC2004B1b Ann. O/5 HSC/53 2014 109 391920-32-4
lubazodone lubazodone 2934.99 NC0730B2 Ann. M/7 HSC/31 2003 87 161178-07-0
lubeluzole lubéluzole 2934.20 40.600 Ann. D, par. 6 HSC/18 1996 70 144665-07-6
lubiprostone lubiprostone 2937.50 NC0730B2 Ann. M/7 HSC/31 2003 87 333963-40-9
lucatumumab lucatumumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 98 903512-50-5 HSC/43 (3002.10)
lucerastat lucérastat 2933.39 NC1874B1b Ann. O/1 HSC/51 2013 106 141206-42-0
lucimycin lucimycine 2941.90 38.100 Ann. Q (No. 437) HSC/11 1993 13 13058-67-8
lucitanib lucitanib 2933.49 NC1874B1b Ann. O/2 HSC/51 2013 107 1058137-23-7
ludaterone ludatérone 2937.29 NC2803Bc Ann. T/7 HSC/67 2021 123 124548-08-9
lufepirsen lufépirsen 2934.99 NC2930Bc Ann. P/27 HSC/69 2022 125 287122-58-1
lufotrelvir lufotrelvir 2933.79 NC2930Bc Ann. P/27 HSC/69 2022 125 2468015-78-1
luliconazole luliconazole 2934.99 NC0730B2 Ann. M/6 HSC/31 2003 86 187164-19-8
lulizumab pegol lulizumab pégol 3002.13 NC2237B1b Ann. T/13 HSC/57 2016 111 1421830-13-8 HSC/55 (3002.10)
lumacaftor lumacaftor 2934.99 NC1760B1b Ann. N/8 HSC/49 2012 105 936727-05-8
lumasiran lumasiran 2934.99 NC2501B1b Ann. M/6 HSC/61 2018 117 1834610-13-7
lumateperone lumatépérone 2933.99 NC2373B1b Ann. O/6 HSC/59 2017 114 313368-91-1
lumefantrine luméfantrine 2922.19 42.100 Ann. O (VI) HSC/21 1998 77 82186-77-4
lumicitabine lumicitabine 2934.99 NC2373B1b Ann. O/7 HSC/59 2017 115 1445385-02-3
lumiliximab lumiliximab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 90 357613-86-6 HSC/35 (3002.10)
luminespib luminespib 2934.99 NC2004B1b Ann. O/4 HSC/53 2014 108 747412-49-3

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
lumiracoxib lumiracoxib 2922.49 NC0730B2 Ann. M/7 HSC/31 2003 87 220991-20-8
lumretuzumab lumrétuzumab 3002.13 NC2237B1b Ann. T/13 HSC/57 2016 111 1448327-63-6 HSC/55 (3002.10)
lunacalcipol lunacalcipol 2930.90 NC1760B1b Ann. N/5 HSC/49 2012 102 250384-82-8
lupartumab lupartumab 3002.13 NC2373B1b Ann. O/7 HSC/59 2017 115 1640971-88-5
lupartumab amadotin lupartumab amadotine 3002.13 NC2373B1b Ann. O/7 HSC/59 2017 115 1640972-00-4
lupitidine lupitidine 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 53 83903-06-4 HSC/11 (2934.90)
lurasidone lurasidone 2934.20 NC0845B2 Ann. M/2 HSC/33 2004 88 367514-87-2
lurbinectedin lurbinectédine 2939.80 NC2930Bc Ann. P/26 HSC/69 2022 105 497871-47-3 HSC/49 (2934.99)
HSC/21 (2939.90)
lurtotecan lurtotécan 2939.79 NC2116B1b Ann. S/1 HSC/55 2015 74 149882-10-0
HSC/53 (2939.99)
lusaperidone lusapéridone 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 82 214548-46-6 HSC/27 (2934.90)
luseogliflozin luséogliflozine 2934.99 NC1760B1b Ann. N/7 HSC/49 2012 104 898537-18-3
luspatercept luspatercept 3002.13 NC2237B1b Ann. T/13 HSC/57 2016 110 1373715-00-4 HSC/55 (3002.10)
lusupultide lusupultide 2933.29 NC0250B2 Ann. P/1 (I) HSC/25 2000 80 200074-80-2
lusutrombopag lusutrombopag 2934.10 NC1760B1b Ann. N/7 HSC/49 2012 104 1110766-97-6
lusvertikimab lusvertikimab 3002.13 NC2930Bc Ann. P/25 HSC/69 2022 124 2375835-91-7
lutetium (177Lu) lilotomab lutécium (177Lu) lilotomab
2844.43 NC2803Bc Ann. T/4 HSC/67 2021 112 1453362-90-7 HSC/57 (2844.40)
satetraxetan satétraxétan
lutetium (177Lu) oxodotreotide lutécium (177Lu) oxodotréotide 2844.43 NC2803Bc Ann. T/4 HSC/67 2021 116 437608-50-9 HSC/61 (2844.40)
lutetium ( Lu) vipivotide
177
lutécium ( Lu) vipivotide
177
2844.43 NC2803Bc Ann. T/7 HSC/67 2021 123 1703749-62-5
tetraxetan tétraxetan
lutetium (177Lu) zadavotide guraxetan
lutécium (177Lu) zadavotide guraxétan
2844.43 NC2930Bc Ann. P/27 HSC/69 2022 125 2447131-70-4
lutikizumab lutikizumab 3002.13 NC2373B1b Ann. O/7 HSC/59 2017 115 1791411-57-8
lutrelin lutréline 2937.19 NC2004B1b Ann. O/6 HSC/53 2014 51 66866-63-5 HSC/11 (2937.99)
lutropin alfa lutropine alfa 2937.19 NC2004B1b Ann. O/6 HSC/53 2014 71 152923-57-4 HSC/18 (2937.10)
luvadaxistat luvadaxistat 2933.99 NC2803Bc Ann. T/6 HSC/67 2021 122 1425511-32-5
luxeptinib luxeptinib 2933.79 NC2930Bc Ann. P/27 HSC/69 2022 125 1616428-23-9
lymecycline lymécycline 2941.30 38.100 Ann. Q (No. 440) HSC/11 1993 14 992-21-2
lynestrenol lynestrénol 2937.23 NC2004B1b Ann. O/6 HSC/53 2014 13 52-76-6 HSC/11 (2937.92)
lypressin lypressine 2937.19 NC2004B1b Ann. O/6 HSC/53 2014 13 50-57-7 HSC/11 (2937.99)
lysergide lysergide 2939.69 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 8 50-37-3
macimorelin macimoréline 2937.90 NC1874B1b Ann. O/3 HSC/51 2013 100 381231-18-1 HSC/45 (2937.40)
macitentan macitentan 2933.59 NC1443B1b Ann. P/6 HSC/43 2009 99 441798-33-0
macozinone macozinone 2934.99 NC2626B1b Ann. O/5 HSC/63 2019 118 1377239-83-2
macrogol ester ester de macrogol 3402.42 NC2803Bc Ann. T/4 HSC/67 2021 34 no mention HSC/25 (3402.13)
macrosalb (131 I) macrosalb (131 I) 2844.43 NC2803Bc Ann. T/4 HSC/67 2021 33 54182-63-7 HSC/11 (2844.40)
macrosalb (99m Tc) macrosalb (99m Tc) 2844.43 NC2803Bc Ann. T/4 HSC/67 2021 33 54277-47-3 HSC/11 (2844.40)
maduramicin maduramicine 2941.90 38.100 Ann. Q (No. 446) HSC/11 1993 55 84878-61-5
maftivimab maftivimab 3002.13 NC2803Bc Ann. T/2 HSC/67 2021 120 2135632-36-7

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
magaldrate magaldrate 2842.90 38.100 Ann. Q (No. 447) HSC/11 1993 49 74978-16-8
magnesium clofibrate clofibrate de magnésium 2918.99 NC2373B1b Ann. O/12 HSC/59 2017 31 14613-30-0 HSC/11 (2918.90)
magrolimab magrolimab 3002.13 NC2803Bc Ann. T/2 HSC/67 2021 120 2169232-81-7
maletamer malétamère 3911.90 38.100 Ann. Q (No. 449) HSC/11 1993 14 29535-27-1
maleylsulfathiazole maléylsulfathiazol 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 1 515-57-1 HSC/11 (2935.00)
malotilate malotilate 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 44 59937-28-9 HSC/11 (2934.90)
managlinat dialanetil managlinat dialanétil 2934.10 NC1310B1b Ann. N/10 HSC/41 2008 96 280782-97-0
manelimab manélimab 3002.13 NC2803Bc Ann. T/3 HSC/67 2021 121 2168561-26-8
manfidokimab manfidokimab 3002.13 NC2930Bc Ann. P/27 HSC/69 2022 125 2428381-56-8
mangafodipir mangafodipir 2933.39 40.600 Ann. D, par. 6 HSC/18 1996 72 155319-91-8
manifaxine manifaxine 2934.99 NC0590B2 Ann. L/15 HSC/29 2002 85 135306-39-7
manitimus manitimus 2926.90 NC1059B2b Ann. O/5 HSC/37 2006 93 202057-76-9
mannitol hexanitrate hexanitrate de mannitol 2920.90 38.100 Ann. Q (No. 452) HSC/11 1993 1 15825-70-4
mannosulfan mannosulfan 2905.49 38.100 Ann. Q (No. 453) HSC/11 1993 24 7518-35-6
manozodil manozodil 2934.20 38.100 Ann. Q (No. 454) HSC/11 1993 47 77528-67-7
mantabegron mantabégron 2922.19 NC0845B2 Ann. M/2 HSC/33 2004 88 36144-08-8
mapatumumab mapatumumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 93 658052-09-6 HSC/37 (3002.10)
mapinastine mapinastine 2933.59 40.600 Ann. D, par. 6 HSC/18 1996 72 140945-32-0
mapracorat mapracorat 2934.99 NC1649B3b Ann. R/13 HSC/47 2011 102 887375-26-0
maraciclatide maraciclatide 2934.99 NC1649B3b Ann. R/14 HSC/47 2011 103 489427-17-0
maralixibat chloride chlorure de maralixibat 2934.99 NC2237B1b Ann. S/8 HSC/57 2016 113 228113-66-4
maraviroc maraviroc 2933.39 NC0938B2b Ann. O/3 (II) HSC/35 2005 91 376348-65-1
mardepodect mardépodect 2933.49 NC2501B1b Ann. M/6 HSC/61 2018 117 898562-94-2
margetuximab margetuximab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 109 1350624-75-7 HSC/53 (3002.10)
maribavir maribavir 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 80 176161-24-3 HSC/23 (2934.90)
maridomycin maridomycine 2941.90 38.100 Ann. Q (No. 455) HSC/11 1993 32 35775-82-7
marimastat marimastat 2928.00 42.100 Ann. O (IV) HSC/21 1998 75 154039-60-8
mariptiline mariptiline 2928.00 38.100 Ann. Q (No. 456) HSC/11 1993 44 60070-14-6
marizomib marizomib 2934.99 NC1604B1b Ann. N/6 HSC/46 2010 102 437742-34-2
marnetegragene autotemcel marnétégragène autotemcel 3002.51 NC2930Bc Ann. P/27 HSC/69 2022 125 no mention
maropitant maropitant 2933.39 NC0938B2b Ann. O/3 (I) HSC/35 2005 90 147116-67-4
marstacimab marstacimab 3002.13 NC2626B1b Ann. O/6 HSC/63 2019 119 1985638-39-8
HSC/57 (3002.10)
marzeptacog alfa (activated) marzeptacog alfa (activé) 3002.13 NC2237B1b Ann. T/11 HSC/57 2016 113 160049-21-4
(S/9)
masilukast masilukast 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 94 136564-68-6 HSC/39 (2935.00)
masitinib masitinib 2934.10 NC1310B1b Ann. N/10 HSC/41 2008 96 790299-79-5
masupirdine masupirdine 2935.90 NC2626B1b Ann. O/6 HSC/63 2019 119 701205-60-9
matuzumab matuzumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 88 339186-68-4 HSC/33 (3002.10)
mavacamten mavacamten 2933.59 NC2501B1b Ann. M/5 HSC/61 2018 116 1642288-47-8

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
mavacoxib mavacoxib 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 94 170569-88-7 HSC/38 (2935.00)
mavatrep mavatrep 2933.99 NC2004B1b Ann. O/5 HSC/53 2014 109 956274-94-5
mavelertinib mavélertinib 2933.59 NC2626B1b Ann. O/5 HSC/63 2019 118 1776112-90-3
mavezelimab mavézélimab 3002.13 NC2803Bc Ann. T/3 HSC/67 2021 121 2231068-83-8
mavilimogene ralaplasmid mavilimogène ralaplasmide 2934.99 NC2626B1b Ann. O/5 HSC/63 2019 118 1977487-95-8
mavoglurant mavoglurant 2933.99 NC1760B1b Ann. N/7 HSC/49 2012 104 543906-09-8
mavorixafor mavorixafor 2933.49 NC2626B1b Ann. O/5 HSC/63 2019 118 558447-26-0
mavrilimumab mavrilimumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 102 1085337-57-0 HSC/46 (3002.10)
maxacalcitol maxacalcitol 2909.49 42.100 Ann. O (IV) HSC/21 1998 75 103909-75-7
mazapertine mazapertine 2933.59 40.600 Ann. D, par. 6 HSC/18 1996 72 134208-17-6
mazindol mazindol 2933.91 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 23 22232-71-9
mazipredone maziprédone 2937.29 38.100 Ann. Q (No. 457) HSC/11 1993 32 13085-08-0
mazokalim mazokalim 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 75 164178-54-5 HSC/21 (2934.90)
mazorelvimab mazorelvimab 3002.13 NC2930Bc Ann. P/27 HSC/69 2022 125 2419087-89-9
mebeverine mébévérine 2922.50 38.100 Ann. Q (No. 458) HSC/11 1993 14 3625-06-7
mebolazine mébolazine 2937.29 NC2004B1b Ann. O/6 HSC/53 2014 21 3625-07-8 HSC/11 (2937.99)
mebutamate mébutamate 2924.19 NC2004B1b Ann. O/6 HSC/53 2014 12 64-55-1 HSC/11 (2924.10)
mebutizide mébutizide 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 15 3568-00-1 HSC/11 (2935.00)
mecamylamine mécamylamine 2921.30 38.100 Ann. Q (No. 462) HSC/11 1993 6 60-40-2
HSC/57 (3002.10)
mecapegfilgrastim mécapegfilgrastim 3002.13 NC2237B1b Ann. T/11 HSC/57 2016 113 1570067-55-8
(S/9)
mecasermin rinfabate mecasermine rinfabate 2933.29 NC0938B2b Ann. O/3 (II) HSC/35 2005 91 478166-15-3
mecillinam mécillinam 2941.90 38.100 Ann. Q (No. 463) HSC/11 1993 32 32887-01-7
meclinertant méclinertant 2933.49 NC0730B2 Ann. M/4 (III) HSC/31 2003 88 146362-70-1
meclocycline méclocycline 2941.30 38.100 Ann. Q (No. 464) HSC/11 1993 14 2013-58-3
mecloqualone mécloqualone 2933.55 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 12 340-57-8
meclorisone méclorisone 2937.22 38.100 Ann. Q (No. 467) HSC/11 1993 40 4732-48-3
mecobalamin mécobalamine 2936.26 38.100 Ann. Q (No. 468) HSC/11 1993 26 13422-55-4
medazepam médazépam 2933.91 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 20 2898-12-6
medifoxamine médifoxamine 2922.50 40.260 Ann. L/2 (No. 88) HSC/17 1996 33 32359-34-5
medorinone médorinone 2933.79 38.100 Ann. Q (No. 470) HSC/11 1993 54 88296-61-1
medorubicin médorubicine 2941.90 38.100 Ann. Q (No. 471) HSC/11 1993 47 64314-52-9
medrogestone médrogestone 2937.23 NC2004B1b Ann. O/6 HSC/53 2014 15 977-79-7 HSC/11 (2937.92)
medroxyprogesterone médroxyprogestérone 2937.23 NC2004B1b Ann. O/6 HSC/53 2014 10 520-85-4 HSC/11 (2937.92)
medrylamine médrylamine 2922.19 40.260 Ann. L/2 (No. 89) HSC/17 1996 1 524-99-2
mefenorex méfénorex 2921.46 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 19 17243-57-1
HSC/21 (2939.90)
mefeserpine méféserpine 2939.79 NC2116B1b Ann. S/1 HSC/55 2015 15 3735-85-1
HSC/53 (2939.99)
mefruside méfruside 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 16 7195-27-9 HSC/11 (2935.00)

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
megalomicin mégalomicine 2941.90 38.100 Ann. Q (No. 476) HSC/11 1993 40 28022-11-9
megestrol mégestrol 2937.23 NC2004B1b Ann. O/6 HSC/53 2014 13 3562-63-8 HSC/11 (2937.92)
meglucycline méglucycline 2941.30 38.100 Ann. Q (No. 478) HSC/11 1993 22 31770-79-3
melagatran mélagatran 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 74 159776-70-2 HSC/21 (2933.90)
meldonium meldonium 2928.00 NC0730B2 Ann. M/6 HSC/31 2003 86 76144-81-5
melengestrol mélengestrol 2937.23 NC2004B1b Ann. O/6 HSC/53 2014 13 5633-18-1 HSC/11 (2937.92)
melevodopa mélévodopa 2922.50 NC0430B2 Ann. Q/1 (II) HSC/27 2001 83 7101-51-1
melogliptin mélogliptine 2933.99 NC1443B1b Ann. P/6 HSC/43 2009 99 868771-57-7
meloxicam méloxicam 2934.10 38.100 Ann. Q (No. 480) HSC/11 1993 52 71125-38-7
melphalan flufenamide melphalan flufénamide 2924.29 NC1760B1b Ann. N/8 HSC/49 2012 105 380449-51-4
melquinast melquinast 2933.59 38.100 Ann. Q (No. 481) HSC/11 1993 62 87611-28-7
melredableukin alfa melrédableukine alfa 3002.13 NC2930Bc Ann. P/27 HSC/69 2022 125 2056881-92-4
melrilimab melrilimab 3002.13 NC2803Bc Ann. T/7 HSC/67 2021 123 2222865-46-3
meluadrine méluadrine 2922.50 42.750 Ann. O HSC/22 1998 78 134865-33-1
menfegol menfégol 3402.42 NC2803Bc Ann. T/4 HSC/67 2021 36 57821-32-6 HSC/11 (3402.13)
menogaril ménogaril 2941.90 38.100 Ann. Q (No. 483) HSC/11 1993 51 71628-96-1
meobentine méobentine 2925.29 NC2004B1b Ann. O/6 HSC/53 2014 38 46464-11-3 HSC/11 (2925.20)
mephenytoin méphénytoïne 2933.21 38.100 Ann. Q (No. 485) HSC/11 1993 1 50-12-4
mepitiostane mépitiostane 2937.29 NC2004B1b Ann. O/6 HSC/53 2014 34 21362-69-6 HSC/11 (2937.99)
mepolizumab mépolizumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 81 196078-29-2 HSC/25 (3002.10)
mepramidil mépramidil 2922.19 40.260 Ann. L/2 (No. 90) HSC/17 1996 27 23891-60-3
meprobamate méprobamate 2924.11 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 6 57-53-4
meproscillarin méproscillarine 2938.90 38.100 Ann. Q (No. 488) HSC/11 1993 38 33396-37-1
meprylcaine méprylcaïne 2922.19 38.100 Ann. Q (No. 489) HSC/11 1993 4 495-70-5
meradimate méradimate 2922.49 NC0430B2 Ann. Q/1 (II) HSC/27 2001 83 134-09-8
meralein sodium méraléine sodique 2932.99 42.100 Ann. O (I) HSC/21 1998 13 4386-35-0
meralluride méralluride 3003.49 NC2237B1b Ann. T/12 HSC/57 2016 1 8069-64-5 HSC/11 (3003.40)
merbromin merbromine 2932.99 42.100 Ann. O (I) HSC/21 1998 1 129-16-8
mercaptomerin mercaptomérine 2930.90 42.100 Ann. O (I) HSC/21 1998 1 20223-84-1
mercumatilin sodium mercumatiline sodique 3003.49 NC2237B1b Ann. T/12 HSC/57 2016 4 60135-06-0 HSC/11 (3003.40)
mercurophylline mercurophylline 3003.49 NC2237B1b Ann. T/12 HSC/57 2016 1 8012-34-8 HSC/11 (3003.40)
merestinib mérestinib 2933.79 NC2237B1b Ann. S/9 HSC/57 2016 113 1206799-15-6
mergocriptine mergocriptine 2939.69 NC2004B1b Ann. O/6 HSC/53 2014 54 81968-16-3 HSC/11 (2939.60)
meribendan méribendan 2933.19 38.100 Ann. Q (No. 494) HSC/11 1993 62 119322-27-9
mericitabine méricitabine 2934.99 NC1760B1b Ann. N/7 HSC/49 2012 104 940908-79-2
merimepodib mérimépodib 2934.99 NC0730B2 Ann. M/7 HSC/31 2003 87 198821-22-6
merisoprol (197 Hg) mérisoprol (197 Hg) 2844.43 NC2803Bc Ann. T/4 HSC/67 2021 24 5579-94-2 HSC/11 (2844.40)
meropenem méropénem 2941.90 38.100 Ann. Q (No. 496) HSC/11 1993 60 96036-03-2
merotocin mérotocine 2937.19 NC2116B1b Ann. R/5 HSC/55 2015 111 1190083-57-8

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
mesabolone mésabolone 2937.29 NC2004B1b Ann. O/6 HSC/53 2014 29 7483-09-2 HSC/11 (2937.99)
mesdopetam mesdopétam 2930.90 NC2803Bc Ann. T/3 HSC/67 2021 121 1403894-72-3
mesmulogene ancovacivec mesmulogène ancovacivec 3002.49 NC2930Bc Ann. P/33 HSC/69 2022 114 1246525-59-6 HSC/59 (3002.90)
mesocarb mésocarb 2934.91 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 34 34262-84-5
mespiperone (11C) mespipérone (11C) 2844.43 NC2803Bc Ann. T/4 HSC/67 2021 78 94153-50-1 HSC/22 (2844.40)
mestanolone mestanolone 2937.29 NC2004B1b Ann. O/6 HSC/53 2014 10 521-11-9 HSC/11 (2937.99)
mesterolone mestérolone 2937.29 NC2004B1b Ann. O/6 HSC/53 2014 15 1424-00-6 HSC/11 (2937.99)
mestranol mestranol 2937.23 NC2004B1b Ann. O/6 HSC/53 2014 15 72-33-3 HSC/11 (2937.92)
mesulergine mésulergine 2939.69 NC2004B1b Ann. O/6 HSC/53 2014 47 64795-35-3 HSC/11 (2939.60)
mesulfamide mésulfamide 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 41 122-89-4 HSC/11 (2935.00)
mesulfen mésulfène 2934.99 NC2004B1b Ann. O/6 HSC/53 2014 1 135-58-0 HSC/11 (2934.90)
mesuprine mésuprine 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 21 7541-30-2 HSC/11 (2935.00)
mesuximide mésuximide 2925.19 38.100 Ann. Q (No. 505) HSC/11 1993 6 77-41-8
metaglycodol métaglycodol 2906.29 38.100 Ann. Q (No. 506) HSC/11 1993 12 13980-94-4
metahexamide métahexamide 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 10 565-33-3 HSC/11 (2935.00)
HSC/25 (2939.91)
metamfetamine métamfétamine 2939.45 NC2803Bc Ann. T/4 HSC/67 2021 55 537-46-2
HSC/55 (2939.71)
metaraminol métaraminol 2939.79 NC2626B1b Ann. E/2 HSC/63 2019 1 54-49-9 HSC/57 (2939.49)
metaterol métatérol 2922.50 38.100 Ann. Q (No. 510) HSC/11 1993 43 3571-71-9
metazocine métazocine 2933.39 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 9 3734-52-9
metelimumab métélimumab 3002.13 NC2116B1b Ann. S/2 HSC/55 2015 86 272780-74-2 HSC/31 (3002.10)
metenkefalin métenkéfaline 2930.90 NC1310B1b Ann. N/4 HSC/41 2008 97 58569-55-4
metenolone méténolone 2937.29 NC2004B1b Ann. O/6 HSC/53 2014 12 153-00-4 HSC/11 (2937.99)
metergoline métergoline 2939.69 42.100 Ann. O (I) HSC/21 1998 18 17692-51-2
metergotamine métergotamine 2939.69 NC2004B1b Ann. O/6 HSC/53 2014 29 22336-84-1 HSC/11 (2939.60)
metescufylline métescufylline 2939.59 NC2004B1b Ann. O/6 HSC/53 2014 15 15518-82-8 HSC/11 (2939.50)
metesculetol métesculétol 2932.20 NC2004B1b Ann. O/6 HSC/53 2014 41 52814-39-8 HSC/11 (2932.29)
metesind métésind 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 76 138384-68-6 HSC/21 (2935.00)
metformin glycinate glycinate de metformine 2925.29 NC1649B3b Ann. R/14 HSC/47 2011 103 121369-64-0
methadone méthadone 2922.31 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 1 76-99-3
methandriol méthandriol 2937.29 NC2004B1b Ann. O/6 HSC/53 2014 1 521-10-8 HSC/11 (2937.99)
methaqualone méthaqualone 2933.55 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 10 72-44-6
metharbital métharbital 2933.54 NC2004B1b Ann. O/6 HSC/53 2014 1 50-11-3 HSC/11 (2933.51)
methazolamide méthazolamide 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 10 554-57-4 HSC/11 (2935.00)
methdilazine methdilazine 2934.30 38.100 Ann. Q (No. 519) HSC/11 1993 90 1982-37-2
methiodal sodium méthiodal sodique 2904.99 NC2116B1b Ann. S/1 HSC/55 2015 1 126-31-8 HSC/11 (2904.90)
methoprene méthoprène 2918.99 NC2373B1b Ann. O/12 HSC/59 2017 60 40596-69-8 HSC/11 (2918.90)
methyldesorphine méthyldésorphine 2939.19 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 5 16008-36-9
methyldihydromorphine méthyldihydromorphine 2939.19 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 5 509-56-8

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.
 Year / List /
Product (En) Produit (Fr) Class 2022 HSC Report / CSH Rapport Session CAS No Other
Année Liste
methylergometrine méthylergométrine 2939.69 NC2004B1b Ann. O/6 HSC/53 2014 1 113-42-8 HSC/11 (2939.60)
methylnaltrexone bromide bromure de méthylnatrexone 2939.19 NC1310B1b Ann. N/10 HSC/41 2008 96 73232-52-7
methylphenidate méthylphénidate 2933.33 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 6 113-45-1
methylphenobarbital méthylphénobarbital 2933.53 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 1 115-38-8
methylrosanilinium chloride chlorure de méthylrosanilinium 3204.13 38.100 Ann. Q (No. 523) HSC/11 1993 1 548-62-9
methylsamidorphan chloride methylsamidorphan chloride 2933.49 NC2004B1b Ann. O/5 HSC/53 2014 109 1118885-67-8
methylthiouracil méthylthiouracile 2933.59 38.100 Ann. Q (No. 524) HSC/11 1993 1 56-04-2
methyprylon méthyprylone 2933.72 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 6 125-64-4
methysergide méthysergide 2939.69 NC2004B1b Ann. O/6 HSC/53 2014 11 361-37-5 HSC/11 (2939.60)
metipirox métipirox 2933.39 38.100 Ann. Q (No. 526) HSC/11 1993 26 29342-02-7
metipranolol métipranolol 2922.19 40.260 Ann. L/2 (No. 91) HSC/17 1996 38 22664-55-7
metkefamide metkéfamide 2930.90 38.100 Ann. Q (No. 527) HSC/11 1993 44 66960-34-7
metogest métogest 2937.23 NC2004B1b Ann. O/6 HSC/53 2014 33 52279-58-0 HSC/11 (2937.92)
metopon métopon 2939.19 E.N. Chap. 29 - List I-I (Narco HSC/25 2000 1 143-52-2
metoprolol métoprolol 2922.19 40.260 Ann. L/2 (No. 92) HSC/17 1996 30 37350-58-6
metoquizine métoquizine 2933.19 38.100 Ann. Q (No. 529) HSC/11 1993 17 7125-67-9
metralindole métralindole 2933.59 40.260 Ann. L/2 (No. 28) HSC/17 1996 42 54188-38-4
metreleptin métréleptine 2937.19 NC0590B2 Ann. L/10 HSC/29 2002 82 186018-45-1
metribolone métribolone 2937.29 NC2004B1b Ann. O/6 HSC/53 2014 17 965-93-5 HSC/11 (2937.99)
metynodiol métynodiol 2937.23 NC2004B1b Ann. O/6 HSC/53 2014 27 23163-42-0 HSC/11 (2937.92)
mevidalen mévidalène 2933.49 NC2930Bc Ann. P/25 HSC/69 2022 124 1638667-79-4
mevociclib mévociclib 2933.59 NC2803Bc Ann. T/3 HSC/67 2021 121 1816989-16-8
mexafylline mexafylline 2939.59 NC2004B1b Ann. O/6 HSC/53 2014 48 80294-25-3 HSC/11 (2939.50)
mexrenoate potassium mexrénoate potassique 2937.29 NC2004B1b Ann. O/6 HSC/53 2014 33 43169-54-6 HSC/11 (2937.99)
mezacopride mézacopride 2933.39 38.100 Ann. Q (No. 534) HSC/11 1993 56 89613-77-4
mezagitamab mézagitamab 3002.13 NC2803Bc Ann. T/3 HSC/67 2021 121 2227490-52-8
mezigdomide mézigdomide 2933.79 NC2930Bc Ann. P/27 HSC/69 2022 125 2259648-80-9
mezilamine mézilamine 2933.59 38.100 Ann. Q (No. 535) HSC/11 1993 36 50335-55-2
mibampator mibampator 2935.90 NC2116B1b Ann. S/1 HSC/55 2015 103 375345-95-2 HSC/47 (2935.00)
mibavademab mibavadémab 3002.13 NC2930Bc Ann. P/25 HSC/69 2022 124 2305770-44-7
mibefradil mibéfradil 2933.99 NC2004B1b Ann. O/6 HSC/53 2014 72 116644-53-2 HSC/18 (2933.90)
mibenratide mibenratide 2934.99 NC2116B1b Ann. R/5 HSC/55 2015 111 1239011-83-6
mibolerone mibolérone 2937.29 NC2004B1b Ann. O/6 HSC/53 2014 27 3704-09-4 HSC/11 (2937.99)
micafungin micafongine 2941.90 NC0730B2 Ann. M/4 HSC/31 2003 84 235114-32-6
midafotel midafotel 2933.59 NC0090B2 Ann. M/1 (II) HSC/23 1999 79 117414-74-1
midaglizole midaglizole 2933.39 38.100 Ann. Q (No. 537) HSC/11 1993 57 66529-17-7
midaxifylline midaxifylline 2939.59 NC2004B1b Ann. O/6 HSC/53 2014 79 151159-23-8 HSC/27 (2939.50)
midazolam midazolam 2933.91 E.N. Chap. 29 - List I-II (Psyc HSC/25 2000 40 59467-70-8
midomafetamine midomafétamine 2932.99 NC2501B1b Ann. M/5 HSC/61 2018 116 42542-10-9

Copyright © 2015 World Customs Organization. / Copyright © 2015 Organisation mondiale des douanes.